04 october 2012 ema/643088/2012 initial notices for ... · 04 october 2012 . ema/643088/2012 ......

255
7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7051 E-mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged. 04 October 2012 EMA/643088/2012 Patient Health Protection Initial Notices for Parallel Distribution –2011 Product name Parallel distributor Date of notification Strength Pharmaceutical dosage form Pack size EU-number Member State(s) of Origin Member State(s) of Destination Date of Notice letter Abilify 2 Care 4 27/06/2011 10 mg Orodispersible tablet 28 x 1 EU/1/04/276/025 Austria, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom Denmark 24/08/2011 Abilify 2 Care 4 27/06/2011 15 mg Orodispersible tablet 28 x 1 EU/1/04/276/028 Austria, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom Denmark 24/08/2011 Abilify Abacus Medicine A/S 28/11/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom Denmark 16/12/2011 Abilify Abacus Medicine A/S 28/11/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom Denmark 16/12/2011

Upload: letram

Post on 26-Jul-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7051 E-mail [email protected] Website www.ema.europa.eu An agency of the European Union

© European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged.

04 October 2012 EMA/643088/2012 Patient Health Protection

Initial Notices for Parallel Distribution –2011

Product name Parallel distributor

Date of notification

Strength Pharmaceutical dosage form

Pack size EU-number Member State(s) of Origin Member State(s) of Destination

Date of Notice letter

Abilify 2 Care 4 27/06/2011 10 mg Orodispersible tablet

28 x 1 EU/1/04/276/025 Austria, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/08/2011

Abilify 2 Care 4 27/06/2011 15 mg Orodispersible tablet

28 x 1 EU/1/04/276/028 Austria, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/08/2011

Abilify Abacus Medicine A/S

28/11/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/12/2011

Abilify Abacus Medicine A/S

28/11/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/12/2011

Page 2: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify ADL Pharma GmbH

18/05/2011 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/06/2011

Abilify ADL Pharma GmbH

18/05/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/06/2011

Abilify ADL Pharma GmbH

18/05/2011 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/06/2011

Abilify ADL Pharma GmbH

18/05/2011 5 mg Tablet 56 x 1 EU/1/04/276/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/06/2011

Abilify ADL Pharma GmbH

18/05/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/06/2011

Abilify Axicorp Pharma GmbH

31/03/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/04/2011

Abilify Axicorp Pharma GmbH

27/09/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/10/2011

Abilify B&S Healthcare Ltd

10/08/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper

EU/1/04/276/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/08/2011

Abilify B2B Medical GmbH

06/12/2010 10 mg Tablet 49 x 1 EU/1/04/276/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/02/2011

Abilify B2B Medical GmbH

06/12/2010 10 mg Tablet 98 x 1 EU/1/04/276/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 2/255

Page 3: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify B2B Medical GmbH

06/12/2010 15 mg Tablet 49 x 1 EU/1/04/276/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/02/2011

Abilify B2B Medical GmbH

06/12/2010 15 mg Tablet 98 x 1 EU/1/04/276/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/02/2011

Abilify B2B Medical GmbH

06/12/2010 30 mg Tablet 49 x 1 EU/1/04/276/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/02/2011

Abilify B2B Medical GmbH

06/12/2010 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/02/2011

Abilify B2B Medical GmbH

01/09/2011 10 mg Tablet 14 x 1 EU/1/04/276/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/09/2011

Abilify B2B Medical GmbH

01/09/2011 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/09/2011

Abilify B2B Medical GmbH

01/09/2011 15 mg Tablet 14 x 1 EU/1/04/276/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/09/2011

Abilify B2B Medical GmbH

01/09/2011 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/09/2011

Abilify B2B Medical GmbH

01/09/2011 30 mg Tablet 28 x 1 EU/1/04/276/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 3/255

Page 4: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify B2B Medical GmbH

01/09/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/09/2011

Abilify B2B Medical GmbH

01/09/2011 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/09/2011

Abilify B2B Medical GmbH

01/09/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/09/2011

Abilify B2B Medical GmbH

01/09/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/09/2011

Abilify BB Farma s.r.l.

04/05/2011 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/05/2011

Abilify BB Farma s.r.l.

17/05/2011 30 mg Tablet 49 x 1 EU/1/04/276/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/05/2011

Abilify BB Farma s.r.l.

18/05/2011 10 mg Tablet 14 x 1 EU/1/04/276/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/05/2011

Abilify BB Farma s.r.l.

18/05/2011 10 mg Tablet 98 x 1 EU/1/04/276/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/05/2011

Abilify BB Farma s.r.l.

18/05/2011 10 mg Tablet 49 x 1 EU/1/04/276/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 4/255

Page 5: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify BB Farma s.r.l.

01/06/2011 15 mg Tablet 14 x 1 EU/1/04/276/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/06/2011

Abilify BB Farma s.r.l.

01/06/2011 15 mg Tablet 49 x 1 EU/1/04/276/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/06/2011

Abilify BB Farma s.r.l.

01/06/2011 15 mg Tablet 98 x 1 EU/1/04/276/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/06/2011

abilify Beragena Arzneimittel GmbH

30/03/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 04/05/2011

Abilify Beragena Arzneimittel GmbH

30/03/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 11/05/2011

Abilify Beragena Arzneimittel GmbH

09/11/2011 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/11/2011

Abilify Beragena Arzneimittel GmbH

09/11/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/11/2011

Abilify Beragena Arzneimittel GmbH

09/11/2011 5 mg Tablet 56 x 1 EU/1/04/276/004 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/11/2011

Abilify BR Pharma International Ltd

25/01/2010 10 mg Tablet 49 x 1 EU/1/04/276/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/02/2011

Abilify BR Pharma International Ltd

25/01/2010 10 mg Tablet 98 x 1 EU/1/04/276/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/02/2011

Abilify BR Pharma International Ltd

10/02/2010 10 mg Tablet 14 x 1 EU/1/04/276/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 5/255

Page 6: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify BR Pharma International Ltd

21/09/2010 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Abilify BR Pharma International Ltd

21/09/2010 15 mg Tablet 14 x 1 EU/1/04/276/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Abilify BR Pharma International Ltd

21/09/2010 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Abilify BR Pharma International Ltd

21/09/2010 15 mg Tablet 49 x 1 EU/1/04/276/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Abilify BR Pharma International Ltd

21/09/2010 15 mg Tablet 98 x 1 EU/1/04/276/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Abilify BR Pharma International Ltd

21/09/2010 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Abilify BR Pharma International Ltd

21/09/2010 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Abilify BR Pharma International Ltd

21/09/2010 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Abilify BR Pharma International Ltd

21/09/2010 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 6/255

Page 7: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify BR Pharma International Ltd

21/02/2011 5 mg Tablet 56 x 1 EU/1/04/276/004 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

Abilify BR Pharma International Ltd

11/03/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

Abilify BR Pharma International Ltd

11/03/2011 15 mg Tablet 56 x 1 EU/1/04/276/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

Abilify BR Pharma International Ltd

11/03/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

Abilify ChemVet Pharma ApS

17/02/2011 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 08/03/2011

Abilify ChemVet Pharma ApS

17/02/2011 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 08/03/2011

Abilify ChemVet Pharma ApS

04/11/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/11/2011

Abilify Docpharm GmbH&CoKGaA

14/06/2011 10 mg Orodispersible tablet

14 x 1 EU/1/04/276/024 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/06/2011

Abilify Docpharm GmbH&CoKGaA

14/06/2011 10 mg Orodispersible tablet

49 x 1 EU/1/04/276/026 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/06/2011

Abilify Emra-Med 27/09/2010 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 7/255

Page 8: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify Emra-Med 27/09/2010 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/01/2011

Abilify Emra-Med 27/09/2010 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/01/2011

Abilify EuroPharma DK

08/06/2011 10 mg Tablet 14 x 1 EU/1/04/276/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/06/2011

Abilify EuroPharma DK

08/06/2011 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/06/2011

Abilify EuroPharma DK

08/06/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/06/2011

Abilify EuroPharma DK

08/06/2011 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/06/2011

Abilify EuroPharma DK

08/06/2011 15 mg Tablet 56 x 1 EU/1/04/276/014 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/06/2011

Abilify EuroPharma DK

22/07/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper

EU/1/04/276/034 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 01/08/2011

Abilify Europharma Sverige AB

16/08/2011 10 mg Orodispersible tablet

28 x 1 EU/1/04/276/025 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 01/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 8/255

Page 9: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify Europharma Sverige AB

16/08/2011 15 mg Orodispersible tablet

28 x 1 EU/1/04/276/028 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 01/09/2011

Abilify G-Pharma Ltd 22/03/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

31/03/2011

Abilify Interport Ltd 07/08/2011 10 mg Orodispersible tablet

28 x 1 EU/1/04/276/025 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands

United Kingdom

12/08/2011

Abilify Kohlpharma GmbH

07/04/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, France, Ireland, Italy, Norway, Spain, United Kingdom

Germany 19/04/2011

Abilify Kohlpharma GmbH

07/06/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Belgium, Greece, United Kingdom Germany 13/07/2011

Abilify Kohlpharma GmbH

25/08/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, France, Ireland, Italy, Spain, United Kingdom

Germany 25/08/2011

Abilify Kosei Pharma UK Limited

27/05/2011 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

21/06/2011

Abilify Medartuum AB 02/11/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 09/11/2011

Abilify Medartuum AB 24/11/2011 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 02/12/2011

Abilify Medartuum AB 24/11/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 29/11/2011

Abilify MedicoPharm AG

18/03/2011 10 mg Tablet 49 x 1 EU/1/04/276/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 9/255

Page 10: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify MedicoPharm AG

18/03/2011 10 mg Tablet 98 x 1 EU/1/04/276/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

Abilify MedicoPharm AG

18/03/2011 15 mg Tablet 49 x 1 EU/1/04/276/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

Abilify MedicoPharm AG

18/03/2011 15 mg Tablet 98 x 1 EU/1/04/276/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

Abilify MedicoPharm AG

18/03/2011 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

Abilify MedicoPharm AG

21/03/2011 10 mg Orodispersible tablet

49 x 1 EU/1/04/276/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

Abilify MedicoPharm AG

21/03/2011 15 mg Orodispersible tablet

49 x 1 EU/1/04/276/029 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

Abilify Omnia Läkemedel AB

04/03/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Sweden 08/04/2011

Abilify Omnia Läkemedel AB

07/03/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Belgium, France, Greece, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 08/04/2011

Abilify Omnia Läkemedel AB

08/06/2011 15 mg Tablet 56 x 1 EU/1/04/276/014 France, Greece, Italy, Romania, Spain, The Netherlands, United Kingdom

Sweden 11/08/2011

Abilify Orifarm AS 16/11/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper

EU/1/04/276/034 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 22/11/2011

Abilify Paranova Danmark AS

13/04/2010 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 10/255

Page 11: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Abilify Paranova Danmark AS

11/11/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper

EU/1/04/276/034 Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/11/2011

Abilify Paranova Läkemedel AB

19/08/2011 5 mg Tablet 56 x 1 EU/1/04/276/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/08/2011

Abilify Paranova Läkemedel AB

19/08/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/08/2011

Abilify Paranova Läkemedel AB

02/12/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper

EU/1/04/276/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 19/12/2011

Abilify Pharma Westen GmbH

07/04/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/04/2011

Abilify S.C. HC PHARMA STORE s.r.l.

12/09/2011 10 mg Tablet 49 x 1 EU/1/04/276/008 Romania, Spain Germany 27/10/2011

Abilify S.C. HC PHARMA STORE s.r.l.

12/09/2011 10 mg Tablet 98 x 1 EU/1/04/276/010 Romania, Spain Germany 27/10/2011

Aclasta Haemato Pharm AG

04/04/2011 5 mg/100 ml Solution for infusion

1 bottle EU/1/05/308/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 14/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 11/255

Page 12: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aclasta Medartuum AB 08/02/2011 5 mg/100 ml Solution for infusion

1 bottle EU/1/05/308/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 17/02/2011

Aclasta Omnia Läkemedel AB

06/09/2011 5 mg/100 ml Solution for infusion

1 bottle EU/1/05/308/001 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Sweden 15/09/2011

Aclasta Paranova Läkemedel AB

25/02/2011 5 mg/100 ml Solution for infusion

1 bottle EU/1/05/308/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 05/04/2011

Aclasta Veron Pharma Vertriebs GmbH

31/01/2011 5 mg/100 ml Solution for infusion

1 bottle EU/1/05/308/001 Austria, Belgium, Finland, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 03/03/2011

Actos BR Pharma International Ltd

14/12/2011 45 mg Tablet 112 EU/1/00/150/029 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/12/2011

Actos CC Pharma 25/08/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 31/08/2011

Actos CC Pharma 25/08/2011 30 mg Tablet 196 EU/1/00/150/028 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 31/08/2011

Actos Docpharm GmbH&CoKGaA

02/08/2011 15 mg Tablet 112 EU/1/00/150/025 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/08/2011

Actos Docpharm GmbH&CoKGaA

02/08/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/08/2011

Actos Docpharm GmbH&CoKGaA

02/08/2011 45 mg Tablet 112 EU/1/00/150/029 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/08/2011

Actos Docpharm GmbH&CoKGaA

28/09/2011 15 mg Tablet 196 EU/1/00/150/026 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 12/255

Page 13: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Actos Docpharm GmbH&CoKGaA

28/09/2011 30 mg Tablet 196 EU/1/00/150/028 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/10/2011

Actos Docpharm GmbH&CoKGaA

28/09/2011 45 mg Tablet 196 EU/1/00/150/030 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/10/2011

Actos Emra-Med 11/03/2011 15 mg Tablet 112 EU/1/00/150/025 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/03/2011

Actos Emra-Med 20/06/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/06/2011

Actos Emra-Med 27/10/2011 45 mg Tablet 112 EU/1/00/150/029 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/11/2011

Actos Eureco-Pharma B.V.

15/12/2010 30 mg Tablet 84 EU/1/00/150/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

31/01/2011

Actos Euro Registratie Collectief BV

08/02/2011 30 mg Tablet 84 EU/1/00/150/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/02/2011

Actos Kohlpharma GmbH

02/12/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/12/2011

Actos Medartuum AB 09/12/2011 15 mg Tablet 98 EU/1/00/150/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 15/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 13/255

Page 14: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Actos Medartuum AB 09/12/2011 45 mg Tablet 98 EU/1/00/150/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/12/2011

Actos MPT Pharma 24/01/2011 15 mg Tablet 196 EU/1/00/150/026 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/02/2011

Actos MPT Pharma 24/01/2011 15 mg Tablet 112 EU/1/00/150/025 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/02/2011

Actos MPT Pharma 24/01/2011 15 mg Tablet 98 EU/1/00/150/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/02/2011

Actos MPT Pharma 24/01/2011 15 mg Tablet 84 EU/1/00/150/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/02/2011

Actos MPT Pharma 24/01/2011 15 mg Tablet 56 EU/1/00/150/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 14/255

Page 15: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Actos MPT Pharma 24/01/2011 15 mg Tablet 28 EU/1/00/150/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/02/2011

Actos MPT Pharma 11/04/2011 15 mg Tablet 50 EU/1/00/150/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/04/2011

Actos MPT Pharma 11/04/2011 15 mg Tablet 30 EU/1/00/150/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/04/2011

Actos O.P.D. Laboratories Ltd

23/07/2001 30 mg Tablet 28 EU/1/00/150/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

12/09/2011

Actos O.P.D. Laboratories Ltd

07/06/2010 45 mg Tablet 28 EU/1/00/150/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

06/01/2011

Actos Pharma Westen GmbH

06/01/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/01/2011

Actos Pharma Westen GmbH

06/01/2011 45 mg Tablet 112 EU/1/00/150/029 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/01/2011

Actos Pharma Westen GmbH

20/01/2011 15 mg Tablet 112 EU/1/00/150/025 Austria, Belgium, Denmark, Estonia, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/01/2011

Actos Swingward Ltd TA Medihealth

13/09/2010 15 mg Tablet 98 EU/1/00/150/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands

United Kingdom

08/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 15/255

Page 16: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Actrapid CC Pharma 27/05/2011 100 IU/ml Solution for injection

5 pre-filled pens

EU/1/02/230/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/06/2011

Actrapid EuroPharma DK

24/03/2011 100 IU/ml Solution for injection

5 pre-filled pens

EU/1/02/230/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 31/03/2011

Adcirca Haemato Pharm AG

23/05/2011 20 mg Film-coated tablet 56 EU/1/08/476/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

10/06/2011

Adcirca Haemato Pharm AG

24/05/2011 20 mg Film-coated tablet 56 EU/1/08/476/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/06/2011

Adrovance Euro Registratie Collectief BV

08/02/2011 70 mg/2800 IU

Tablet 4 EU/1/06/364/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

10/03/2011

Advagraf 2 Care 4 13/05/2011 3 mg Prolonged-release capsules, hard

50 EU/1/07/387/012 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 16/05/2011

Advagraf BR Pharma International Ltd

14/09/2011 3 mg Prolonged-release capsules, hard

100 x 1 EU/1/07/387/023 Belgium Germany 28/09/2011

Advagraf BR Pharma International Ltd

14/10/2011 1 mg Prolonged-release capsules, hard

100 x 1 EU/1/07/387/020 Belgium Germany 29/11/2011

Advagraf CC Pharma 29/08/2011 3 mg Prolonged-release capsules, hard

100 x 1 EU/1/07/387/023 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/09/2011

Advagraf Euro Registratie Collectief BV

13/10/2011 1 mg Prolonged-release capsules, hard

50 EU/1/07/387/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 16/255

Page 17: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Advagraf Euro Registratie Collectief BV

24/11/2011 1 mg Prolonged-release capsules, hard

60 x 1 EU/1/07/387/019 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/12/2011

Advagraf Euro Registratie Collectief BV

24/11/2011 5 mg Prolonged-release capsules, hard

30 x 1 EU/1/07/387/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/12/2011

Advagraf Kohlpharma GmbH

01/12/2009 3 mg Prolonged-release capsules, hard

100 EU/1/07/387/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/06/2011

Advagraf Medcor Pharmaceuticals BV

08/04/2011 5 mg Prolonged-release capsules, hard

50 EU/1/07/387/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

11/04/2011

Advagraf Medcor Pharmaceuticals BV

16/08/2011 3 mg Prolonged-release capsules, hard

50 EU/1/07/387/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

17/08/2011

Advagraf NewNeopharm BV

05/05/2011 3 mg Prolonged-release capsules, hard

30 EU/1/07/387/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/05/2011

Advagraf NewNeopharm BV

05/05/2011 5 mg Prolonged-release capsules, hard

30 EU/1/07/387/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/05/2011

Advagraf Omnia Läkemedel AB

10/05/2011 0.5 mg Prolonged-release capsules, hard

50 EU/1/07/387/002 France, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 22/06/2011

Advagraf Omnia Läkemedel AB

10/05/2011 1 mg Prolonged-release capsules, hard

50 EU/1/07/387/004 France, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 22/06/2011

Advagraf Omnia Läkemedel AB

10/05/2011 3 mg Prolonged-release capsules, hard

50 EU/1/07/387/012 France, Italy, Portugal, Spain, The Netherlands, United Kingdom

Sweden 22/06/2011

Advagraf Omnia Läkemedel AB

10/05/2011 5 mg Prolonged-release capsules, hard

50 EU/1/07/387/008 France, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 22/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 17/255

Page 18: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Advagraf Orifarm AB 21/09/2011 0.5 mg Prolonged-release capsules, hard

50 EU/1/07/387/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 03/10/2011

Advagraf Orifarm AB 21/09/2011 3 mg Prolonged-release capsules, hard

50 EU/1/07/387/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 03/10/2011

Advagraf Orifarm AS 11/05/2011 0.5 mg Prolonged-release capsules, hard

50 EU/1/07/387/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/05/2011

Advagraf Paranova Läkemedel AB

14/10/2011 3 mg Prolonged-release capsules, hard

50 EU/1/07/387/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 09/12/2011

Advagraf Paranova Läkemedel AB

14/10/2011 5 mg Prolonged-release capsules, hard

50 EU/1/07/387/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 09/12/2011

Advagraf Paranova Läkemedel AB

22/11/2011 1 mg Prolonged-release capsules, hard

50 EU/1/07/387/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 09/12/2011

Aerius 2 Care 4 22/11/2010 5 mg Film-coated tablet 30 EU/1/00/160/011 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/01/2011

Aerius 2 Care 4 22/11/2010 5 mg Film-coated tablet 100 EU/1/00/160/013 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 18/255

Page 19: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aerius Cross Pharma AB

08/03/2011 5 mg Film-coated tablet 30 EU/1/00/160/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/03/2011

Aerius Cross Pharma AB

11/03/2011 5 mg Film-coated tablet 100 EU/1/00/160/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/03/2011

Aerius Cross Pharma AB

29/11/2011 5 mg Film-coated tablet 90 EU/1/00/160/036 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 05/12/2011

Aerius EU-Pharma BV 14/06/2011 5 mg Film-coated tablet 90 EU/1/00/160/036 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

27/06/2011

Aerius EU-Pharma BV 15/08/2011 0.5 mg/ml Oral solution 1 bottle EU/1/00/160/066 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

16/08/2011

Aerius Ichem SpZoo 08/11/2011 0.5 mg/ml Oral solution 1 bottle EU/1/00/160/069 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 21/12/2011

Aerius Medartuum AB 22/02/2011 5 mg Film-coated tablet 100 EU/1/00/160/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 19/255

Page 20: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aerius Paranova Läkemedel AB

25/11/2011 5 mg Film-coated tablet 30 EU/1/00/160/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/12/2011

Aerius Paranova Läkemedel AB

25/11/2011 5 mg Film-coated tablet 100 EU/1/00/160/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/12/2011

Aerius S.C. Farmastore Prest S.R.L.

04/02/2011 5 mg Film-coated tablet 10 EU/1/00/160/006 Austria, Belgium, France, Germany, Greece, Italy, Portugal, Spain, United Kingdom

Romania 22/02/2011

Afinitor Orifarm AB 23/08/2011 10 mg Tablet 30 EU/1/09/538/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/08/2011

Aldara Cross Pharma AB

17/11/2011 5% w/w Cream 12 sachets EU/1/98/080/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 16/12/2011

Alimta AXicorp Pharma GmbH

04/10/2011 500 mg Powder for concentrate for solution for infusion

1 vial EU/1/04/290/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/10/2011

Alimta mibe GmbH Arzneimittel

27/05/2011 500 mg Powder for concentrate for solution for infusion

1 vial EU/1/04/290/001 Greece Germany 16/06/2011

Alimta Orifarm OY 10/02/2011 100 mg Powder for concentrate for solution for infusion

1 vial EU/1/04/290/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 29/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 20/255

Page 21: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Alimta Orifarm OY 16/03/2011 500 mg Powder for concentrate for solution for infusion

1 vial EU/1/04/290/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 29/03/2011

Alimta Veron Pharma Vertriebs GmbH

31/03/2011 500 mg Powder for concentrate for solution for infusion

1 vial EU/1/04/290/001 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 17/06/2011

alli CC Pharma 24/05/2011 60 mg Capsule, hard 120 EU/1/07/401/011 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/06/2011

Altargo Pharmachim AB

30/05/2011 1 % Ointment 1 tube EU/1/07/390/002 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Latvia, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 10/06/2011

Angiox Orifarm AB 23/05/2011 250 mg Powder for concentrate for solution for injection or infusion

10 vials EU/1/04/289/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/05/2011

Apidra Axicorp Pharma GmbH

18/08/2011 100 Units/ml Solution for injection

5 cartridges EU/1/04/285/008 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/09/2011

Apidra Axicorp Pharma GmbH

18/08/2011 100 Units/ml Solution for injection

10 cartridges

EU/1/04/285/012 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/09/2011

Apidra CC Pharma 26/11/2010 100 Units/ml Solution for injection

5 cartridges EU/1/04/285/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/01/2011

Apidra CC Pharma 07/12/2010 100 Units/ml Solution for injection

10 cartridges

EU/1/04/285/012 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/01/2011

Apidra CC Pharma 13/10/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/016 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 21/255

Page 22: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Apidra CC Pharma 13/10/2011 100 Units/ml Solution for injection

10 pre-filled pens

EU/1/04/285/020 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/11/2011

Apidra Dr Fisher Farma BV

01/06/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/06/2011

Apidra Emra-Med 19/01/2010 100 Units/ml Solution for injection

5 vials EU/1/04/285/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/03/2011

Apidra Eureco-Pharma B.V.

03/01/2011 100 Units/ml Solution for injection

5 cartridges EU/1/04/285/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/02/2011

Apidra Euro Registratie Collectief BV

07/06/2011 100 Units/ml Solution for injection

5 cartridges EU/1/04/285/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

27/06/2011

Apidra Kohlpharma GmbH

25/10/2010 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/032 Austria, Belgium, France, Greece, Italy, Norway, United Kingdom

Germany 25/01/2011

Apidra Kohlpharma GmbH

25/10/2010 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/016 Austria, Greece, Italy Germany 25/01/2011

Apidra Kohlpharma GmbH

25/10/2010 100 Units/ml Solution for injection

10 pre-filled pens

EU/1/04/285/020 Austria, Greece, Italy Germany 25/01/2011

Apidra Kohlpharma GmbH

25/10/2010 100 Units/ml Solution for injection

5 cartridges EU/1/04/285/008 Austria, France, Greece, Italy, Romania Germany 25/01/2011

Apidra Kohlpharma GmbH

25/10/2010 100 Units/ml Solution for injection

10 cartridges

EU/1/04/285/012 Austria, France, Greece, Italy, Romania Germany 25/01/2011

Apidra Orifarm AB 02/02/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 03/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 22/255

Page 23: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Apidra (SoloStar) Beragena Arzneimittel GmbH

19/04/2011 100 Units/ml Solution for injection

10 pre-filled pens

EU/1/04/285/036 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 10/05/2011

Apidra (SoloStar) Beragena Arzneimittel GmbH

19/04/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/032 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 10/05/2011

Apidra Optiset Emra-Med 10/12/2010 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/02/2011

Apidra Optiset Emra-Med 10/12/2010 100 Units/ml Solution for injection

10 pre-filled pens

EU/1/04/285/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/02/2011

Apidra SoloStar Axicorp Pharma GmbH

18/08/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/032 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/09/2011

Apidra SoloStar Axicorp Pharma GmbH

18/08/2011 100 Units/ml Solution for injection

10 pre-filled pens

EU/1/04/285/036 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/09/2011

Apidra Solostar CC Pharma 26/11/2010 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/04/285/032 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/01/2011

Apidra Solostar CC Pharma 07/12/2010 100 Units/ml Solution for injection

10 pre-filled pens

EU/1/04/285/036 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/01/2011

Apidra Solostar Kohlpharma GmbH

25/10/2010 100 Units/ml Solution for injection

10 pre-filled pens

EU/1/04/285/036 Austria, Belgium, France, Greece, Italy, Norway, United Kingdom

Germany 25/01/2011

Aprovel CC Pharma 21/12/2010 75 mg Film-coated tablet 28 EU/1/97/046/017 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/01/2011

Aprovel CC Pharma 21/12/2010 75 mg Film-coated tablet 56 EU/1/97/046/018 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 23/255

Page 24: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aprovel CC Pharma 22/12/2010 75 mg Film-coated tablet 98 EU/1/97/046/020 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/01/2011

Aprovel CC Pharma 17/02/2011 300 mg Film-coated tablet 56 EU/1/97/046/028 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 24/03/2011

Aprovel EU-Pharma BV 03/05/2011 150 mg Film-coated tablet 28 EU/1/97/046/022 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

10/05/2011

Aprovel EU-Pharma BV 17/05/2011 150 mg Tablet 28 EU/1/97/046/004 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

18/05/2011

Aranesp Axicorp Pharma GmbH

22/07/2011 500 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/098 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Aranesp Beragena Arzneimittel GmbH

17/03/2011 100 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/018 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 26/04/2011

Aranesp Beragena Arzneimittel GmbH

17/03/2011 150 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/020 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 19/04/2011

Aranesp Beragena Arzneimittel GmbH

17/03/2011 500 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/098 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 26/04/2011

Aranesp Beragena Arzneimittel GmbH

17/03/2011 500 µg Solution for injection

1 pre-filled syringe

EU/1/01/185/031 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 26/04/2011

Aranesp Beragena Arzneimittel GmbH

19/04/2011 100 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/091 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 27/04/2011

Aranesp Beragena Arzneimittel GmbH

19/04/2011 150 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/095 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 27/04/2011

Aranesp Beragena Arzneimittel GmbH

25/05/2011 60 µg Solution for injection

4 pre-filled syringe

EU/1/01/185/014 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 08/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 24/255

Page 25: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aranesp Beragena Arzneimittel GmbH

25/05/2011 80 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/016 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 08/07/2011

Aranesp Beragena Arzneimittel GmbH

21/09/2011 30 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/081 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/09/2011

Aranesp Beragena Arzneimittel GmbH

21/09/2011 40 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/083 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/09/2011

Aranesp Beragena Arzneimittel GmbH

21/09/2011 60 µg Solution for injection

4 pre-filled syringe with needle guard

EU/1/01/185/087 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/09/2011

Aranesp Beragena Arzneimittel GmbH

21/09/2011 80 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/089 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/09/2011

Aranesp Beragena Arzneimittel GmbH

12/10/2011 20 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/006 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 04/11/2011

Aranesp Beragena Arzneimittel GmbH

12/10/2011 30 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/008 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 04/11/2011

Aranesp Beragena Arzneimittel GmbH

12/10/2011 40 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/010 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 04/11/2011

Aranesp Beragena Arzneimittel GmbH

12/10/2011 50 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/012 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 04/11/2011

Aranesp Beragena Arzneimittel GmbH

07/11/2011 50 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/085 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 14/11/2011

Aranesp CC Pharma 04/01/2011 15 µg Solution for injection

4 pre-filled syringes with needle guards

EU/1/01/185/077 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/01/2011

Aranesp CC Pharma 22/03/2011 50 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/085 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 25/255

Page 26: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aranesp CC Pharma 04/05/2011 150 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/095 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Aranesp CC Pharma 23/05/2011 100 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/091 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/06/2011

Aranesp CC Pharma 23/05/2011 300 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/096 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/06/2011

Aranesp CC Pharma 23/05/2011 500 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/098 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/06/2011

Aranesp Emra-Med 04/11/2010 300 µg Solution for injection

1 pre-filled syringe (non-blister)

EU/1/01/185/043 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/02/2011

Aranesp Emra-Med 04/11/2010 500 µg Solution for injection

1 pre-filled syringe (non-blister)

EU/1/01/185/044 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/02/2011

Aranesp Emra-Med 01/02/2011 150 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/095 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/02/2011

Aranesp Emra-Med 01/02/2011 300 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/096 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/02/2011

Aranesp Emra-Med 01/02/2011 50 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/085 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/02/2011

Aranesp Emra-Med 01/02/2011 500 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/098 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 26/255

Page 27: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aranesp Euro Registratie Collectief BV

25/02/2011 20 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/078 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

14/06/2011

Aranesp Haemato Pharm AG

06/04/2011 100 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/018 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 14/04/2011

Aranesp Haemato Pharm AG

06/04/2011 150 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 14/04/2011

Aranesp Haemato Pharm AG

06/04/2011 300 µg Solution for injection

1 pre-filled syringe

EU/1/01/185/021 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 14/04/2011

Aranesp Haemato Pharm AG

06/04/2011 500 µg Solution for injection

1 pre-filled syringe

EU/1/01/185/031 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 14/04/2011

Aranesp Haemato Pharm AG

06/04/2011 80 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 14/04/2011

Aranesp Haemato Pharm AG

26/04/2011 10 µg Solution for injection

4 pre-filled syringes

EU/1/01/185/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 27/255

Page 28: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aranesp Haemato Pharm AG

26/04/2011 20 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/079 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Aranesp Haemato Pharm AG

26/04/2011 30 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/081 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Aranesp Haemato Pharm AG

27/04/2011 130 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/093 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Aranesp Haemato Pharm AG

27/04/2011 300 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/096 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Aranesp Haemato Pharm AG

27/04/2011 40 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/083 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Aranesp Haemato Pharm AG

27/04/2011 50 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/085 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 28/255

Page 29: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aranesp Haemato Pharm AG

27/04/2011 500 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/098 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Aranesp Haemato Pharm AG

27/04/2011 60 µg Solution for injection

4 pre-filled syringe with needle guard

EU/1/01/185/087 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/05/2011

Aranesp Haemato Pharm AG

07/06/2011 100 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/091 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/06/2011

Aranesp Haemato Pharm AG

07/06/2011 150 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/095 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/06/2011

Aranesp Haemato Pharm AG

08/06/2011 80 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/089 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/06/2011

Aranesp Medcor Pharmaceuticals BV

01/03/2011 300 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/096 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/03/2011

Aranesp Medcor Pharmaceuticals BV

01/07/2011 500 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/098 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

04/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 29/255

Page 30: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aranesp Medcor Pharmaceuticals BV

16/08/2011 20 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/079 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

23/08/2011

Aranesp Medcor Pharmaceuticals BV

16/08/2011 30 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/081 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

23/08/2011

Aranesp Medcor Pharmaceuticals BV

16/08/2011 40 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/083 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

23/08/2011

Aranesp Medcor Pharmaceuticals BV

16/08/2011 60 µg Solution for injection

4 pre-filled syringe with needle guard

EU/1/01/185/087 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

23/08/2011

Aranesp Medcor Pharmaceuticals BV

16/08/2011 80 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/089 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

23/08/2011

Aranesp Medcor Pharmaceuticals BV

05/09/2011 100 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/091 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

07/09/2011

Aranesp Orifarm AS 16/03/2011 150 µg Solution for injection

1 pre-filled pen

EU/1/01/185/054 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/04/2011

Aranesp Orifarm AS 12/07/2011 20 µg Solution for injection

1 pre-filled pen

EU/1/01/185/047 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 30/255

Page 31: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Aranesp Orifarm AS 12/07/2011 40 µg Solution for injection

1 pre-filled pen

EU/1/01/185/049 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/07/2011

Aranesp Paranova Läkemedel AB

17/11/2011 300 µg Solution for injection

1 pre-filled syringe with needle guard

EU/1/01/185/096 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 23/11/2011

Aranesp Pharma Westen GmbH

04/11/2011 100 µg Solution for injection

4 pre-filled syringes with needle guard

EU/1/01/185/091 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/11/2011

Aranesp (SureClick)

Paranova OY 30/08/2011 500 µg Solution for injection

1 pre-filled pen

EU/1/01/185/056 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 04/10/2011

Arava ADL Pharma GmbH

31/01/2011 10 mg Film-coated tablet 30 EU/1/99/118/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/04/2011

Arava ADL Pharma GmbH

31/01/2011 10 mg Film-coated tablet 100 EU/1/99/118/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/07/2011

Arava ADL Pharma GmbH

30/06/2011 20 mg Film-coated tablet 30 EU/1/99/118/007 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 13/07/2011

Arava ADL Pharma GmbH

30/06/2011 20 mg Film-coated tablet 100 EU/1/99/118/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 13/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 31/255

Page 32: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Arava BB Farma s.r.l.

18/08/2011 10 mg Film-coated tablet 30 EU/1/99/118/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Arava BB Farma s.r.l.

18/08/2011 20 mg Film-coated tablet 30 EU/1/99/118/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Arava CC Pharma 18/07/2011 10 mg Film-coated tablet 30 EU/1/99/118/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Lithuania, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/08/2011

Arava Haemato Pharm AG

15/04/2011 10 mg Film-coated tablet 100 EU/1/99/118/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/04/2011

Arava Haemato Pharm AG

15/04/2011 20 mg Film-coated tablet 100 EU/1/99/118/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/05/2011

Arava MPT Pharma 16/11/2010 10 mg Film-coated tablet 30 EU/1/99/118/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

26/01/2011

Arava MPT Pharma 16/11/2010 10 mg Film-coated tablet 100 EU/1/99/118/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

26/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 32/255

Page 33: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Arava MPT Pharma 14/03/2011 20 mg Film-coated tablet 30 EU/1/99/118/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/03/2011

Arava Propharmed GmbH

24/02/2011 20 mg Film-coated tablet 100 EU/1/99/118/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/03/2011

Arixtra 2 Care 4 22/06/2011 1.5 mg/0.3 ml Solution for injection

7 pre-filled syringes

EU/1/02/206/006 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/08/2011

Arixtra 2 Care 4 22/06/2011 10 mg/0.8 ml Solution for injection

10 pre-filled syringes

EU/1/02/206/017 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/08/2011

Arixtra 2 Care 4 22/06/2011 2.5 mg/0.5 ml Solution for injection

20 pre-filled syringes

EU/1/02/206/004 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/08/2011

Arixtra 2 Care 4 22/06/2011 5 mg/0.4 ml Solution for injection

10 pre-filled syringes

EU/1/02/206/011 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/08/2011

Arixtra 2 Care 4 22/06/2011 7.5 mg/0.6 ml Solution for injection

10 pre-filled syringes

EU/1/02/206/014 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/08/2011

Arixtra Axicorp Pharma GmbH

15/03/2011 2.5 mg/0.5 ml Solution for injection

20 pre-filled syringes

EU/1/02/206/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Arixtra Elpis Ltd. 22/12/2009 2.5 mg/0.5 ml Solution for injection

7 pre-filled syringes

EU/1/02/206/002 Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Latvia 11/03/2011

Arixtra Emra-Med 03/01/2011 1.5 mg/0.3 ml Solution for injection

7 pre-filled syringes

EU/1/02/206/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 33/255

Page 34: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Arixtra Orifarm AS 03/01/2011 7.5 mg/0.6 ml Solution for injection

10 pre-filled syringes

EU/1/02/206/014 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/03/2011

Arixtra Orifarm AS 03/08/2011 1.5 mg/0.3 ml Solution for injection

7 pre-filled syringes

EU/1/02/206/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 09/08/2011

Arixtra Orifarm AS 03/08/2011 10 mg/0.8 ml Solution for injection

10 pre-filled syringes

EU/1/02/206/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 09/08/2011

Arixtra Orifarm AS 03/08/2011 5 mg/0.4 ml Solution for injection

10 pre-filled syringes

EU/1/02/206/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 09/08/2011

atriance Haemato Pharm AG

04/04/2011 5 mg/ml Solution for infusion

6 vials EU/1/07/403/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/04/2011

Atripla Delphi Pharmaceuticals BV

23/02/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Luxembourg, Portugal, Spain, United Kingdom

The Netherlands

27/04/2011

Atripla EU-Pharma BV 26/04/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

03/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 34/255

Page 35: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Atripla Haemato Pharm AG

21/04/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 29/04/2011

Atripla Medartuum AB 10/05/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 16/05/2011

Atripla NewNeopharm BV

28/10/2010 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/01/2011

Atripla Orifarm AB 03/08/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 22/08/2011

Atripla Orifarm OY 15/03/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 28/03/2011

Atripla Paranova Läkemedel AB

29/08/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/11/2011

Atripla Paranova OY 10/03/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 14/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 35/255

Page 36: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Atripla Pharmachim AB

23/11/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 29/11/2011

Avamys Clear Pharmacy

15/07/2011 27.5 micrograms/ spray

Nasal spray, suspension

1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

21/07/2011

Avamys EU-Pharma BV 14/07/2011 27.5 micrograms/ spray

Nasal spray, suspension

1 bottle EU/1/07/434/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

20/07/2011

Avamys Imed Healthcare Ltd

11/08/2011 27.5 micrograms/ spray

Nasal spray, suspension

1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

12/08/2011

Avamys Mediwin Ltd 20/06/2011 27.5 micrograms/ spray

Nasal spray, suspension

1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Sweden, The Netherlands, United Kingdom

Spain 19/07/2011

Avamys Mediwin Ltd 20/06/2011 27.5 micrograms/ spray

Nasal spray, suspension

1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Italy 19/07/2011

Avamys PCO Manufacturing

28/04/2010 27.5 micrograms/ spray

Nasal spray, suspension

1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/01/2011

Avamys Pharmachim AB

26/09/2011 27.5 micrograms/ spray

Nasal spray, suspension

1 bottle EU/1/07/434/003 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 17/10/2011

Avandamet Emra-Med 16/04/2010 4 mg/1000 mg Film-coated tablet 56 EU/1/03/258/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 36/255

Page 37: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Avandia Cross Pharma AB

04/05/2010 4 mg Film-coated tablet 28 EU/1/00/137/006 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Sweden 12/01/2011

Avastin Dr Fisher Farma BV

08/02/2011 25 mg/ml Concentrate for solution for infusion

1 vial EU/1/04/300/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/03/2011

Avastin Orifarm AB 31/03/2011 25 mg/ml Concentrate for solution for infusion

1 vial EU/1/04/300/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 06/04/2011

Avastin Orifarm AB 31/03/2011 25 mg/ml Concentrate for solution for infusion

1 vial EU/1/04/300/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 06/04/2011

Avastin Orifarm OY 17/02/2011 25 mg/ml Concentrate for solution for infusion

1 vial EU/1/04/300/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 07/03/2011

Avastin Orifarm OY 17/02/2011 25 mg/ml Concentrate for solution for infusion

1 vial EU/1/04/300/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 07/03/2011

Avonex CC Pharma 14/10/2011 30 µg/0.5 ml (6 million IU)

Solution for injection

4 pre-filled pens

EU/1/97/033/005 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 37/255

Page 38: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Avonex Emra-Med 05/09/2011 30 µg/0.5 ml (6 million IU)

Solution for injection

12 pre-filled syringes + 12 needles

EU/1/97/033/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/09/2011

Avonex Inopha GmbH 22/03/2011 30 µg/0.5 ml (6 million IU)

Solution for injection

4 pre-filled syringes + 4 needles

EU/1/97/033/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

28/03/2011

Avonex Pharma Westen GmbH

15/11/2011 30 µg/0.5 ml (6 million IU)

Solution for injection

4 pre-filled pens

EU/1/97/033/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/12/2011

Avonex Veron Pharma Vertriebs GmbH

13/12/2010 30 µg/0.5 ml (6 million IU)

Solution for injection

4 pre-filled syringes + 4 needles

EU/1/97/033/003 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 09/02/2011

Axura 2 Care 4 30/11/2011 10 mg Film-coated tablet 28 EU/1/02/218/007 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/12/2011

Axura 2 Care 4 30/11/2011 10 mg Film-coated tablet 56 EU/1/02/218/008 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/12/2011

Axura 2 Care 4 02/12/2011 10 mg Film-coated tablet 98 EU/1/02/218/014 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/12/2011

Axura 2 Care 4 02/12/2011 10 mg Film-coated tablet 112 EU/1/02/218/009 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/12/2011

Axura CC Pharma 04/07/2011 5 mg + 10 mg + 15 mg + 20 mg

Film-coated tablet 7 x 5 mg + 7 x 10 mg +7 x 15 mg +7 x 20 mg

EU/1/02/218/016 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/09/2011

Axura Ethigen Limited

04/10/2011 10 mg Film-coated tablet 28 EU/1/02/218/007 Germany United Kingdom

27/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 38/255

Page 39: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Axura Omnia Läkemedel AB

11/08/2011 10 mg Film-coated tablet 98 EU/1/02/218/014 Bulgaria, Germany, Portugal Sweden 16/08/2011

Axura Pharma Westen GmbH

21/04/2011 10 mg Film-coated tablet 98 EU/1/02/218/014 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

Azarga B&S Healthcare Ltd

15/11/2011 10 mg/ml / 5 mg/ml

Eye drops, suspension

1 bottle EU/1/08/482/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

02/12/2011

Azarga CC Pharma 07/12/2010 10 mg/ml / 5 mg/ml

Eye drops, suspension

1 bottle EU/1/08/482/001 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/01/2011

Azarga CC Pharma 07/12/2010 10 mg/ml / 5 mg/ml

Eye drops, suspension

3 bottles EU/1/08/482/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/01/2011

Azarga Mevita HandelsGmbH

02/12/2011 10 mg/ml / 5 mg/ml

Eye drops, suspension

1 bottle EU/1/08/482/001 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 14/12/2011

Azarga Mevita HandelsGmbH

02/12/2011 10 mg/ml / 5 mg/ml

Eye drops, suspension

3 bottles EU/1/08/482/002 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 14/12/2011

Azarga Orifarm AB 12/10/2011 10 mg/ml / 5 mg/ml

Eye drops, suspension

3 bottles EU/1/08/482/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 22/11/2011

Azarga Paranova Läkemedel AB

02/12/2011 10 mg/ml / 5 mg/ml

Eye drops, suspension

1 bottle EU/1/08/482/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 39/255

Page 40: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Azarga Paranova Läkemedel AB

02/12/2011 10 mg/ml / 5 mg/ml

Eye drops, suspension

3 bottles EU/1/08/482/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/12/2011

Azarga Swingward Ltd TA Medihealth

26/08/2009 10 mg/ml / 5 mg/ml

Eye drops, suspension

1 bottle EU/1/08/482/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

06/01/2011

Azilect Abacus Medicine A/S

20/04/2011 1 mg Tablet 112 EU/1/04/304/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/04/2011

Azilect Abacus Medicine A/S

20/04/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/04/2011

AZILECT BR Pharma International Ltd

04/04/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

13/04/2011

AZILECT Clear Pharmacy

31/03/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

07/04/2011

AZILECT Dr Fisher Farma BV

12/07/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

20/07/2011

AZILECT EuroPharma DK

13/01/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 40/255

Page 41: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

AZILECT EuroPharma DK

13/01/2011 1 mg Tablet 112 EU/1/04/304/006 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/01/2011

AZILECT Interport Ltd 29/07/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

United Kingdom

12/08/2011

AZILECT Omnia Läkemedel AB

09/08/2011 1 mg Tablet 112 EU/1/04/304/006 Belgium, Czech Republic, France, Germany, Greece, Italy, Norway, Poland, Portugal, Spain, United Kingdom

Sweden 15/08/2011

AZILECT Orifarm AS 11/05/2011 1 mg Tablet 30 EU/1/04/304/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 13/05/2011

AZILECT Paranova Danmark AS

09/03/2011 1 mg Tablet 112 EU/1/04/304/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/05/2011

Azopt Medartuum AB 31/03/2011 10 mg/ml Eye drops, suspension

3 bottles EU/1/00/129/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 13/04/2011

Azopt Mevita HandelsGmbH

07/10/2011 10 mg/ml Eye drops, suspension

1 bottle EU/1/00/129/001 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 26/10/2011

Azopt Mevita HandelsGmbH

07/10/2011 10 mg/ml Eye drops, suspension

3 bottles EU/1/00/129/003 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 26/10/2011

Baraclude CC Pharma 22/03/2011 0.05 mg/ml Oral solution 1 bottle + 1 measuring spoon

EU/1/06/343/005 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

Baraclude Combiphar Europe BV

08/10/2009 0.5 mg Film-coated tablet 30 x 1 EU/1/06/343/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

12/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 41/255

Page 42: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Baraclude Haemato Pharm AG

15/04/2011 0.5 mg Film-coated tablet 30 x 1 EU/1/06/343/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/04/2011

Baraclude Omnia Läkemedel AB

16/09/2011 0.5 mg Film-coated tablet 30 x 1 EU/1/06/343/003 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 26/09/2011

Baraclude Paranova Läkemedel AB

21/06/2011 0.5 mg Film-coated tablet 30 x 1 EU/1/06/343/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 25/07/2011

Benlysta Emra-Med 18/11/2011 120 mg Powder for concentrate for solution for infusion

1 vial EU/1/11/700/001 Austria, Belgium, Ireland, Malta, The Netherlands, United Kingdom

Germany 21/12/2011

Benlysta Emra-Med 18/11/2011 400 mg Powder for concentrate for solution for infusion

1 vial EU/1/11/700/002 Austria, Belgium, Ireland, Malta, The Netherlands, United Kingdom

Germany 21/12/2011

Benlysta Haemato Pharm AG

19/09/2011 120 mg Powder for concentrate for solution for infusion

1 vial EU/1/11/700/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/09/2011

Benlysta Haemato Pharm AG

19/09/2011 400 mg Powder for concentrate for solution for infusion

1 vial EU/1/11/700/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/09/2011

Betaferon Axicorp Pharma B.V.

23/08/2011 0.25 mg/ml Powder and solvent for solution for injection

3 x 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/010 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 42/255

Page 43: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Betaferon Axicorp Pharma B.V.

24/08/2011 0.25 mg/ml Powder and solvent for solution for injection

3 x 15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/007 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/09/2011

Betaferon Axicorp Pharma B.V.

07/12/2011 0.25 mg/ml Powder and solvent for solution for injection

14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/009 Austria, Belgium, Bulgaria, Czech Republic, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom

Germany 16/12/2011

Betaferon Emra-Med 04/01/2010 0.25 mg/ml Powder and solvent for solution for injection

3 x 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/05/2011

Betaferon EVE Packs GmbH

16/02/2011 0.25 mg/ml Powder and solvent for solution for injection

3 x 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

Betaferon Haemato Pharm AG

14/03/2011 0.25 mg/ml Powder and solvent for solution for injection

15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 13/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 43/255

Page 44: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Betaferon Medartuum AB 13/07/2011 0.25 mg/ml Powder and solvent for solution for injection

15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/09/2011

Betaferon Omnia Läkemedel AB

13/07/2011 0.25 mg/ml Powder and solvent for solution for injection

15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/005 Belgium, Bulgaria, France, Greece, Italy, Lithuania, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 08/09/2011

Betaferon Orifarm AB 17/05/2011 0.25 mg/ml Powder and solvent for solution for injection

15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/07/2011

Betaferon Orifarm OY 13/09/2011 0.25 mg/ml Powder and solvent for solution for injection

15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 20/10/2011

Betaferon Paranova OY 25/08/2011 0.25 mg/ml Powder and solvent for solutionfor injection

15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/005 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 11/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 44/255

Page 45: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Betaferon Pharma Westen GmbH

21/01/2010 0.25 mg/ml Powder and solvent for solution for injection

14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/009 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/12/2011

Betaferon Pharma Westen GmbH

21/01/2010 0.25 mg/ml Powder and solvent for solution for injection

3 x 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/010 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/12/2011

Betaferon Pharma Westen GmbH

07/10/2010 0.25 mg/ml Powder and solvent for solution for injection

5 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/12/2011

Betaferon Pharmachim AB

20/10/2011 0.25 mg/ml Powder and solvent for solution for injection

15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)

EU/1/95/003/005 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 13/12/2011

Bondronat Kohlpharma GmbH

18/10/2011 6 mg/6 ml Concentrate for solution for infusion

5 vials EU/1/96/012/012 Czech Republic, Greece, Romania Germany 03/11/2011

Bonviva Abacus Medicine A/S

03/03/2011 150 mg Film-coated tablet 1 EU/1/03/265/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 08/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 45/255

Page 46: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Bonviva MPT Pharma 26/07/2011 150 mg Film-coated tablet 1 EU/1/03/265/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

03/08/2011

Bonviva MPT Pharma 26/07/2011 150 mg Film-coated tablet 3 EU/1/03/265/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

03/08/2011

Bridion Orifarm AB 12/05/2011 100 mg/ml Solution for injection

10 vials EU/1/08/466/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 18/05/2011

Brilique CC Pharma 24/05/2011 90 mg Film-coated tablet 56 EU/1/10/655/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/06/2011

Brilique CC Pharma 24/05/2011 90 mg Film-coated tablet 100 x 1 EU/1/10/655/006 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/06/2011

Brilique Doncaster Pharmaceuticals Group Ltd

30/08/2011 90 mg Film-coated tablet 56 EU/1/10/655/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

14/09/2011

BYETTA CC Pharma 30/09/2010 10 micrograms

Solution for injection

1 pre-filled pen

EU/1/06/362/003 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 18/05/2011

BYETTA Orifarm AB 07/04/2011 10 micrograms

Solution for injection

1 pre-filled pen

EU/1/06/362/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 19/04/2011

BYETTA PCO Manufacturing

18/03/2011 5 micrograms Solution for injection

1 pre-filled pen

EU/1/06/362/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

10/06/2011

Caelyx Euro Registratie Collectief BV

24/02/2011 2.0 mg/ml Concentrate for solution for infusion

1 vial EU/1/96/011/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 46/255

Page 47: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Caelyx Euro Registratie Collectief BV

24/02/2011 2.0 mg/ml Concentrate for solution for infusion

1 vial EU/1/96/011/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/03/2011

Caelyx Inopha GmbH 16/03/2011 2.0 mg/ml Concentrate for solution for infusion

1 vial EU/1/96/011/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

23/03/2011

Caelyx Inopha GmbH 16/03/2011 2.0 mg/ml Concentrate for solution for infusion

1 vial EU/1/96/011/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

23/03/2011

Caelyx InPharm Spzoo

25/08/2011 2.0 mg/ml Concentrate for solution for infusion

1 vial EU/1/96/011/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 04/10/2011

Caelyx Orifarm AB 29/11/2010 2.0 mg/ml Concentrate for solution for infusion

1 vial EU/1/96/011/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 19/01/2011

Caelyx Pharmachim AB

04/03/2011 2.0 mg/ml Concentrate for solution for infusion

1 vial EU/1/96/011/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 28/03/2011

Caelyx Pharmachim AB

07/03/2011 2.0 mg/ml Concentrate for solution for infusion

1 vial EU/1/96/011/003 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 28/03/2011

Cancidas Emra-Med 15/03/2011 50 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 31/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 47/255

Page 48: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cancidas Haemato Pharm AG

27/04/2011 50 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/05/2011

Cancidas Haemato Pharm AG

27/04/2011 70 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/05/2011

Cancidas InPharm Spzoo

22/07/2011 50 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 15/09/2011

Cancidas InPharm Spzoo

22/07/2011 70 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 15/09/2011

Cancidas Paranova Läkemedel AB

28/04/2011 50 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 17/05/2011

Cancidas Paranova Läkemedel AB

28/04/2011 70 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 17/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 48/255

Page 49: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cancidas Pharmachim AB

21/01/2011 50 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 21/02/2011

Cancidas Pharmachim AB

21/01/2011 70 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/196/003 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 21/02/2011

CellCept BB Farma s.r.l.

05/10/2011 250 mg Capsule, hard 300 EU/1/96/005/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/11/2011

CellCept BB Farma s.r.l.

05/10/2011 250 mg Capsule, hard 100 EU/1/96/005/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/11/2011

CellCept BB Farma s.r.l.

05/10/2011 500 mg Film-coated tablet 50 EU/1/96/005/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/11/2011

CellCept BB Farma s.r.l.

05/10/2011 500 mg Film-coated tablet 150 EU/1/96/005/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/11/2011

CellCept EU-Pharma BV 07/12/2011 500 mg Film-coated tablet 150 EU/1/96/005/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

19/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 49/255

Page 50: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

CellCept EuroPharma DK

16/02/2011 250 mg Capsule, hard 100 EU/1/96/005/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 04/03/2011

CellCept EuroPharma DK

16/02/2011 250 mg Capsule, hard 300 EU/1/96/005/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 31/03/2011

CellCept Europharma Sverige AB

06/07/2011 250 mg Capsule, hard 100 EU/1/96/005/001 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Poland, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 18/07/2011

CellCept Europharma Sverige AB

06/07/2011 500 mg Film-coated tablet 50 EU/1/96/005/002 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Norway, Poland, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 18/07/2011

CellCept Haemato Pharm AG

27/04/2011 500 mg Film-coated tablet 150 EU/1/96/005/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/05/2011

CellCept MPT Pharma 04/01/2011 500 mg Film-coated tablet 50 EU/1/96/005/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

13/01/2011

CellCept MPT Pharma 04/01/2011 500 mg Film-coated tablet 150 EU/1/96/005/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

13/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 50/255

Page 51: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cellcept MPT Pharma 10/06/2011 250 mg Capsule, hard 100 EU/1/96/005/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

28/06/2011

CellCept Orifarm AS 27/09/2011 1 g/5 ml Powder for oral suspension

1 bottle EU/1/96/005/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/10/2011

Celsentri Haemato Pharm AG

04/04/2011 150 mg Film-coated tablet 60 EU/1/07/418/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 13/04/2011

Celsentri Haemato Pharm AG

04/04/2011 300 mg Film-coated tablet 60 EU/1/07/418/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 13/04/2011

Celsentri MedicoPharm AG

03/08/2011 150 mg Film-coated tablet 60 EU/1/07/418/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/08/2011

Celsentri MedicoPharm AG

03/08/2011 300 mg Film-coated tablet 60 EU/1/07/418/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/08/2011

Celsentri Orifarm AS 23/11/2011 150 mg Film-coated tablet 60 EU/1/07/418/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 23/11/2011

Celsentri Orifarm AS 23/11/2011 300 mg Film-coated tablet 60 EU/1/07/418/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 23/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 51/255

Page 52: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Celsentri Paranova Danmark AS

28/10/2011 300 mg Film-coated tablet 60 EU/1/07/418/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/12/2011

Cerezyme Medartuum AB 20/06/2011 400 U Powder for concentrate for solution for infusion

1 vial EU/1/97/053/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 30/06/2011

Cervarix Axicorp Pharma GmbH

20/06/2011 - - Suspension for injection

1 pre-filled syringe + 1 needle

EU/1/07/419/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/07/2011

Cervarix CC Pharma 18/05/2011 - - Suspension for injection

1 pre-filled syringe + 1 needle

EU/1/07/419/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/06/2011

Cetrotide Axicorp Pharma GmbH

17/08/2011 0.25 mg Powder and solvent for solution for injection

1 vial + 1 pre-filled syringe + 2 injection needles + 2 alcohol swabs

EU/1/99/100/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/08/2011

Cetrotide CC Pharma 15/03/2011 0.25 mg Powder and solvent for solution for injection

7 vials + 7 pre-filled syringes + 14 injection needles + 14 alcohol swabs

EU/1/99/100/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/04/2011

Cetrotide CC Pharma 15/03/2011 3 mg Powder and solvent for solution for injection

1 vial + 1 pre-filled syringe + 2 injection needles + 2 alcohol swabs

EU/1/99/100/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 52/255

Page 53: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cetrotide Dr Fisher Farma BV

22/09/2010 0.25 mg Powder and solvent for solution for injection

1 vial + 1 pre-filled syringe + 2 injection needles + 2 alcohol swabs

EU/1/99/100/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

25/02/2011

Cetrotide Emra-Med 18/07/2011 0.25 mg Powder and solvent for solution for injection

7 vials + 7 pre-filled syringes + 14 injection needles + 14 alcohol swabs

EU/1/99/100/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Cetrotide Emra-Med 18/07/2011 3 mg Powder and solvent for solution for injection

1 vial + 1 pre-filled syringe + 2 injection needles + 2 alcohol swabs

EU/1/99/100/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Champix EU-Pharma BV 06/09/2011 1.0 mg Film-coated tablet 28 EU/1/06/360/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

14/09/2011

Champix Imed Healthcare Ltd

07/07/2011 1.0 mg Film-coated tablet 56 EU/1/06/360/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

28/07/2011

Champix Omnia Läkemedel AB

08/06/2011 1.0 mg Film-coated tablet 112 EU/1/06/360/011 Belgium, France, Greece, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 02/08/2011

Champix Paranova Danmark AS

10/05/2011 1.0 mg Film-coated tablet 56 EU/1/06/360/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/07/2011

Cholestagel CC Pharma 15/03/2010 625 mg Film-coated tablet 180 EU/1/03/268/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 53/255

Page 54: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cialis 2 Care 4 22/07/2010 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/02/2011

Cialis Abacus Medicine A/S

27/09/2011 10 mg Film-coated tablet 4 EU/1/02/237/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 26/10/2011

Cialis Abacus Medicine A/S

27/09/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/10/2011

Cialis ABACUS MEDICINE A/S

19/12/2011 20 mg Film-coated tablet 4 EU/1/02/237/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/12/2011

Cialis Beragena Arzneimittel GmbH

06/09/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/09/2011

Cialis CC Pharma 08/02/2011 10 mg Film-coated tablet 4 EU/1/02/237/001 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/03/2011

Cialis CC Pharma 08/11/2011 20 mg Film-coated tablet 12 EU/1/02/237/005 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/12/2011

Cialis ChemVet Pharma ApS

07/04/2011 20 mg Film-coated tablet 4 EU/1/02/237/003 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/05/2011

Cialis ChemVet Pharma ApS

07/04/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/05/2011

Cialis Docpharm GmbH&CoKGaA

19/01/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 54/255

Page 55: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cialis Emra-Med 25/11/2011 5 mg Film-coated tablet 14 EU/1/02/237/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/12/2011

Cialis Euro Registratie Collectief BV

20/06/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

27/06/2011

Cialis EuroPharma DK

14/01/2011 10 mg Film-coated tablet 4 EU/1/02/237/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 08/02/2011

Cialis Kohlpharma GmbH

21/11/2011 5 mg Film-coated tablet 14 EU/1/02/237/007 France, The Netherlands, United Kingdom Germany 30/11/2011

Cialis MedicoPharm AG

03/02/2011 20 mg Film-coated tablet 8 EU/1/02/237/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/02/2011

Cialis Mevita HandelsGmbH

08/11/2010 20 mg Film-coated tablet 8 EU/1/02/237/004 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 07/06/2011

Cialis Mevita HandelsGmbH

08/11/2010 20 mg Film-coated tablet 4 EU/1/02/237/003 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 07/06/2011

Cialis Singad Pharma ApS

03/08/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/08/2011

Cialis Singad Pharma ApS

04/08/2011 10 mg Film-coated tablet 4 EU/1/02/237/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/08/2011

Cimzia Axicorp Pharma GmbH

26/10/2011 200 mg Solution for injection

2 pre-filled syringes + 2 alcohol swabs

EU/1/09/544/001 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/11/2011

Cimzia CC Pharma 13/04/2011 200 mg Solution for injection

6 (3 x 2) pre-filled syringes + 6 (3 x 2) alcohol swabs

EU/1/09/544/002 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 55/255

Page 56: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cimzia Dr Fisher Farma BV

26/07/2011 200 mg Solution for injection

2 pre-filled syringes + 2 alcohol swabs

EU/1/09/544/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

20/09/2011

Cimzia Euro Registratie Collectief BV

18/03/2011 200 mg Solution for injection

2 pre-filled syringes + 2 alcohol swabs

EU/1/09/544/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

10/05/2011

Cimzia Kohlpharma GmbH

26/07/2011 200 mg Solution for injection

6 (3 x 2) pre-filled syringes + 6 (3 x 2) alcohol swabs

EU/1/09/544/002 Austria, Belgium, France, Sweden, United Kingdom

Germany 05/09/2011

Cimzia Orifarm AB 12/10/2011 200 mg Solution for injection

2 pre-filled syringes + 2 alcohol swabs

EU/1/09/544/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 25/10/2011

Cimzia Orifarm AS 06/05/2011 200 mg Solution for injection

2 pre-filled syringes + 2 alcohol swabs

EU/1/09/544/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 25/05/2011

Cimzia Pharma Westen GmbH

07/12/2010 200 mg Solution for injection

2 pre-filled syringes + 2 alcohol swabs

EU/1/09/544/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/02/2011

Cimzia Pharma Westen GmbH

13/01/2011 200 mg Solution for injection

6 (3 x 2) pre-filled syringes + 6 (3 x 2) alcohol swabs

EU/1/09/544/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/02/2011

Circadin Dr Fisher Farma BV

26/09/2011 2 mg Prolonged-release tablet

21 EU/1/07/392/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

12/10/2011

Circadin Euro Registratie Collectief BV

07/03/2011 2 mg Prolonged-release tablet

21 EU/1/07/392/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

09/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 56/255

Page 57: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

circadin Ginova Ltd 18/04/2011 2 mg Prolonged-release tablet

21 EU/1/07/392/001 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

20/04/2011

Circadin Pharmachim AB

10/08/2011 2 mg Prolonged-release tablet

21 EU/1/07/392/001 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/09/2011

Clopidogrel Mylan Euromedicines, S.L.

12/07/2010 75 mg Film-coated tablet 28 EU/1/09/559/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 15/03/2011

Clopidogrel Teva Delfarma SpZoo

25/10/2011 75 mg Film-coated tablet 28 x 1 EU/1/09/540/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 08/12/2011

CoAprovel B&S Healthcare

05/09/2011 300 mg/ 25 mg

Film-coated tablet 28 EU/1/98/086/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

04/10/2011

CoAprovel CC Pharma 04/11/2011 150 mg/ 12.50 mg

Film-coated tablet 56 x 1 EU/1/98/086/014 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/12/2011

CoAprovel Chemilines Ltd 18/10/2011 300 mg/ 25 mg

Film-coated tablet 28 EU/1/98/086/024 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

15/11/2011

CoAprovel Dr Fisher Farma BV

05/07/2011 300 mg/ 25 mg

Film-coated tablet 28 EU/1/98/086/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

14/07/2011

CoAprovel Emra-Med 11/07/2011 300 mg/ 12.50 mg

Film-coated tablet 28 EU/1/98/086/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 57/255

Page 58: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

CoAprovel Emra-Med 11/07/2011 300 mg/ 12.50 mg

Film-coated tablet 98 EU/1/98/086/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/08/2011

CoAprovel Emra-Med 11/07/2011 300 mg/ 12.50 mg

Film-coated tablet 56 EU/1/98/086/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/08/2011

CoAprovel EU-Pharma BV 20/07/2011 150 mg/ 12.50 mg

Tablet 28 EU/1/98/086/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

26/07/2011

CoAprovel EU-Pharma BV 27/07/2011 150 mg/ 12.50 mg

Film-coated tablet 28 EU/1/98/086/012 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

08/08/2011

CoAprovel Orifarm AB 12/05/2011 300 mg/ 25 mg

Film-coated tablet 98 EU/1/98/086/027 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 19/05/2011

Combivir Docpharm GmbH&CoKGaA

26/01/2011 150 mg/ 300 mg

Film-coated tablet 60 EU/1/98/058/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/02/2011

Combivir Medartuum AB 27/09/2011 150 mg/ 300 mg

Film-coated tablet 60 EU/1/98/058/001 Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 03/10/2011

Competact Chemilines Ltd 20/06/2011 15 mg/ 850 mg

Film-coated tablet 60 EU/1/06/354/006 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

13/09/2011

Competact Docpharm GmbH&CoKGaA

15/02/2011 15 mg/ 850 mg

Film-coated tablet 112 EU/1/06/354/010 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 58/255

Page 59: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Competact Docpharm GmbH&CoKGaA

15/02/2011 15 mg/ 850 mg

Film-coated tablet 196 (2 x 98)

EU/1/06/354/011 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/03/2011

Competact Kohlpharma GmbH

07/06/2011 15 mg/ 850 mg

Film-coated tablet 112 EU/1/06/354/010 France Germany 30/06/2011

Comtess Docpharm GmbH&CoKGaA

15/11/2011 200 mg Film-coated tablet 30 EU/1/98/082/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/11/2011

Comtess EuroPharma DK

22/07/2011 200 mg Film-coated tablet 100 EU/1/98/082/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 01/08/2011

Comtess Paranova Läkemedel AB

05/08/2011 200 mg Film-coated tablet 100 EU/1/98/082/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/08/2011

Cubicin CC Pharma 02/05/2011 350 mg Powder for solution for injection or infusion

1 vial EU/1/05/328/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/05/2011

Cubicin CC Pharma 02/05/2011 500 mg Powder for solution for injection or infusion

1 vial EU/1/05/328/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/05/2011

Cymbalta Abacus Medicine A/S

23/11/2011 30 mg Gastro-resistant capsule, hard

28 EU/1/04/296/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

Cymbalta Abacus Medicine A/S

23/11/2011 30 mg Gastro-resistant capsule, hard

98 EU/1/04/296/009 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

Cymbalta Abacus Medicine A/S

23/11/2011 60 mg Gastro-resistant capsule, hard

28 EU/1/04/296/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 59/255

Page 60: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cymbalta Abacus Medicine A/S

23/11/2011 60 mg Gastro-resistant capsule, hard

98 EU/1/04/296/004 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

Cymbalta B2B Medical GmbH

16/04/2011 30 mg Gastro-resistant capsule, hard

98 EU/1/04/296/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/05/2011

Cymbalta B2B Medical GmbH

16/04/2011 60 mg Gastro-resistant capsule, hard

98 EU/1/04/296/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/05/2011

Cymbalta BB Farma s.r.l.

17/05/2011 30 mg Gastro-resistant capsule, hard

28 EU/1/04/296/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/05/2011

Cymbalta BB Farma s.r.l.

17/05/2011 30 mg Gastro-resistant capsule, hard

98 EU/1/04/296/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/05/2011

Cymbalta BB Farma s.r.l.

09/06/2011 60 mg Gastro-resistant capsule, hard

28 EU/1/04/296/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/06/2011

Cymbalta BB Farma s.r.l.

09/06/2011 60 mg Gastro-resistant capsule, hard

98 EU/1/04/296/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/06/2011

Cymbalta Cross Healthcare Ltd

10/12/2010 30 mg Gastro-resistant capsule, hard

7 EU/1/04/296/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

17/02/2011

Cymbalta Haemato Pharm AG

12/04/2011 30 mg Gastro-resistant capsule, hard

28 EU/1/04/296/001 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 28/04/2011

Cymbalta Haemato Pharm AG

12/04/2011 60 mg Gastro-resistant capsule, hard

28 EU/1/04/296/002 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 28/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 60/255

Page 61: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Cymbalta Haemato Pharm AG

13/04/2011 60 mg Gastro-resistant capsule, hard

98 EU/1/04/296/004 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 28/04/2011

Cymbalta Pharmachim AB

16/09/2011 60 mg Gastro-resistant capsule, hard

28 EU/1/04/296/002 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 11/10/2011

Cymbalta Propharmed GmbH

15/03/2011 30 mg Gastro-resistant capsule, hard

98 EU/1/04/296/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/03/2011

Cymbalta Propharmed GmbH

15/03/2011 60 mg Gastro-resistant capsule, hard

98 EU/1/04/296/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/03/2011

Cymbalta Propharmed GmbH

16/03/2011 60 mg Gastro-resistant capsule, hard

28 EU/1/04/296/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/03/2011

Cymbalta Veron Pharma Vertriebs GmbH

09/06/2011 30 mg Gastro-resistant capsule, hard

98 EU/1/04/296/009 Austria, Belgium, Finland, France, Greece, Italy, Portugal, Sweden, The Netherlands, United Kingdom

Germany 13/07/2011

Cystagon CC Pharma 21/04/2011 150 mg Capsule, hard 100 EU/1/97/039/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/05/2011

Cystagon CC Pharma 21/04/2011 50 mg Capsule, hard 100 EU/1/97/039/001 Austria, Belgium, Denmark, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/05/2011

Dukoral Omnia Läkemedel AB

08/02/2011 - - Suspension of vaccine and effervescent granules for oral solution

2 x 1 dose EU/1/03/263/002 Belgium, France, Italy, Poland, Spain, The Netherlands, United Kingdom

Sweden 22/02/2011

DuoPlavin BR Pharma International Ltd

11/05/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

DuoPlavin BR Pharma International Ltd

19/10/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

DuoPlavin CC Pharma 21/04/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 61/255

Page 62: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

DuoPlavin Docpharm GmbH&CoKGaA

02/02/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/04/2011

DuoPlavin Docpharm GmbH&CoKGaA

02/02/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/04/2011

DuoPlavin Doncaster Pharmaceuticals Group Ltd

18/02/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

16/03/2011

DuoPlavin Dr Fisher Farma BV

02/02/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

19/04/2011

DuoPlavin Emra-Med 22/06/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/08/2011

DuoPlavin Kohlpharma GmbH

13/04/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 France, Italy, Spain Germany 24/05/2011

DuoPlavin Kohlpharma GmbH

13/04/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 France, Italy, Spain Germany 09/08/2011

DuoPlavin Medcor Pharmaceuticals BV

25/02/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/03/2011

DuoPlavin Pharma Westen GmbH

08/03/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

DuoPlavin Veron Pharma Vertriebs GmbH

19/10/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 15/11/2011

DuoPlavin Veron Pharma Vertriebs GmbH

19/10/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 Austria, Belgium, France, Germany, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 15/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 62/255

Page 63: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

DuoTrav 2 Care 4 07/07/2010 40 µg /ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/01/2011

DuoTrav 2 Care 4 07/07/2010 40 µg /ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/01/2011

DuoTrav Abacus Medicine A/S

25/08/2011 40 µg /ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/08/2011

DuoTrav Abacus Medicine A/S

25/08/2011 40 µg /ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/08/2011

DuoTrav Cross Pharma AB

24/01/2011 40 µg /ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/02/2011

DuoTrav Doncaster Pharmaceuticals Group Ltd

01/09/2011 40 µg /ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

29/09/2011

DuoTrav Parallell Pharma AB

15/08/2011 40 µg /ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 05/09/2011

DuoTrav Parallell Pharma AB

15/08/2011 40 µg /ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 05/09/2011

DuoTrav Singad Pharma ApS

15/08/2011 40 µg /ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 63/255

Page 64: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

DuoTrav Singad Pharma ApS

15/08/2011 40 µg /ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/09/2011

Dynastat Pharmachim AB

28/07/2011 40 mg Powder and solvent for solution for injection

5 vials + 5 ampoules

EU/1/02/209/008 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/08/2011

Ebixa Beragena Arzneimittel GmbH

11/10/2011 10 mg Film-coated tablet 42 EU/1/02/219/017 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 17/11/2011

Ebixa Beragena Arzneimittel GmbH

11/10/2011 10 mg Film-coated tablet 98 EU/1/02/219/020 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 17/11/2011

Ebixa Dr Fisher Farma BV

21/06/2011 10 mg Film-coated tablet 42 EU/1/02/219/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

27/06/2011

Ebixa Euro Registratie Collectief BV

20/09/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

22/09/2011

Ebixa EuroPharma DK

29/03/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/05/2011

Ebixa EuroPharma DK

29/03/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/05/2011

Ebixa Medartuum AB 13/10/2011 20 mg Film-coated tablet 98 EU/1/02/219/045 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 25/11/2011

Ebixa Medcor Pharmaceuticals BV

03/01/2011 10 mg Film-coated tablet 42 EU/1/02/219/017 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

10/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 64/255

Page 65: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Ebixa Medcor Pharmaceuticals BV

13/05/2011 10 mg Film-coated tablet 98 EU/1/02/219/020 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

16/05/2011

Ebixa Medcor Pharmaceuticals BV

02/09/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

07/09/2011

Ebixa MTK Pharma GmbH

07/04/2011 10 mg Film-coated tablet 42 EU/1/02/219/017 Poland Germany 22/06/2011

Ebixa Omnia Läkemedel AB

30/11/2011 10 mg Film-coated tablet 100 EU/1/02/219/003 Germany, Greece, Italy, Spain, The Netherlands, United Kingdom

Sweden 07/12/2011

Ebixa Orifarm AB 24/01/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 31/01/2011

Ebixa Orifarm AS 24/01/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 28/02/2011

Ebixa Orifarm AS 24/01/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 31/01/2011

Ebixa Paranova Danmark AS

05/04/2011 10 mg Film-coated tablet 56 EU/1/02/219/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 65/255

Page 66: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Ebixa Paranova Danmark AS

05/04/2011 10 mg Film-coated tablet 28 EU/1/02/219/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, TheNetherlands, United Kingdom

Denmark 19/05/2011

Ebixa Paranova Danmark AS

29/06/2011 10 mg Film-coated tablet 112 EU/1/02/219/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 13/07/2011

Ebixa Paranova Läkemedel AB

13/10/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 01/12/2011

Ebixa Paranova Läkemedel AB

13/10/2011 20 mg Film-coated tablet 98 EU/1/02/219/045 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 01/12/2011

Ebixa PCO Manufacturing

17/06/2011 10 mg Film-coated tablet 30 EU/1/02/219/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

06/07/2011

Ebixa Pharmachim AB

06/06/2011 10 mg Film-coated tablet 30 EU/1/02/219/001 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 16/06/2011

Ebixa Pharmachim AB

06/06/2011 10 mg Film-coated tablet 100 EU/1/02/219/003 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 16/06/2011

Ebixa Pharmachim AB

28/07/2011 10 mg Film-coated tablet 28 EU/1/02/219/007 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 27/10/2011

Ebixa Pharmachim AB

28/07/2011 10 mg Film-coated tablet 56 EU/1/02/219/008 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 11/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 66/255

Page 67: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Ebixa Pharmachim AB

28/07/2011 10 mg Film-coated tablet 98 EU/1/02/219/020 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 11/08/2011

Ebixa Pharmacodane Aps

07/06/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/06/2011

Ebixa Pharmacodane Aps

07/06/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 23/06/2011

ECALTA Orifarm AB 08/11/2011 100 mg Powder for concentrate for solution for infusion

1 vial EU/1/07/416/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 10/11/2011

ECALTA Orifarm AS 04/07/2011 100 mg Powder for concentrate for solution for infusion

1 vial EU/1/07/416/002 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/08/2011

Efient Amimed Direct Ltd

27/10/2010 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

05/07/2011

Efient Amimed Direct Ltd

27/10/2010 5 mg Film-coated tablet 28 EU/1/08/503/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

10/01/2011

Efient Emra-Med 13/09/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/09/2011

Efient Emra-Med 13/09/2011 10 mg Film-coated tablet 98 EU/1/08/503/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 67/255

Page 68: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Efient EuroPharma DK

22/07/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/08/2011

Efient EuroPharma DK

22/07/2011 10 mg Film-coated tablet 56 EU/1/08/503/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 01/08/2011

Efient EuroPharma DK

22/07/2011 10 mg Film-coated tablet 84 EU/1/08/503/012 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 01/08/2011

Efient EuroPharma DK

22/07/2011 10 mg Film-coated tablet 98 EU/1/08/503/014 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 01/08/2011

Efient Medcor Pharmaceuticals BV

22/04/2011 10 mg Film-coated tablet 14 EU/1/08/503/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

05/05/2011

Efient Medcor Pharmaceuticals BV

04/11/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

25/11/2011

Efient Mevita HandelsGmbH

07/04/2011 5 mg Film-coated tablet 28 EU/1/08/503/002 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 13/04/2011

Efient Mevita HandelsGmbH

07/04/2011 5 mg Film-coated tablet 98 EU/1/08/503/007 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 13/04/2011

Efient Mevita HandelsGmbH

02/05/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 05/05/2011

Efient Mevita HandelsGmbH

02/05/2011 10 mg Film-coated tablet 98 EU/1/08/503/014 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 05/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 68/255

Page 69: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Efient Orifarm AB 12/10/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Sweden 22/11/2011

Efient Orifarm AS 27/10/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/11/2011

Efient Paranova Danmark AS

28/10/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 22/11/2011

Efient Pharmachim AB

09/10/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 24/10/2011

Efient Swingward Ltd TA Medihealth

08/02/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

10/02/2011

Efient Waymade PLC 31/01/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

22/02/2011

Efient Waymade PLC 31/01/2011 5 mg Film-coated tablet 28 EU/1/08/503/002 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

24/02/2011

Elaprase Haemato Pharm AG

05/05/2011 2 mg/ml Concentrate for solution for infusion

1 vial EU/1/06/365/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

07/06/2011

Elaprase Haemato Pharm AG

12/05/2011 2 mg/ml Concentrate for solution for infusion

1 vial EU/1/06/365/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 69/255

Page 70: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

ellaOne Emra-Med 15/04/2011 30 mg Tablet 1 EU/1/09/522/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/06/2011

ellaOne Kohlpharma GmbH

31/03/2011 30 mg Tablet 1 EU/1/09/522/001 Austria Germany 13/04/2011

Emadine Kohlpharma GmbH

17/02/2011 0.05% Eye drops, solution 1 bottle EU/1/98/095/001 Czech Republic, Greece Germany 11/03/2011

Emend Dr Fisher Farma BV

14/12/2010 125 mg + 80 mg

Capsule, hard 1 capsule (125 mg) + 2 (80 mg)

EU/1/03/262/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

11/01/2011

Emend Dr Fisher Farma BV

23/09/2011 125 mg Capsule, hard 5 x 1 EU/1/03/262/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/10/2011

Emselex Beragena Arzneimittel GmbH

19/05/2011 15 mg Prolonged-release tablet

98 EU/1/04/294/026 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 25/05/2011

Emselex Emra-Med 25/07/2011 15 mg Prolonged release tablet

98 EU/1/04/294/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/08/2011

Emselex EuroPharma DK

02/08/2011 15 mg Prolonged-release tablet

28 EU/1/04/294/023 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/08/2011

Emselex EuroPharma DK

02/08/2011 15 mg Prolonged-release tablet

98 EU/1/04/294/026 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/08/2011

Emselex EuroPharma DK

02/08/2011 7.5 mg Prolonged-release tablet

28 EU/1/04/294/017 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 70/255

Page 71: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Emselex EuroPharma DK

02/08/2011 7.5 mg Prolonged-release tablet

98 EU/1/04/294/020 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/08/2011

Emselex Pharmachim AB

01/08/2011 15 mg Prolonged-release tablet

28 EU/1/04/294/023 Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/08/2011

Emselex Pharmachim AB

01/08/2011 15 mg Prolonged-release tablet

98 EU/1/04/294/026 Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/08/2011

Emselex Pharmachim AB

01/08/2011 7.5 mg Prolonged-release tablet

28 EU/1/04/294/017 Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/08/2011

Emselex Pharmachim AB

01/08/2011 7.5 mg Prolonged-release tablet

98 EU/1/04/294/020 Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/08/2011

Enbrel Abacus Medicine A/S

17/01/2011 25 mg Solution for injection in pre-filled syringe

4 pre-filled syringes + 8 alcohol swabs

EU/1/99/126/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 18/01/2011

Enbrel Abacus Medicine A/S

17/01/2011 50 mg Solution for injection in pre-filled syringe

4 pre-filled syringes + 8 alcohol swabs

EU/1/99/126/017 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 18/01/2011

Enbrel Emra-Med 08/03/2010 50 mg Solution for injection in pre-filled pen

4 pre-filled pens + 8 alcohol swabs

EU/1/99/126/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/01/2011

Enbrel Haemato Pharm AG

31/03/2011 50 mg Solution for injection in pre-filled pen

4 pre-filled pens + 8 alcohol swabs

EU/1/99/126/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 24/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 71/255

Page 72: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Enbrel Haemato Pharm AG

20/07/2011 50 mg Solution for injection in pre-filled pen

12 pre-filled pens + 24 alcohol swabs

EU/1/99/126/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/08/2011

Enbrel Kohlpharma GmbH

23/11/2011 50 mg Solution for injection in pre-filled pen

12 pre-filled pens + 24 alcohol swabs

EU/1/99/126/021 France, The Netherlands Germany 28/11/2011

Enbrel Orifarm AB 31/03/2011 25 mg Solution for injection in pre-filled syringe

4 pre-filled syringes + 8 alcohol swabs

EU/1/99/126/013 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 07/04/2011

Enbrel Orifarm AB 31/03/2011 50 mg Solution for injection in pre-filled syringe

4 pre-filled syringes + 8 alcohol swabs

EU/1/99/126/017 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 07/04/2011

Enbrel Orifarm AB 06/06/2011 50 mg Solution for injection in pre-filled pen

4 pre-filled pens + 8 alcohol swabs

EU/1/99/126/020 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 24/06/2011

Enbrel Orifarm AB 16/11/2011 25 mg Powder and solvent for solution for injection

4 vials + 4 pre-filled syringes + 8 syringes + 20 needles + 24 alcohol swabs

EU/1/99/126/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 16/12/2011

Enbrel Pharma Westen GmbH

09/03/2010 50 mg Solution for injection in pre-filled pen

4 pre-filled pens + 8 alcohol swabs

EU/1/99/126/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/01/2011

Enbrel Pharma Westen GmbH

26/03/2010 50 mg Solution for injection in pre-filled pen

12 pre-filled pens + 24 alcohol swabs

EU/1/99/126/021 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/01/2011

Enbrel Pharmachim AB

27/09/2011 25 mg Solution for injection in pre-filled syringe

4 pre-filled syringes + 8 alcohol swabs

EU/1/99/126/013 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 10/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 72/255

Page 73: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Enbrel Pharmachim AB

27/09/2011 50 mg Solution for injection in pre-filled syringe

4 pre-filled syringes + 8 alcohol swabs

EU/1/99/126/017 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 10/11/2011

erbitux Haemato Pharm AG

01/04/2011 5 mg/ml Solution for infusion

1 vial EU/1/04/281/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 06/04/2011

erbitux Haemato Pharm AG

04/04/2011 5 mg/ml Solution for infusion

1 vial EU/1/04/281/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 06/04/2011

Erbitux Orifarm AS 11/05/2011 5 mg/ml Solution for infusion

1 vial EU/1/04/281/005 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/07/2011

Eucreas 2 Care 4 15/11/2011 50 mg / 850 mg

Film-coated tablet 60 EU/1/07/425/003 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/11/2011

Eucreas 2 Care 4 15/11/2011 50 mg / 850 mg

Film-coated tablet 180 EU/1/07/425/005 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/11/2011

Eucreas Abacus Medicine A/S

18/10/2011 50 mg / 850 mg

Film-coated tablet 60 EU/1/07/425/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 08/11/2011

Eucreas Abacus Medicine A/S

20/10/2011 50 mg / 850 mg

Film-coated tablet 180 EU/1/07/425/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 08/11/2011

Eucreas CC Pharma 18/01/2011 50 mg / 1000 mg

Film-coated tablet 180 tablet (3 x 60)

EU/1/07/425/017 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 73/255

Page 74: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Eucreas CC Pharma 18/01/2011 50 mg / 850 mg

Film-coated tablet 180 tablet (3 x 60)

EU/1/07/425/014 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/01/2011

Eucreas EuroPharma DK

29/03/2011 50 mg / 1000 mg

Film-coated tablet 60 EU/1/07/425/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/04/2011

Eucreas EuroPharma DK

29/03/2011 50 mg / 1000 mg

Film-coated tablet 180 EU/1/07/425/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/04/2011

Eucreas EuroPharma DK

02/08/2011 50 mg / 850 mg

Film-coated tablet 60 EU/1/07/425/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/08/2011

Eucreas EuroPharma DK

03/08/2011 50 mg / 850 mg

Film-coated tablet 180 EU/1/07/425/005 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/08/2011

Eucreas Orifarm AS 18/07/2011 50 mg / 1000 mg

Film-coated tablet 60 EU/1/07/425/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/08/2011

Eucreas Orifarm AS 04/11/2011 50 mg / 1000 mg

Film-coated tablet 180 EU/1/07/425/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 09/11/2011

Eucreas Paranova Danmark AS

28/04/2011 50 mg / 1000 mg

Film-coated tablet 60 EU/1/07/425/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 74/255

Page 75: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Eucreas Paranova Danmark AS

28/04/2011 50 mg / 1000 mg

Film-coated tablet 180 tablet (3 x 60)

EU/1/07/425/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/05/2011

Eucreas Pharmacodane Aps

24/01/2011 50 mg / 1000 mg

Film-coated tablet 60 EU/1/07/425/009 United Kingdom Denmark 25/05/2011

Eucreas Pharmacodane Aps

24/01/2011 50 mg / 1000 mg

Film-coated tablet 180 EU/1/07/425/011 United Kingdom Denmark 25/05/2011

Evista Mediwin Ltd 25/11/2011 60 mg Film-coated tablet 28 EU/1/98/073/002 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

France 05/12/2011

Evista Mediwin Ltd 25/11/2011 60 mg Film-coated tablet 84 EU/1/98/073/003 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

France 05/12/2011

EVRA BCN Farma SL 12/11/2010 - - Transdermal patch 3 transdermal patches

EU/1/02/223/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 14/01/2011

EVRA Elpis Ltd. 09/08/2011 - - Transdermal patch 3 transdermal patches

EU/1/02/223/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Latvia 25/08/2011

EVRA Medkon Hurt Sp. z o.o.

08/07/2011 - - Transdermal patch 3 transdermal patches

EU/1/02/223/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 16/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 75/255

Page 76: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

EVRA Storkpharm Sp.z.o.o.

25/01/2011 - - Transdermal patch 3 transdermal patches

EU/1/02/223/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 27/05/2011

Exelon Chemilines Ltd 21/09/2011 4.6 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/066/020 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

10/10/2011

Exelon Delfarma SpZoo

25/10/2011 3 mg Capsule, hard 28 EU/1/98/066/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands

Poland 08/12/2011

Exelon Delfarma SpZoo

25/10/2011 3 mg Capsule, hard 56 EU/1/98/066/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 08/12/2011

Exelon Dr Fisher Farma BV

28/06/2011 9.5 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/066/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

25/07/2011

Exelon Emra-Med 08/11/2011 3 mg Capsule, hard 112 EU/1/98/066/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

Exelon Emra-Med 08/11/2011 3 mg Capsule, hard 56 EU/1/98/066/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 76/255

Page 77: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Exelon EuroPharma DK

05/01/2011 4.6 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/066/020 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/01/2011

Exelon EuroPharma DK

05/01/2011 4.6 mg / 24 hours

Transdermal patch 60 (30 x 2) sachets

EU/1/98/066/021 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/01/2011

Exelon EuroPharma DK

05/01/2011 4.6 mg / 24 hours

Transdermal patch 90 (30 x 3) sachets

EU/1/98/066/022 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/01/2011

Exelon EuroPharma DK

05/01/2011 9.5 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/066/024 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/01/2011

Exelon EuroPharma DK

05/01/2011 9.5 mg / 24 hours

Transdermal patch 60 sachets (30 x 2 sachets)

EU/1/98/066/025 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/01/2011

Exelon EuroPharma DK

05/01/2011 9.5 mg / 24 hours

Transdermal patch 90 sachets (30 x 3 sachets)

EU/1/98/066/026 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/01/2011

Exelon PCO Manufacturing

06/06/2011 4.6 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/066/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

21/06/2011

Exelon PCO Manufacturing

06/06/2011 9.5 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/066/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

21/06/2011

Exelon S.C. Farmastore Prest S.R.L.

26/01/2011 4.6 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/066/020 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Poland, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Romania 24/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 77/255

Page 78: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Exelon S.C. Farmastore Prest S.R.L.

26/01/2011 9.5 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/066/024 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Poland, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Romania 24/03/2011

Exforge Autumn Healthcare Ltd

19/04/2011 10 mg/160 mg Film-coated tablet 28 EU/1/06/370/019 Ireland, United Kingdom Ireland, United Kingdom

17/05/2011

Exforge Autumn Healthcare Ltd

19/04/2011 5 mg/160 mg Film-coated tablet 28 EU/1/06/370/011 Ireland, United Kingdom Ireland, United Kingdom

17/05/2011

Exforge Autumn Healthcare Ltd

19/04/2011 5 mg/80 mg Film-coated tablet 28 EU/1/06/370/003 Ireland, United Kingdom Ireland, United Kingdom

17/05/2011

Exforge PCO Manufacturing

07/05/2009 10 mg/160 mg Film-coated tablet 28 EU/1/06/370/019 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/02/2011

Exforge PCO Manufacturing

07/05/2009 5 mg/160 mg Film-coated tablet 28 EU/1/06/370/011 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/02/2011

Exforge PCO Manufacturing

07/05/2009 5 mg/80 mg Film-coated tablet 28 EU/1/06/370/003 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/02/2011

Exforge Pharmachim AB

07/09/2011 10 mg/160 mg Film-coated tablet 28 EU/1/06/370/019 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 27/09/2011

Exforge Pharmachim AB

07/09/2011 10 mg/160 mg Film-coated tablet 98 EU/1/06/370/023 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 27/09/2011

Exforge Pharmachim AB

07/09/2011 5 mg/160 mg Film-coated tablet 28 EU/1/06/370/011 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 27/09/2011

Exforge Pharmachim AB

07/09/2011 5 mg/160 mg Film-coated tablet 98 EU/1/06/370/015 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 27/09/2011

Exforge Pharmachim AB

07/09/2011 5 mg/80 mg Film-coated tablet 28 EU/1/06/370/003 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 27/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 78/255

Page 79: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Exforge Pharmachim AB

07/09/2011 5 mg/80 mg Film-coated tablet 98 EU/1/06/370/007 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 27/09/2011

Exforge HCT Dr Fisher Farma BV

16/11/2010 10 mg/ 160 mg/ 12.5 mg

Film-coated tablet 28 EU/1/09/569/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/03/2011

Exforge HCT Dr Fisher Farma BV

16/11/2010 10 mg/ 320 mg/ 25 mg

Film-coated tablet 28 EU/1/09/569/050 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/03/2011

Exforge HCT Dr Fisher Farma BV

16/11/2010 5 mg/ 160 mg/ 12.5 mg

Film-coated tablet 28 EU/1/09/569/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/03/2011

Exforge HCT Eureco-Pharma B.V.

05/05/2010 10 mg/ 160 mg/ 12.5 mg

Film-coated tablet 28 EU/1/09/569/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

11/01/2011

Exforge HCT Eureco-Pharma B.V.

05/05/2010 10 mg/ 160 mg/ 25 mg

Film-coated tablet 28 EU/1/09/569/038 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

11/01/2011

Exforge HCT Eureco-Pharma B.V.

05/05/2010 10 mg/ 320 mg/ 25 mg

Film-coated tablet 28 EU/1/09/569/050 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

11/01/2011

Exforge HCT Eureco-Pharma B.V.

05/05/2010 5 mg/ 160 mg/ 12.5 mg

Film-coated tablet 28 EU/1/09/569/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

11/01/2011

Exforge HCT Eureco-Pharma B.V.

05/05/2010 5 mg/ 160 mg/ 25 mg

Film-coated tablet 28 EU/1/09/569/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

11/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 79/255

Page 80: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Exforge HCT Euro Registratie Collectief BV

27/01/2011 10 mg/ 320 mg/ 25 mg

Film-coated tablet 28 EU/1/09/569/050 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

01/02/2011

Exjade Kohlpharma GmbH

07/02/2011 250 mg Dispersible tablet 84 EU/1/06/356/004 Romania, United Kingdom Germany 21/03/2011

Exjade Kohlpharma GmbH

29/03/2011 125 mg Dispersible tablet 84 EU/1/06/356/002 France, Spain, United Kingdom Germany 01/04/2011

Extavia Orifarm AB 01/02/2011 250 µg / ml Powder and solvent for solution for injection

15 vials + 15 pre-filled syringes

EU/1/08/454/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 03/03/2011

Extavia Orifarm AS 13/12/2010 250 µg / ml Powder and solvent for solution for injection

15 vials + 15 pre-filled syringes

EU/1/08/454/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/01/2011

Fabrazyme Orifarm AS 11/05/2011 35 mg Powder for concentrate for solution for infusion

1 vial EU/1/01/188/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/06/2011

Faslodex Axicorp Pharma GmbH

13/05/2011 250 mg/5 ml Solution for injection

1 pre-filled syringe + 1 safety needle

EU/1/03/269/001 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/05/2011

Faslodex Dr Fisher Farma BV

26/07/2011 250 mg/5 ml Solution for injection

1 pre-filled syringe + 1 safety needle

EU/1/03/269/001 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

02/08/2011

Faslodex Dr Fisher Farma BV

25/11/2011 250 mg/5 ml Solution for injection

2 pre-filled syringes + 2 safety needles

EU/1/03/269/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

13/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 80/255

Page 81: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Faslodex Euro Registratie Collectief BV

14/11/2011 250 mg/5 ml Solution for injection

2 pre-filled syringes + 2 safety needles

EU/1/03/269/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

18/11/2011

Faslodex Haemato Pharm AG

19/01/2011 250 mg/5 ml Solution for injection

2 pre-filled syringes + 2 safety needles

EU/1/03/269/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

26/01/2011

Faslodex Haemato Pharm AG

10/03/2011 250 mg/5 ml Solution for injection

1 pre-filled syringe + 1 safety needle

EU/1/03/269/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/03/2011

Faslodex Haemato Pharm AG

16/03/2011 250 mg/5 ml Solution for injection

2 pre-filled syringes + 2 safety needles

EU/1/03/269/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/03/2011

Faslodex Pharma Westen GmbH

06/09/2011 250 mg/5 ml Solution for injection

2 pre-filled syringes + 2 safety needles

EU/1/03/269/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/11/2011

Faslodex Propharmed GmbH

18/03/2011 250 mg/5 ml Solution for injection

1 pre-filled syringe + 1 safety needle

EU/1/03/269/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/04/2011

Fendrix Medcor Pharmaceuticals BV

01/04/2011 20 µg/0.5 ml Suspension for injection

1 pre-filled syringe + 1 needle

EU/1/04/299/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

04/04/2011

Ferriprox Abacus Medicine A/S

13/07/2011 500 mg Film-coated tablet 1 bottle EU/1/99/108/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 81/255

Page 82: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Firmagon Dr Fisher Farma BV

25/05/2011 80 mg Powder and solvent for solutionfor injection

1 vial + 1 vial + 1 syringe + 2 needles

EU/1/08/504/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

28/06/2011

Firmagon Dr Fisher Farma BV

13/07/2011 120 mg Powder and solvent for solution for injection

2 vials + 2 vials + 2 syringes+ 4 needles

EU/1/08/504/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/08/2011

Firmagon Euro Registratie Collectief BV

18/10/2011 80 mg Powder and solvent for solution for injection

1 vial + 1 vial + 1 syringe + 2 needles

EU/1/08/504/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/11/2011

Firmagon Medcor Pharmaceuticals BV

25/08/2011 120 mg Powder and solvent for solution for injection

2 vials + 2 vials + 2 syringes+ 4 needles

EU/1/08/504/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

06/09/2011

Firmagon Medcor Pharmaceuticals BV

25/08/2011 80 mg Powder and solvent for solution for injection

1 vial + 1 vial + 1 syringe + 2 needles

EU/1/08/504/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

06/09/2011

Forsteo Mevita HandelsGmbH

14/01/2011 20 µg/80 µl Solution for injection

1 pre-filled pen

EU/1/03/247/001 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 09/03/2011

Forsteo Omnia Läkemedel AB

13/12/2011 20 µg/80 µl Solution for injection

1 pre-filled pen

EU/1/03/247/001 Austria, Belgium, Bulgaria, Finland, France, Germany, Greece, Ireland, Italy, Lithuania, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 19/12/2011

Fosavance Axicorp Pharma GmbH

16/10/2009 70 mg/ 2800 IU

Tablet 1 x 4 EU/1/05/310/002 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/02/2011

Fosavance Axicorp Pharma GmbH

16/10/2009 70 mg/ 2800 IU

Tablet 3 x 4 EU/1/05/310/004 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/02/2011

FOSAVANCE Axicorp Pharma GmbH

27/09/2011 70 mg / 5600 IU

Tablet 4 EU/1/05/310/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 82/255

Page 83: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

FOSAVANCE Axicorp Pharma GmbH

28/09/2011 70 mg / 5600 IU

Tablet 12 EU/1/05/310/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/10/2011

FOSAVANCE Clear Pharmacy

05/09/2011 70 mg / 5600 IU

Tablet 4 EU/1/05/310/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

27/09/2011

FOSAVANCE Dr Fisher Farma BV

10/08/2011 70 mg / 5600 IU

Tablet 4 EU/1/05/310/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

30/08/2011

Fosavance Eureco-Pharma B.V.

15/03/2010 70 mg/ 2800 IU

Tablet 1 x 4 EU/1/05/310/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

25/03/2011

FOSAVANCE PCO Manufacturing

17/05/2010 70 mg / 5600 IU

Tablet 4 EU/1/05/310/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

13/01/2011

Fosavance Pharma Lab 25/03/2010 70 mg / 5600 IU

Tablet 12 EU/1/05/310/008 Belgium France 11/01/2011

FOSAVANCE PHARMECO ApS

24/08/2011 70 mg / 2800 IU

Tablet 1 x 4 EU/1/05/310/002 Czech Republic, Greece, Italy, Lithuania, Romania, United Kingdom

Denmark 21/09/2011

FOSAVANCE PHARMECO ApS

24/08/2011 70 mg / 2800 IU

Tablet 3 x 4 EU/1/05/310/004 Czech Republic, Greece, Italy, Lithuania, Romania, United Kingdom

Denmark 21/09/2011

Galvus Dr Fisher Farma BV

06/04/2011 50 mg Tablet 112 EU/1/07/414/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

12/05/2011

Galvus Swingward Ltd TA Medihealth

28/11/2011 50 mg Tablet 28 EU/1/07/414/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

06/12/2011

Ganfort Autumn Healthcare Ltd

23/05/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Ireland, United Kingdom Ireland, United Kingdom

23/06/2011

Ganfort Doncaster Pharmaceuticals Group Ltd

07/09/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Poland Ireland, Malta, United Kingdom

04/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 83/255

Page 84: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Ganfort Eureco-Pharma B.V.

28/11/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

02/12/2011

Ganfort EuroPharma DK

30/09/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 09/11/2011

Ganfort EuroPharma DK

30/09/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/340/002 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 09/11/2011

Ganfort Mediwin Ltd 14/01/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

France 18/01/2011

Ganfort Oy Cross Pharma AB

01/03/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/340/002 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Finland 02/03/2011

Ganfort Paranova Läkemedel AB

14/03/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Sweden 11/04/2011

Ganfort Paranova Läkemedel AB

14/03/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/340/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/04/2011

Ganfort Paranova OY 14/03/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 3 bottles EU/1/06/340/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 10/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 84/255

Page 85: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Ganfort PCO Manufacturing

11/05/2010 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

04/02/2011

Ganfort STRATHCLYDE PHARMACEUTICALS LTD

01/09/2011 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

13/09/2011

Ganfort Swingward Ltd TA Medihealth

11/04/2007 300 µg/ml + 5 mg/ml

Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands

United Kingdom

16/11/2011

Gardasil Cross Pharma AB

31/03/2011 - - Suspension for injection

1 pre-filled syringe + 2 needles

EU/1/06/357/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 04/05/2011

Gardasil Emra-Med 30/06/2011 - - Suspension for injection

10 pre-filled syringes + 20 needles

EU/1/06/357/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/09/2011

Gardasil Parallell Pharma AB

11/01/2011 - - Suspension for injection

1 pre-filled syringe + 2 needles

EU/1/06/357/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/04/2011

Gilenya Haemato Pharm AG

28/06/2011 0.5 mg Capsule, hard 28 EU/1/11/677/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/07/2011

Glivec Clear Pharmacy

25/07/2011 100 mg Film-coated tablet 60 EU/1/01/198/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

29/07/2011

Glivec Clear Pharmacy

25/07/2011 400 mg Film-coated tablet 30 EU/1/01/198/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

29/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 85/255

Page 86: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Glivec MedicoPharm AG

24/03/2009 100 mg Film-coated tablet 60 EU/1/01/198/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/02/2011

Glivec MedicoPharm AG

24/03/2009 400 mg Film-coated tablet 30 EU/1/01/198/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/02/2011

Glivec Orifarm AB 12/05/2011 400 mg Film-coated tablet 30 EU/1/01/198/010 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 19/05/2011

Glivec Paranova Läkemedel AB

12/10/2011 400 mg Film-coated tablet 30 EU/1/01/198/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 27/10/2011

GONAL-f 2 Care 4 20/06/2011 900 IU/ 1.5 ml (66 micrograms/ 1.5 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 14 needles

EU/1/95/001/035 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/07/2011

GONAL-f Axicorp Pharma GmbH

04/04/2011 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 12 needles

EU/1/95/001/034 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/05/2011

GONAL-f Axicorp Pharma GmbH

04/04/2011 900 IU/ 1.5 ml (66 micrograms/ 1.5 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 20 needles

EU/1/95/001/035 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/05/2011

GONAL-f eurorx Arzneimittel GmbH

17/11/2010 300 IU/ 0.5 ml (22 micrograms/ 0.5 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 5 needles

EU/1/95/001/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 86/255

Page 87: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

GONAL-f eurorx Arzneimittel GmbH

17/11/2010 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 7 needles

EU/1/95/001/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/01/2011

GONAL-f eurorx Arzneimittel GmbH

17/11/2010 900 IU/ 1.5 ml (66 micrograms/ 1.5 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 14 needles

EU/1/95/001/035 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/01/2011

GONAL-f Paranova Danmark AS

15/09/2009 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml)

Powder and solvent for solution for injection

1 vial + 1 pre-filled syringe + 6 disposable syringes

EU/1/95/001/031 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/08/2011

GONAL-f Paranova Danmark AS

18/10/2011 300 IU/ 0.5 ml (22 micrograms/ 0.5 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 5 needles

EU/1/95/001/033 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/12/2011

GONAL-f Paranova Danmark AS

18/10/2011 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 7 needles

EU/1/95/001/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/12/2011

GONAL-f Paranova Läkemedel AB

19/10/2011 300 IU/ 0.5 ml (22 micrograms/ 0.5 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 8 needles

EU/1/95/001/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 09/12/2011

GONAL-f Paranova Läkemedel AB

19/10/2011 450 IU/0.75 ml (33 micrograms/0.75 ml)

Solution for injection in pre-filled pen

1 pre-filled pen + 12 needles

EU/1/95/001/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 09/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 87/255

Page 88: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Halaven Haemato Pharm AG

20/05/2011 0.44 mg/ml Solution for injection

1 vial EU/1/11/678/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 23/05/2011

Halaven Haemato Pharm AG

30/06/2011 0.44 mg/ml Solution for injection

1 vial EU/1/11/678/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

05/07/2011

Hepsera Delfarma SpZoo

11/08/2011 10 mg Tablet 30 EU/1/03/251/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 17/08/2011

Hepsera Inopha GmbH 30/03/2011 10 mg Tablet 30 EU/1/03/251/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

05/04/2011

Hepsera Parallell Pharma AB

19/08/2011 10 mg Tablet 30 EU/1/03/251/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/09/2011

Hepsera Propharmed GmbH

19/05/2011 10 mg Tablet 30 EU/1/03/251/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

Hepsera Propharmed GmbH

19/05/2011 10 mg Tablet 3 x 30 EU/1/03/251/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/05/2011

Herceptin Abacus Medicine A/S

07/07/2011 150 mg Powder for concentrate for solution for infusion

1 vial EU/1/00/145/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 25/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 88/255

Page 89: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Herceptin Dr Fisher Farma BV

31/03/2011 150 mg Powder for concentrate for solution for infusion

1 vial EU/1/00/145/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

05/04/2011

Herceptin Inopha GmbH 29/04/2011 150 mg Powder for concentrate for solution for infusion

1 vial EU/1/00/145/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 19/05/2011

Herceptin Paranova Läkemedel AB

17/05/2011 150 mg Powder for concentrate for solution for infusion

1 vial EU/1/00/145/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 01/06/2011

Herceptin Pharmachim AB

30/05/2011 150 mg Powder for concentrate for solution for infusion

1 vial EU/1/00/145/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/06/2011

Herceptin Simgen GmbH 24/05/2011 150 mg Powder for concentrate for solution for infusion

1 vial EU/1/00/145/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/06/2011

Hirobriz Breezhaler

CC Pharma 02/12/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/594/007 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/12/2011

Hirobriz Breezhaler

CC Pharma 02/12/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/594/009 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/12/2011

Hirobriz Breezhaler

Dr Fisher Farma BV

18/11/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/594/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

07/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 89/255

Page 90: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Hirobriz Breezhaler

Dr Fisher Farma BV

18/11/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/594/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

07/12/2011

Hirobriz Breezhaler

Emra-Med 18/07/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/594/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/09/2011

Hirobriz Breezhaler

Emra-Med 18/07/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/594/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/09/2011

Humalog Euro Registratie Collectief BV

28/09/2011 100 U/ml Solution for injection

5 pens EU/1/96/007/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

05/10/2011

Humalog Medcor Pharmaceuticals BV

15/03/2011 100 U/ml Suspension for injection

5 cartridges EU/1/96/007/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, United Kingdom

The Netherlands

28/03/2011

Humalog Medcor Pharmaceuticals BV

17/03/2011 100 U/ml Suspension for injection

5 pens EU/1/96/007/033 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, United Kingdom

The Netherlands

28/03/2011

Humalog Medcor Pharmaceuticals BV

17/03/2011 100 U/ml Solution for injection

5 pens EU/1/96/007/031 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, United Kingdom

The Netherlands

28/03/2011

Humalog Mix50 Pharma Westen GmbH

02/03/2010 100 U/ml Suspension for injection

2 x 5 pens EU/1/96/007/036 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/02/2011

Humira Axicorp Pharma GmbH

27/06/2011 40 mg Solution for injection

6 pre-filled pens + 6 alcohol pads in a blister

EU/1/03/256/010 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 90/255

Page 91: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Humira Axicorp Pharma GmbH

27/06/2011 40 mg Solution for injection

2 pre-filled pens + 2 alcohol pads in a blister

EU/1/03/256/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/07/2011

Humira CC Pharma 11/10/2011 40 mg/0.8 ml Solution for injection

2 carton pack. Each carton contains: 1 vial + 1 syringe + 1 sterile adapter + 2 alcohol pads

EU/1/03/256/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 24/10/2011

Humira Orifarm AS 04/05/2011 40 mg Solution for injection

2 pre-filled pens + 2 alcohol pads in a blister

EU/1/03/256/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 06/06/2011

Humira Veron Pharma Vertriebs GmbH

13/12/2010 40 mg Solution for injection

2 pre-filled syringes + 2 alcohol pads

EU/1/03/256/003 Austria Germany 14/02/2011

Hycamtin EuroPharma DK

04/02/2011 0.25 mg Capsule, hard 10 EU/1/96/027/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/02/2011

Hycamtin EuroPharma DK

04/02/2011 1 mg Capsule, hard 10 EU/1/96/027/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/02/2011

Hycamtin Medartuum AB 17/10/2011 4 mg Powder for concentrate for solution for infusion

1 vial (17 ml)

EU/1/96/027/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 29/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 91/255

Page 92: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Hycamtin Omnia Läkemedel AB

10/05/2011 4 mg Powder for concentrate for solution for infusion

1 vial (17 ml)

EU/1/96/027/003 France, Greece, Italy, Lithuania, Spain, United Kingdom

Sweden 24/05/2011

Hycamtin Omnia Läkemedel AB

11/05/2011 1 mg Capsule, hard 10 EU/1/96/027/007 Bulgaria, Germany, Spain, The Netherlands, United Kingdom

Sweden 09/06/2011

Hycamtin Orifarm AB 14/12/2011 1 mg Capsule, hard 10 EU/1/96/027/007 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 21/12/2011

Infanrix hexa CC Pharma 06/12/2010 - - Powder and suspension for suspension for injection

50 vials + 50 pre-filled syringes

EU/1/00/152/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/01/2011

Infanrix hexa CC Pharma 21/06/2011 - - Powder and suspension for suspension for injection

20 vials + 20 pre-filled syringes

EU/1/00/152/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/07/2011

Infanrix hexa Pharma Westen GmbH

06/05/2011 - - Powder and suspension for suspension for injection

50 vials + 50 pre-filledsyringes + 100 needles

EU/1/00/152/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/05/2011

Inovelon 2 Care 4 27/10/2011 400 mg Film-coated tablet 100 EU/1/06/378/015 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/11/2011

Inovelon Emra-Med 30/05/2011 400 mg Film-coated tablet 200 EU/1/06/378/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/06/2011

Inovelon Orifarm AS 07/10/2011 400 mg Film-coated tablet 60 EU/1/06/378/014 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 25/10/2011

Inovelon Orifarm AS 07/10/2011 400 mg Film-coated tablet 100 EU/1/06/378/015 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 25/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 92/255

Page 93: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Insuman CC Pharma 03/01/2011 100 IU/ml Suspension for injection

10 cartridges

EU/1/97/030/062 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Hungary, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/01/2011

Insuman Basal Emra-Med 24/01/2011 100 IU/ml OptiSet, suspension for injection

5 pens EU/1/97/030/071 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/02/2011

Insuman Basal Emra-Med 24/01/2011 100 IU/ml OptiSet, suspension for injection

10 pens EU/1/97/030/072 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/02/2011

Insuman Basal Emra-Med 30/06/2011 100 IU/ml Suspension for injection

5 cartridges EU/1/97/030/035 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/09/2011

Insuman Basal Emra-Med 30/06/2011 100 IU/ml Suspension for injection

10 cartridges

EU/1/97/030/058 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/09/2011

Insuman Comb 25 Emra-Med 12/05/2011 100 IU/ml OptiSet, suspension for injection

5 pens EU/1/97/030/079 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/06/2011

Insuman Comb 25 Emra-Med 12/05/2011 100 IU/ml OptiSet, suspension for injection

10 pens EU/1/97/030/080 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 93/255

Page 94: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Insuman Comb 25 Pharma Westen GmbH

22/07/2011 100 IU/ml Suspension for injection

10 pre-filled pens

EU/1/97/030/163 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/09/2011

Insuman Comb 50 Pharma Westen GmbH

22/07/2011 100 IU/ml OptiSet, suspension for injection

10 pens EU/1/97/030/084 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/09/2011

Insuman Rapid Emra-Med 01/03/2011 100 IU/ml Solution for injection

5 pre-filled pens

EU/1/97/030/142 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

Insuman Rapid Emra-Med 01/03/2011 100 IU/ml Solution for injection

10 pre-filled pens

EU/1/97/030/145 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

Insuman Rapid Emra-Med 13/04/2011 100 IU/ml OptiSet, solution for injection

10 pens EU/1/97/030/068 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

Insuman Rapid Emra-Med 13/04/2011 100 IU/ml OptiSet, solution for injection

5 pens EU/1/97/030/067 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

INTELENCE Orifarm AS 16/11/2011 100 mg Tablet 120 EU/1/08/468/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/11/2011

Intrinsa Doncaster Pharmaceuticals Group Ltd

29/11/2010 300 µ/ 24 hours

Transdermal patch 8 patches EU/1/06/352/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

10/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 94/255

Page 95: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Intrinsa G-Pharma Ltd 12/01/2011 300 µg/ 24 hours

Transdermal patch 8 patches EU/1/06/352/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

26/01/2011

Invanz Omnia Läkemedel AB

04/10/2011 1 g Powder for concentrate for solution for infusion

1 vial EU/1/02/216/001 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/10/2011

Invanz Omnia Läkemedel AB

17/11/2011 1 g Powder for concentrate for solution for infusion

10 vials EU/1/02/216/002 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, The Netherlands, United Kingdom

Sweden 07/12/2011

Invanz Orifarm AB 23/11/2011 1 g Powder for concentrate for solution for infusion

1 vial EU/1/02/216/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 23/11/2011

Invanz Orifarm AB 23/11/2011 1 g Powder for concentrate for solution for infusion

10 vials EU/1/02/216/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 23/11/2011

Invanz Paranova Danmark AS

24/06/2011 1 g Powder for concentrate for solution for infusion

1 vial EU/1/02/216/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/07/2011

Invega 2 Care 4 07/09/2011 3 mg Prolonged-release tablet

28 EU/1/07/395/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 23/09/2011

Invega 2 Care 4 07/09/2011 6 mg Prolonged-release tablet

28 EU/1/07/395/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/09/2011

Invega 2 Care 4 07/09/2011 9 mg Prolonged-release tablet

28 EU/1/07/395/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/09/2011

Invega Abacus Medicine A/S

10/10/2011 3 mg Prolonged-release tablet

28 EU/1/07/395/001 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 95/255

Page 96: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Invega Abacus Medicine A/S

10/10/2011 9 mg Prolonged-release tablet

28 EU/1/07/395/011 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/10/2011

Invega Abacus Medicine A/S

20/10/2011 6 mg Prolonged-release tablet

28 EU/1/07/395/006 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/10/2011

Invega EuroPharma DK

15/03/2011 9 mg Prolonged-release tablet

28 EU/1/07/395/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 04/04/2011

Invega EuroPharma DK

18/05/2011 3 mg Prolonged-release tablet

28 EU/1/07/395/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/06/2011

Invega EuroPharma DK

18/05/2011 3 mg Prolonged-release tablet

28 EU/1/07/395/021 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/06/2011

Invega Orifarm AB 09/02/2011 3 mg Prolonged-release tablet

28 EU/1/07/395/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 23/03/2011

Invega Orifarm AS 09/02/2011 3 mg Prolonged-release tablet

28 EU/1/07/395/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/05/2011

Invega PCO Manufacturing

07/07/2009 6 mg Prolonged-release tablet

28 EU/1/07/395/006 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

03/02/2011

Invega PCO Manufacturing

22/03/2011 6 mg Prolonged-release tablet

28 EU/1/07/395/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

10/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 96/255

Page 97: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Invirase Abacus Medicine A/S

23/06/2011 500 mg Film-coated tablet 1 bottle EU/1/96/026/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/08/2011

Invirase Haemato Pharm AG

30/05/2011 500 mg Film-coated tablet 1 bottle EU/1/96/026/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 22/06/2011

Invirase Orifarm AS 05/01/2011 500 mg Film-coated tablet 1 bottle EU/1/96/026/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/01/2011

Isentress Dr Fisher Farma BV

25/11/2011 400 mg Film-coated tablet 60 EU/1/07/436/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/12/2011

Ixiaro Abacus Medicine A/S

04/10/2011 6 µg Suspension for injection

1 pre-filled syringe

EU/1/08/501/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/10/2011

Janumet 2 Care 4 06/07/2011 50 mg / 1000 mg

Film-coated tablet 196 EU/1/08/455/013 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Sweden 12/07/2011

Janumet Dr Fisher Farma BV

22/09/2010 50 mg / 850 mg

Film-coated tablet 56 EU/1/08/455/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

25/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 97/255

Page 98: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Janumet Medartuum AB 12/10/2011 50 mg / 1000 mg

Film-coated tablet 196 (2 x 98)

EU/1/08/455/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/11/2011

Janumet Orifarm AB 25/03/2011 50 mg / 1000 mg

Film-coated tablet 196 EU/1/08/455/013 Austria, Belgium, Cyprus, Denmark, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 13/04/2011

Janumet Paranova Danmark AS

24/10/2011 50 mg / 1000 mg

Film-coated tablet 196 EU/1/08/455/013 Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 22/11/2011

Janumet Paranova Danmark AS

24/10/2011 50 mg / 1000 mg

Film-coated tablet 56 EU/1/08/455/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 22/11/2011

Janumet PCO Manufacturing

12/08/2011 50 mg / 850 mg

Film-coated tablet 56 EU/1/08/455/003 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Romania, Spain, Sweden, The Netherlands

Ireland, United Kingdom

16/08/2011

Janumet Pharmachim AB

26/09/2011 50 mg / 1000 mg

Film-coated tablet 56 EU/1/08/455/010 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/10/2011

Janumet Pharmachim AB

26/09/2011 50 mg / 1000 mg

Film-coated tablet 196 EU/1/08/455/013 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/10/2011

Januvia B&S Healthcare Ltd

08/11/2011 100 mg Film-coated tablet 28 EU/1/07/383/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

28/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 98/255

Page 99: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Januvia Cross Pharma AB

17/01/2011 100 mg Film-coated tablet 28 EU/1/07/383/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 25/02/2011

Januvia Cross Pharma AB

20/01/2011 100 mg Film-coated tablet 98 EU/1/07/383/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 25/02/2011

Januvia Omnia Läkemedel AB

13/05/2011 100 mg Film-coated tablet 98 EU/1/07/383/017 Belgium, France, Greece, Italy, Spain, The Netherlands, United Kingdom

Sweden 22/06/2011

Januvia Orifarm AB 02/02/2011 100 mg Film-coated tablet 98 EU/1/07/383/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 17/02/2011

Januvia Paranova Läkemedel AB

18/11/2011 100 mg Film-coated tablet 98 EU/1/07/383/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 07/12/2011

Januvia Paranova Läkemedel AB

18/11/2011 100 mg Film-coated tablet 28 EU/1/07/383/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 07/12/2011

Januvia STRATHCLYDE PHARMACEUTICALS LTD

18/01/2011 100 mg Film-coated tablet 28 EU/1/07/383/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

17/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 99/255

Page 100: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Kaletra Abacus Medicine A/S

19/01/2011 200 mg / 50 mg

Film-coated tablet 120 EU/1/01/172/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Cyprus 24/01/2011

Kaletra Abacus Medicine A/S

24/01/2011 100 mg / 25mg

Film-coated tablet 60 EU/1/01/172/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/01/2011

Kaletra Abacus Medicine A/S

24/01/2011 200 mg / 50 mg

Film-coated tablet 120 EU/1/01/172/004 Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/01/2011

Kaletra Axicorp Pharma GmbH

27/01/2011 200 mg / 50 mg

Film-coated tablet 120 EU/1/01/172/005 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/02/2011

Kaletra Axicorp Pharma GmbH

04/05/2011 200 mg / 50 mg

Film-coated tablet 120 EU/1/01/172/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Kaletra Axicorp Pharma GmbH

28/06/2011 200 mg / 50 mg

Film-coated tablet 120 (10 x 12)

EU/1/01/172/008 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/07/2011

Kaletra CC Pharma 11/07/2011 200 mg / 50 mg

Film-coated tablet 120 (10 x 12)

EU/1/01/172/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/07/2011

Kaletra Emra-Med 02/05/2011 200 mg / 50 mg

Film-coated tablet 120 (10 x 12)

EU/1/01/172/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Kaletra Haemato Pharm AG

26/05/2011 200 mg / 50 mg

Film-coated tablet 120 (10 x 12) ; blister

EU/1/01/172/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 31/05/2011

Kaletra Kohlpharma GmbH

07/06/2011 200 mg / 50 mg

Film-coated tablet 120 (10 x 12)

EU/1/01/172/008 Norway, Sweden, The Netherlands, United Kingdom

Germany 29/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 100/255

Page 101: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Kaletra MedicoPharm AG

02/02/2011 200 mg / 50 mg

Film-coated tablet 360 (3 x 120)

EU/1/01/172/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/02/2011

Kaletra MedicoPharm AG

11/10/2011 200 mg / 50 mg

Film-coated tablet 120 (10 x 12)

EU/1/01/172/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/11/2011

Kaletra Orifarm OY 24/02/2011 200 mg / 50 mg

Film-coated tablet 120 EU/1/01/172/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 13/04/2011

Kaletra Paranova OY 10/03/2011 200 mg / 50 mg

Film-coated tablet 120 EU/1/01/172/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 14/04/2011

Kaletra Pharma Westen GmbH

01/03/2011 200 mg / 50 mg

Film-coated tablet 120 (10 x 12)

EU/1/01/172/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/04/2011

Kaletra Pharma Westen GmbH

06/06/2011 200 mg / 50 mg

Film-coated tablet 360 (3 x 120)

EU/1/01/172/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/08/2011

KARVEA Beragena Arzneimittel GmbH

21/04/2011 150 mg Tablet 98 EU/1/97/049/006 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 05/05/2011

Karvea Beragena Arzneimittel GmbH

21/04/2011 300 mg Tablet 98 EU/1/97/049/009 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 05/05/2011

Karvea Emra-Med 08/12/2011 75 mg Film-coated tablet 98 EU/1/97/049/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

Karvea Kohlpharma GmbH

11/01/2011 75 mg Tablet 98 EU/1/97/049/003 Greece Germany 24/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 101/255

Page 102: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Karvea MPT Pharma 04/07/2011 150 mg Film-coated tablet 28 EU/1/97/049/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

14/07/2011

Karvea MPT Pharma 04/07/2011 300 mg Film-coated tablet 28 EU/1/97/049/027 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

20/07/2011

Karvea Orifarm AB 11/03/2011 150 mg Film-coated tablet 98 EU/1/97/049/025 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 24/03/2011

Karvea Orifarm AB 11/03/2011 300 mg Film-coated tablet 98 EU/1/97/049/030 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 24/03/2011

Karvezide Axicorp Pharma GmbH

11/07/2011 150 mg/ 12.50 mg

Tablet 14 EU/1/98/085/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/07/2011

Karvezide Axicorp Pharma GmbH

12/10/2011 300 mg/ 12.50 mg

Film-coated tablet 98 EU/1/98/085/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/11/2011

Karvezide Axicorp Pharma GmbH

04/11/2011 150 mg/ 12.50 mg

Film-coated tablet 98 EU/1/98/085/015 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/11/2011

Karvezide B&S Healthcare Ltd

16/08/2011 150 mg/ 12.50 mg

Film-coated tablet 28 EU/1/98/085/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

02/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 102/255

Page 103: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Karvezide B&S Healthcare Ltd

16/08/2011 300 mg/ 12.50 mg

Film-coated tablet 28 EU/1/98/085/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

02/09/2011

Karvezide Emra-Med 25/08/2011 150 mg/ 12.50 mg

Film-coated tablet 98 EU/1/98/085/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 31/08/2011

Karvezide Emra-Med 09/09/2011 300 mg/ 12.50 mg

Film-coated tablet 98 EU/1/98/085/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/11/2011

Karvezide Pharma Westen GmbH

23/03/2011 300 mg/ 12.50 mg

Film-coated tablet 98 EU/1/98/085/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/04/2011

Karvezide Waymade PLC 25/10/2011 150 mg/ 12.50 mg

Film-coated tablet 28 EU/1/98/085/012 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

27/10/2011

Karvezide Waymade PLC 25/10/2011 300 mg/ 12.50 mg

Film-coated tablet 28 EU/1/98/085/017 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

27/10/2011

Kentera PCO Manufacturing

01/06/2011 3.9 mg/ 24 h

Transdermal patch 8 transdermal patches

EU/1/03/270/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/07/2011

Keppra 2 Care 4 22/07/2010 250 mg Film-coated tablet 100 EU/1/00/146/005 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 06/01/2011

Keppra 2 Care 4 05/11/2010 1000 mg Film-coated tablet 100 EU/1/00/146/025 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 103/255

Page 104: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Keppra 2 Care 4 08/11/2010 500 mg Film-coated tablet 200 EU/1/00/146/013 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 31/01/2011

Keppra 2 Care 4 08/11/2010 500 mg Film-coated tablet 100 EU/1/00/146/011 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/01/2011

Keppra Abacus Medicine A/S

13/12/2010 250 mg Film-coated tablet 50 EU/1/00/146/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 06/01/2011

Keppra Abacus Medicine A/S

13/12/2010 250 mg Film-coated tablet 200 EU/1/00/146/029 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 03/01/2011

Keppra Abacus Medicine A/S

13/12/2010 750 mg Film-coated tablet 50 EU/1/00/146/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/01/2011

Keppra Abacus Medicine A/S

01/08/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 10 ml

EU/1/00/146/027 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/09/2011

Keppra ADL Pharma GmbH

11/03/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 10 ml

EU/1/00/146/027 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 104/255

Page 105: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Keppra BB Farma s.r.l.

17/05/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 10 ml

EU/1/00/146/027 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/06/2011

Keppra Chemilines Ltd 18/03/2010 1000 mg Film-coated tablet 60 EU/1/00/146/024 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

05/07/2011

Keppra Kohlpharma GmbH

25/08/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 1 ml

EU/1/00/146/032 Italy, The Netherlands Germany 25/08/2011

Keppra Lexon (UK) Ltd

09/03/2011 250 mg Film-coated tablet 30 EU/1/00/146/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

28/03/2011

Keppra Orifarm AB 03/02/2011 750 mg Film-coated tablet 100 EU/1/00/146/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 02/03/2011

Keppra Paranova Danmark AS

13/07/2011 750 mg Film-coated tablet 100 EU/1/00/146/019 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/07/2011

Keppra Paranova Läkemedel AB

12/05/2011 250 mg Film-coated tablet 50 EU/1/00/146/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 18/05/2011

Keppra Paranova Läkemedel AB

12/05/2011 250 mg Film-coated tablet 100 EU/1/00/146/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 17/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 105/255

Page 106: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Keppra PCO Manufacturing

17/06/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 10 ml

EU/1/00/146/027 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

14/07/2011

Keppra STRATHCLYDE PHARMACEUTICALS LTD

19/01/2011 250 mg Film-coated tablet 100 EU/1/00/146/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

27/01/2011

Keppra Waymade PLC 04/03/2011 250 mg Film-coated tablet 30 EU/1/00/146/002 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

31/03/2011

Keppra Waymade PLC 07/03/2011 1000 mg Film-coated tablet 50 EU/1/00/146/023 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/04/2011

Keppra Waymade PLC 07/03/2011 250 mg Film-coated tablet 50 EU/1/00/146/003 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/04/2011

Keppra Waymade PLC 07/03/2011 500 mg Film-coated tablet 50 EU/1/00/146/009 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/04/2011

Kinzalkomb MTK Pharma GmbH

07/06/2011 40 mg/ 12.5 mg

Tablet 98 EU/1/02/214/005 The Netherlands Germany 20/06/2011

Kinzalkomb MTK Pharma GmbH

07/06/2011 80 mg/ 12.5 mg

Tablet 98 EU/1/02/214/010 The Netherlands Germany 20/06/2011

Kiovig Axicorp Pharma GmbH

26/07/2011 100 mg/ml Solution for infusion

1 vial EU/1/05/329/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/07/2011

Kiovig Axicorp Pharma GmbH

23/08/2011 100 mg/ml Solution for infusion

1 vial EU/1/05/329/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/08/2011

Kiovig Dr Fisher Farma BV

28/09/2011 100 mg/ml Solution for infusion

1 vial EU/1/05/329/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

06/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 106/255

Page 107: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Kiovig Medcor Pharmaceuticals BV

24/02/2011 100 mg/ml Solution for infusion

1 vial EU/1/05/329/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/03/2011

Kiovig Medcor Pharmaceuticals BV

04/11/2011 100 mg/ml Solution for infusion

1 vial EU/1/05/329/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/11/2011

Kiovig Pharma Westen GmbH

07/02/2011 100 mg/ml Solution for infusion

1 vial EU/1/05/329/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/03/2011

Kiovig Pharma Westen GmbH

07/02/2011 100 mg/ml Solution for infusion

1 vial EU/1/05/329/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/03/2011

Kivexa Axicorp Pharma B.V.

01/03/2011 600mg/ 300mg

Film-coated tablet 3 x 30 EU/1/04/298/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/03/2011

Kivexa Orifarm AB 11/03/2011 - - Film-coated tablet 30 EU/1/04/298/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 28/03/2011

Kivexa Orifarm OY 11/03/2011 600 mg/ 300 mg

Film-coated tablet 30 EU/1/04/298/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 17/03/2011

Kivexa Paranova OY 10/03/2011 - - Film-coated tablet 30 EU/1/04/298/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 14/04/2011

Kivexa Veron Pharma Vertriebs GmbH

19/10/2011 - - Film-coated tablet 30 EU/1/04/298/002 Austria, Belgium, France, Greece, Italy, Portugal, Spain, United Kingdom

Germany 23/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 107/255

Page 108: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lantus Cross Pharma AB

03/02/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/00/134/033 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 25/02/2011

Lantus (SoloStar) Orifarm AB 01/09/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/00/134/033 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 27/09/2011

Lantus OptiClik PCO Manufacturing

03/09/2007 100 Units/ml Solution for injection in cartridge

5 cartridges EU/1/00/134/025 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

10/05/2011

Lantus OptiSet ABACUS MEDICINE A/S

14/12/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/00/134/010 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 22/12/2011

Lantus OptiSet Medartuum AB 25/03/2010 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/00/134/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/01/2011

Lantus SoloStar Orifarm OY 30/05/2011 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/00/134/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 30/06/2011

Lantus Solostar Paranova Danmark AS

15/09/2009 100 Units/ml Solution for injection

5 pre-filled pens

EU/1/00/134/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 21/07/2011

Levemir Delphi Pharmaceuticals BV

11/11/2010 100 U/ml Solution for injection

5 cartridges EU/1/04/278/002 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Luxembourg, Portugal, Spain, United Kingdom

The Netherlands

17/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 108/255

Page 109: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Levemir Medartuum AB 25/08/2011 100 U/ml Solution for injection

5 cartridges EU/1/04/278/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 01/09/2011

Levemir Pharmachim AB

19/08/2011 100 U/ml Solution for injection

5 cartridges EU/1/04/278/002 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/08/2011

Levemir Pharmachim AB

19/08/2011 100 U/ml Solution for injection

5 pre-filled pens

EU/1/04/278/005 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/08/2011

Levemir FlexPen Medartuum AB 08/07/2011 100 U/ml Solution for injection

5 pre-filled pens

EU/1/04/278/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 20/07/2011

Levitra Amimed Direct Ltd

07/04/2011 10 mg Film-coated tablet 12 EU/1/03/248/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

12/04/2011

Levitra Amimed Direct Ltd

10/11/2011 10 mg Film-coated tablet 4 EU/1/03/248/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

07/12/2011

Levitra Euro Registratie Collectief BV

11/11/2011 10 mg Film-coated tablet 4 EU/1/03/248/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

24/11/2011

Levitra Euro Registratie Collectief BV

11/11/2011 5 mg Film-coated tablet 4 EU/1/03/248/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

24/11/2011

Levitra MedicoPharm AG

08/02/2011 20 mg Film-coated tablet 4 EU/1/03/248/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 109/255

Page 110: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Levitra Pharmachim AB

06/07/2011 10 mg Film-coated tablet 4 EU/1/03/248/006 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/07/2011

Levitra Pharmachim AB

06/07/2011 10 mg Film-coated tablet 8 EU/1/03/248/007 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/07/2011

Levitra Pharmachim AB

06/07/2011 20 mg Film-coated tablet 8 EU/1/03/248/011 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/07/2011

Levitra Pharmachim AB

06/07/2011 20 mg Film-coated tablet 4 EU/1/03/248/010 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/07/2011

Levitra Pharmachim AB

06/07/2011 5 mg Film-coated tablet 4 EU/1/03/248/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/07/2011

Lucentis Dr Fisher Farma BV

06/07/2011 10 mg/ml Solution for injection

1 vial EU/1/06/374/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

18/07/2011

Lucentis Orifarm AB 01/02/2011 10 mg/ml Solution for injection

1 vial EU/1/06/374/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 17/03/2011

Lumigan BR Pharma International Ltd

10/02/2010 0.3 mg/ml Eye drops, solution 3 bottles EU/1/02/205/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/01/2011

Lumigan Parallell Pharma AB

24/10/2011 0.3 mg/ml Eye drops, solution 1 bottle EU/1/02/205/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom

Sweden 29/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 110/255

Page 111: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lumigan Parallell Pharma AB

24/10/2011 0.3 mg/ml Eye drops, solution 3 bottles EU/1/02/205/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom

Sweden 29/11/2011

Lyrica Abacus Medicine A/S

18/02/2011 150 mg Capsule, hard 56 EU/1/04/279/018 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 25/02/2011

Lyrica ADL Pharma GmbH

23/08/2010 75 mg Capsule, hard 14 EU/1/04/279/011 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/01/2011

Lyrica ADL Pharma GmbH

23/08/2010 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/01/2011

Lyrica ADL Pharma GmbH

16/09/2010 300 mg Capsule, hard 100 EU/1/04/279/043 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/01/2011

Lyrica ADL Pharma GmbH

15/12/2010 75 mg Capsule, hard 100 EU/1/04/279/038 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/01/2011

Lyrica BB Farma s.r.l.

20/06/2011 200 mg Capsule, hard 21 EU/1/04/279/020 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/07/2011

Lyrica BB Farma s.r.l.

20/06/2011 50 mg Capsule, hard 21 EU/1/04/279/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/07/2011

Lyrica BB Farma s.r.l.

24/06/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 111/255

Page 112: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lyrica BB Farma s.r.l.

28/06/2011 75 mg Capsule, hard 14 EU/1/04/279/011 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/07/2011

Lyrica BB Farma s.r.l.

28/06/2011 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/07/2011

Lyrica BR Pharma International Ltd

23/09/2011 75 mg Capsule, hard 100 x 1 EU/1/04/279/013 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

10/10/2011

Lyrica CC Pharma 28/04/2011 150 mg Capsule, hard 100 x 1 EU/1/04/279/019 Norway Germany 16/05/2011

Lyrica CC Pharma 06/05/2011 225 mg Capsule, hard 56 EU/1/04/279/034 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/05/2011

Lyrica CC Pharma 06/05/2011 225 mg Capsule, hard 100 EU/1/04/279/042 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/06/2011

Lyrica CC Pharma 06/05/2011 25 mg Capsule, hard 100 EU/1/04/279/036 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/06/2011

Lyrica CC Pharma 04/10/2011 100 mg Capsule, hard 100 EU/1/04/279/039 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/10/2011

Lyrica CC Pharma 04/10/2011 50 mg Capsule, hard 100 EU/1/04/279/037 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/10/2011

Lyrica Docpharm GmbH&CoKGaA

28/06/2011 100 mg Capsule, hard 100 EU/1/04/279/039 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/08/2011

Lyrica Emra-Med 09/02/2011 300 mg Capsule, hard 100 EU/1/04/279/043 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 112/255

Page 113: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lyrica Ethigen Limited

07/10/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 100 mg Capsule, hard 84 EU/1/04/279/015 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 100 mg Capsule, hard 100 EU/1/04/279/039 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 150 mg Capsule, hard 14 EU/1/04/279/017 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 150 mg Capsule, hard 56 EU/1/04/279/018 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 150 mg Capsule, hard 100 EU/1/04/279/040 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 200 mg Capsule, hard 21 EU/1/04/279/020 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 113/255

Page 114: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lyrica Ethigen Limited

07/10/2011 200 mg Capsule, hard 84 EU/1/04/279/021 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 25 mg Capsule, hard 14 EU/1/04/279/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 25 mg Capsule, hard 56 EU/1/04/279/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 25 mg Capsule, hard 84 EU/1/04/279/004 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 25 mg Capsule, hard 100 EU/1/04/279/036 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 25 mg Capsule, hard 112 (2 x 56)

EU/1/04/279/026 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 50 mg Capsule, hard 56 EU/1/04/279/008 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 114/255

Page 115: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lyrica Ethigen Limited

07/10/2011 50 mg Capsule, hard 21 EU/1/04/279/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 50 mg Capsule, hard 84 EU/1/04/279/009 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 50 mg Capsule, hard 100 EU/1/04/279/037 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 75 mg Capsule, hard 14 EU/1/04/279/011 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

07/10/2011 75 mg Capsule, hard 100 EU/1/04/279/038 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/10/2011

Lyrica Ethigen Limited

11/11/2011 75 mg Capsule, hard 112 (2 x 56)

EU/1/04/279/027 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

23/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 115/255

Page 116: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lyrica EuroPharma DK

04/02/2011 300 mg Capsule, hard 56 EU/1/04/279/024 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/02/2011

Lyrica Ginova Ltd 28/06/2011 50 mg Capsule, hard 56 EU/1/04/279/008 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

18/08/2011

Lyrica Kosei Pharma UK Limited

23/05/2011 150 mg Capsule, hard 56 EU/1/04/279/018 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

21/06/2011

Lyrica Kosei Pharma UK Limited

23/05/2011 25 mg Capsule, hard 56 EU/1/04/279/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

21/06/2011

Lyrica Kosei Pharma UK Limited

23/05/2011 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

21/06/2011

Lyrica Kosei Pharma UK Limited

01/07/2011 50 mg Capsule, hard 21 EU/1/04/279/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

21/07/2011

Lyrica Kosei Pharma UK Limited

05/07/2011 25 mg Capsule, hard 14 EU/1/04/279/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 116/255

Page 117: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lyrica Kosei Pharma UK Limited

05/07/2011 50 mg Capsule, hard 84 EU/1/04/279/009 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/07/2011

Lyrica Kosei Pharma UK Limited

06/07/2011 100 mg Capsule, hard 84 EU/1/04/279/015 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/07/2011

Lyrica Kosei Pharma UK Limited

06/07/2011 200 mg Capsule, hard 84 EU/1/04/279/021 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/07/2011

Lyrica Kosei Pharma UK Limited

06/07/2011 25 mg Capsule, hard 84 EU/1/04/279/004 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/07/2011

Lyrica Kosei Pharma UK Limited

06/07/2011 75 mg Capsule, hard 14 EU/1/04/279/011 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/07/2011

Lyrica Kosei Pharma UK Limited

07/07/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 117/255

Page 118: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lyrica Kosei Pharma UK Limited

07/07/2011 150 mg Capsule, hard 14 EU/1/04/279/017 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/07/2011

Lyrica Kosei Pharma UK Limited

07/07/2011 25 mg Capsule, hard 21 EU/1/04/279/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/07/2011

Lyrica Kosei Pharma UK Limited

25/11/2011 25 mg Capsule, hard 100 EU/1/04/279/036 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

22/12/2011

Lyrica Lexon (UK) Ltd

21/03/2011 50 mg Capsule, hard 56 EU/1/04/279/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

05/04/2011

Lyrica Lexon (UK) Ltd

06/10/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

11/11/2011

Lyrica Mediwin Ltd 02/03/2011 25 mg Capsule, hard 100 EU/1/04/279/036 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands

United Kingdom

08/03/2011

Lyrica Orifarm AB 27/10/2011 225 mg Capsule, hard 56 EU/1/04/279/034 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 16/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 118/255

Page 119: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lyrica Orifarm AS 27/10/2011 225 mg Capsule, hard 56 EU/1/04/279/034 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/11/2011

Lyrica PCO Manufacturing

28/04/2010 200 mg Capsule, hard 84 EU/1/04/279/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/01/2011

Lyrica Pharmachim AB

15/04/2011 225 mg Capsule, hard 56 EU/1/04/279/034 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Latvia, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 19/04/2011

Lyrica Propharmed GmbH

15/04/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

Lyrica Propharmed GmbH

15/04/2011 150 mg Capsule, hard 100 EU/1/04/279/040 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

Lyrica Propharmed GmbH

15/04/2011 50 mg Capsule, hard 21 EU/1/04/279/007 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

Lyrica Propharmed GmbH

15/04/2011 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

Lyrica Propharmed GmbH

11/05/2011 200 mg Capsule, hard 21 EU/1/04/279/020 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/05/2011

Lyrica Propharmed GmbH

17/08/2011 300 mg Capsule, hard 56 EU/1/04/279/024 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/08/2011

Lyrica Propharmed GmbH

17/08/2011 75 mg Capsule, hard 100 x 1 EU/1/04/279/013 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Lyrica Waymade PLC 01/02/2011 75 mg Capsule, hard 100 x 1 EU/1/04/279/013 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

07/02/2011

Lyrica Waymade PLC 24/05/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

07/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 119/255

Page 120: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Lysodren MedicoPharm AG

18/02/2010 500 mg Tablet 100 EU/1/04/273/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/01/2011

MabCampath Abacus Medicine A/S

07/07/2011 30 mg/ml Concentrate for solution for infusion

3 vials EU/1/01/193/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 14/07/2011

MabCampath Medartuum AB 31/10/2011 30 mg/ml Concentrate for solution for infusion

3 vials EU/1/01/193/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/11/2011

MabCampath Orifarm AS 16/02/2011 30 mg/ml Concentrate for solution for infusion

3 vials EU/1/01/193/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/03/2011

MabCampath Orifarm OY 16/02/2011 30 mg/ml Concentrate for solution for infusion

3 vials EU/1/01/193/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 28/02/2011

Mabthera Abacus Medicine A/S

15/11/2011 100 mg Concentrate for solution for infusion

2 vials EU/1/98/067/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Cyprus 17/11/2011

Mabthera Abacus Medicine A/S

15/11/2011 500 mg Concentrate for solution for infusion

1 vial EU/1/98/067/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Cyprus 17/11/2011

Mabthera Pharmachim AB

13/04/2011 100 mg Concentrate for solution for infusion

2 vials EU/1/98/067/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 18/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 120/255

Page 121: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Metalyse Lex ano UAB 09/03/2011 10000 Units Powder and solvent for solution for injection

1 vial + 1 pre-filled syringe + 1 vial adapter + 1 needle

EU/1/00/169/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Lithuania 24/03/2011

Metalyse Orifarm AB 14/09/2011 10000 Units Powder and solvent for solution for injection

1 vial + 1 pre-filled syringe + 1 vial adapter + 1 needle

EU/1/00/169/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 16/12/2011

Micardis AN Pharmacy Sp. z o.o.

21/02/2011 80 mg Tablet 28 EU/1/98/090/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 28/02/2011

Micardis Axicorp Pharma GmbH

10/01/2011 80 mg Tablet 98 EU/1/98/090/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/01/2011

Micardis BR Pharma International Ltd

13/09/2011 40 mg Tablet 14 EU/1/98/090/001 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

13/12/2011

Micardis BR Pharma International Ltd

13/09/2011 80 mg Tablet 14 EU/1/98/090/005 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

13/12/2011

Micardis Orifarm AB 15/12/2010 80 mg Tablet 98 EU/1/98/090/008 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, The Netherlands

Sweden 24/01/2011

Micardis Pharmachim AB

19/09/2011 20 mg Tablet 98 EU/1/98/090/012 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 17/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 121/255

Page 122: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Micardis Pharmachim AB

19/09/2011 40 mg Tablet 28 EU/1/98/090/002 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 11/10/2011

Micardis Pharmachim AB

19/09/2011 40 mg Tablet 98 EU/1/98/090/004 Austria, Belgium, Czech Republic, Estonia, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 11/10/2011

Micardis Pharmachim AB

29/11/2011 80 mg Tablet 28 EU/1/98/090/006 Austria, Belgium, Czech Republic, France, Germany, Greece, Italy, Malta, Norway, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 02/12/2011

Micardis Pharmachim AB

29/11/2011 80 mg Tablet 98 EU/1/98/090/008 Austria, Belgium, Czech Republic, France, Germany, Greece, Italy, Malta, Norway, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 06/12/2011

Micardis STRATHCLYDE PHARMACEUTICALS LTD

15/12/2010 40 mg Tablet 28 EU/1/98/090/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

28/02/2011

Micardis STRATHCLYDE PHARMACEUTICALS LTD

15/12/2010 80 mg Tablet 28 EU/1/98/090/006 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

28/02/2011

Micardis STRATHCLYDE PHARMACEUTICALS LTD

15/03/2011 40 mg Tablet 14 EU/1/98/090/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/04/2011

Micardis STRATHCLYDE PHARMACEUTICALS LTD

15/03/2011 80 mg Tablet 14 EU/1/98/090/005 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/04/2011

Micardis Swingward Ltd TA Medihealth

19/08/2011 40 mg Tablet 14 EU/1/98/090/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

12/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 122/255

Page 123: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Micardis Swingward Ltd TA Medihealth

01/09/2011 80 mg Tablet 14 EU/1/98/090/005 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

12/10/2011

MicardisPlus AN Pharmacy Sp. z o.o.

22/02/2011 80 mg/ 12.5 mg

Tablet 28 EU/1/02/213/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 28/02/2011

MicardisPlus Beragena Arzneimittel GmbH

24/02/2011 80 mg/ 12.5 mg

Tablet 98 EU/1/02/213/010 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 02/03/2011

MicardisPlus Beragena Arzneimittel GmbH

24/02/2011 80 mg/ 25 mg

Tablet 98 EU/1/02/213/023 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 02/03/2011

MicardisPlus BR Pharma International Ltd

10/05/2011 80 mg/ 25 mg

Tablet 14 EU/1/02/213/017 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

28/09/2011

MicardisPlus BR Pharma International Ltd

10/05/2011 80 mg/ 25 mg

Tablet 28 EU/1/02/213/018 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

28/09/2011

MicardisPlus Clear Pharmacy

17/12/2010 40 mg/ 12.5 mg

Tablet 28 EU/1/02/213/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

10/01/2011

MicardisPlus Clear Pharmacy

17/12/2010 80 mg/ 12.5 mg

Tablet 28 EU/1/02/213/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

10/01/2011

MicardisPlus Dr Fisher Farma BV

20/04/2011 80 mg/ 25 mg

Tablet 28 EU/1/02/213/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

26/04/2011

MicardisPlus EU-Pharma BV 30/03/2011 80 mg/ 12.5 mg

Tablet 28 EU/1/02/213/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

12/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 123/255

Page 124: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

MicardisPlus Imed Healthcare Ltd

11/07/2011 80 mg/ 12.5 mg

Tablet 28 EU/1/02/213/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

22/07/2011

MicardisPlus Pharmachim AB

09/09/2011 80 mg/ 12.5 mg

Tablet 28 EU/1/02/213/007 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 26/09/2011

MicardisPlus Pharmachim AB

09/09/2011 80 mg/ 12.5 mg

Tablet 98 EU/1/02/213/010 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 26/09/2011

MicardisPlus PI-Pharma N.V.

15/10/2010 80 mg/ 12.5 mg

Tablet 28 EU/1/02/213/007 Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Belgium 11/01/2011

MicardisPlus PI-Pharma N.V.

12/01/2011 80 mg/ 12.5 mg

Tablet 98 EU/1/02/213/010 Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Belgium 20/01/2011

MicardisPlus STRATHCLYDE PHARMACEUTICALS LTD

07/02/2011 40 mg/ 12.5 mg

Tablet 14 EU/1/02/213/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/03/2011

MicardisPlus STRATHCLYDE PHARMACEUTICALS LTD

07/02/2011 80 mg/ 12.5 mg

Tablet 14 EU/1/02/213/006 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/03/2011

MicardisPlus STRATHCLYDE PHARMACEUTICALS LTD

02/03/2011 40 mg/ 12.5 mg

Tablet 28 EU/1/02/213/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

03/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 124/255

Page 125: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

MicardisPlus STRATHCLYDE PHARMACEUTICALS LTD

02/03/2011 80 mg/ 12.5 mg

Tablet 28 EU/1/02/213/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

03/03/2011

MicardisPlus Vital Supplies UK Limited

17/06/2010 80 mg/ 25 mg

Tablet 28 EU/1/02/213/018 France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

24/01/2011

Mimpara Dr Fisher Farma BV

18/11/2010 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

20/04/2011

Mimpara Haemato Pharm AG

23/03/2011 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/04/2011

Mimpara Haemato Pharm AG

23/03/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/04/2011

Mimpara Haemato Pharm AG

23/03/2011 90 mg Film-coated tablet 28 EU/1/04/292/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/04/2011

Mimpara Medartuum AB 07/10/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 19/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 125/255

Page 126: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mimpara Medartuum AB 14/11/2011 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

Sweden 14/11/2011

Mimpara Paranova Danmark AS

12/07/2011 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/07/2011

Mimpara Paranova Danmark AS

12/07/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/07/2011

Mimpara Paranova Danmark AS

12/07/2011 90 mg Film-coated tablet 28 EU/1/04/292/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/07/2011

Mimpara Paranova Läkemedel AB

18/10/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 07/11/2011

Mimpara Paranova Läkemedel AB

18/10/2011 90 mg Film-coated tablet 28 EU/1/04/292/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 07/11/2011

Mimpara Pharmachim AB

10/06/2011 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 126/255

Page 127: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mimpara Pharmachim AB

10/06/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/06/2011

Mimpara Pharmachim AB

10/06/2011 90 mg Film-coated tablet 28 EU/1/04/292/010 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/06/2011

Mirapexin 2 Care 4 17/12/2010 0.52 mg Prolonged-release tablet

100 EU/1/97/051/018 Austria, Belgium, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 11/02/2011

Mirapexin 2 Care 4 17/12/2010 1.05 mg Prolonged-release tablet

100 EU/1/97/051/021 Austria, Belgium, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 11/02/2011

Mirapexin 2 Care 4 17/12/2010 2.1 mg Prolonged-release tablet

100 EU/1/97/051/024 Austria, Belgium, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 11/02/2011

Mirapexin 2 Care 4 08/02/2011 0.18 mg Tablet 30 EU/1/97/051/003 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 04/03/2011

Mirapexin 2 Care 4 08/02/2011 0.18 mg Tablet 100 EU/1/97/051/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 04/03/2011

Mirapexin 2 Care 4 08/02/2011 0.7 mg Tablet 100 EU/1/97/051/006 Austria, Belgium, Bulgaria, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 29/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 127/255

Page 128: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin 2 Care 4 28/02/2011 3.15 mg Prolonged-release tablet

100 EU/1/97/051/027 Austria, Belgium, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 28/03/2011

Mirapexin Axicorp Pharma GmbH

26/04/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/05/2011

Mirapexin Axicorp Pharma GmbH

26/04/2011 1.05 mg Prolonged-release tablet

100 EU/1/97/051/021 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/05/2011

Mirapexin Axicorp Pharma GmbH

26/04/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/05/2011

Mirapexin Axicorp Pharma GmbH

26/04/2011 2.1 mg Prolonged-release tablet

100 EU/1/97/051/024 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/05/2011

Mirapexin B2B Medical GmbH

19/12/2010 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/03/2011

Mirapexin B2B Medical GmbH

19/12/2010 1.05 mg Prolonged-release tablet

100 EU/1/97/051/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/03/2011

Mirapexin B2B Medical GmbH

19/12/2010 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/03/2011

Mirapexin B2B Medical GmbH

19/12/2010 2.1 mg Prolonged-release tablet

100 EU/1/97/051/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/03/2011

Mirapexin B2B Medical GmbH

13/02/2011 0.52 mg Prolonged-release tablet

30 EU/1/97/051/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 128/255

Page 129: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin B2B Medical GmbH

13/02/2011 0.52 mg Prolonged-release tablet

100 EU/1/97/051/018 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/03/2011

Mirapexin B2B Medical GmbH

13/02/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/03/2011

Mirapexin B2B Medical GmbH

13/02/2011 3.15 mg Prolonged-release tablet

100 EU/1/97/051/027 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/03/2011

Mirapexin BR Pharma International Ltd

13/01/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

10/05/2011

Mirapexin BR Pharma International Ltd

13/01/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

10/05/2011

Mirapexin BR Pharma International Ltd

04/02/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

06/05/2011

Mirapexin Chemilines Ltd 06/01/2011 0.26 mg Prolonged-release tablet

10 EU/1/97/051/013 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

08/04/2011

Mirapexin Chemilines Ltd 06/01/2011 0.52 mg Prolonged-release tablet

10 EU/1/97/051/016 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

08/04/2011

Mirapexin Chemilines Ltd 06/01/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

11/04/2011

Mirapexin Chemilines Ltd 06/01/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

11/04/2011

Mirapexin Chemilines Ltd 11/04/2011 1.05 mg Prolonged-release tablet

100 EU/1/97/051/021 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

15/04/2011

Mirapexin Chemilines Ltd 11/04/2011 2.1 mg Prolonged-release tablet

100 EU/1/97/051/024 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

15/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 129/255

Page 130: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin Chemilines Ltd 24/06/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

04/07/2011

Mirapexin Chemilines Ltd 09/09/2011 0.26 mg Prolonged-release tablet

30 EU/1/97/051/014 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

10/10/2011

Mirapexin Cross Healthcare Ltd

28/01/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

15/02/2011

Mirapexin Cross Healthcare Ltd

28/01/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

15/02/2011

Mirapexin Cross Healthcare Ltd

28/01/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

15/02/2011

Mirapexin Cross Healthcare Ltd

31/01/2011 0.26 mg Prolonged-release tablet

10 EU/1/97/051/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

15/02/2011

Mirapexin Cross Healthcare Ltd

31/01/2011 0.26 mg Prolonged-release tablet

30 EU/1/97/051/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

16/02/2011

Mirapexin Cross Healthcare Ltd

31/01/2011 0.52 mg Prolonged-release tablet

10 EU/1/97/051/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

15/02/2011

Mirapexin Cross Healthcare Ltd

31/01/2011 0.52 mg Prolonged-release tablet

30 EU/1/97/051/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

16/02/2011

Mirapexin Doncaster Pharmaceuticals Group Ltd

20/05/2010 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

03/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 130/255

Page 131: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin Doncaster Pharmaceuticals Group Ltd

21/06/2011 0.26 mg Prolonged-release tablet

30 EU/1/97/051/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

07/07/2011

Mirapexin Ebb Medical AB

04/10/2011 0.18 mg Tablet 30 EU/1/97/051/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/11/2011

Mirapexin Ebb Medical AB

04/10/2011 0.18 mg Tablet 100 EU/1/97/051/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/11/2011

Mirapexin Ebb Medical AB

04/10/2011 0.7 mg Tablet 100 EU/1/97/051/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/11/2011

Mirapexin Emra-Med 10/02/2011 2.1 mg Prolonged-release tablet

100 EU/1/97/051/024 Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/03/2011

Mirapexin Emra-Med 10/02/2011 3.15 mg Prolonged-release tablet

100 EU/1/97/051/027 Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/03/2011

Mirapexin G-Pharma Ltd 25/02/2011 0.26 mg Prolonged-release tablet

30 EU/1/97/051/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

United Kingdom

14/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 131/255

Page 132: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin Interport Ltd 08/08/2011 0.52 mg Prolonged-release tablet

10 EU/1/97/051/016 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

United Kingdom

24/10/2011

Mirapexin Interport Ltd 08/08/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

United Kingdom

24/10/2011

Mirapexin Interport Ltd 08/08/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

United Kingdom

24/10/2011

Mirapexin Interport Ltd 08/08/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

United Kingdom

24/10/2011

Mirapexin Kohlpharma GmbH

09/03/2011 0.26 mg Prolonged-release tablet

10 EU/1/97/051/013 Italy Germany 26/04/2011

Mirapexin Kosei Pharma UK Limited

23/05/2011 0.26 mg Prolonged-release tablet

10 EU/1/97/051/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

25/07/2011

Mirapexin Kosei Pharma UK Limited

23/05/2011 0.26 mg Prolonged-release tablet

30 EU/1/97/051/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

25/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 132/255

Page 133: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin Kosei Pharma UK Limited

23/05/2011 0.52 mg Prolonged-release tablet

10 EU/1/97/051/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

25/07/2011

Mirapexin Kosei Pharma UK Limited

23/05/2011 0.52 mg Prolonged-release tablet

30 EU/1/97/051/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

25/07/2011

Mirapexin Kosei Pharma UK Limited

24/05/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

25/07/2011

Mirapexin Kosei Pharma UK Limited

24/05/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

25/07/2011

Mirapexin Kosei Pharma UK Limited

24/05/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

25/07/2011

Mirapexin Lexon (UK) Ltd

14/12/2011 0.26 mg Prolonged-release tablet

10 EU/1/97/051/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 133/255

Page 134: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin Lexon (UK) Ltd

14/12/2011 0.52 mg Prolonged-release tablet

10 EU/1/97/051/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/12/2011

Mirapexin Lexon (UK) Ltd

14/12/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/12/2011

Mirapexin Lexon (UK) Ltd

14/12/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/12/2011

Mirapexin Lexon (UK) Ltd

14/12/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

19/12/2011

Mirapexin Medartuum AB 17/02/2011 0.7 mg Tablet 100 EU/1/97/051/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 21/02/2011

Mirapexin Medartuum AB 18/02/2011 0.26 mg Prolonged-release tablet

100 EU/1/97/051/015 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 134/255

Page 135: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin Medartuum AB 18/02/2011 1.05 mg Prolonged-release tablet

100 EU/1/97/051/021 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 02/03/2011

Mirapexin Medartuum AB 18/02/2011 2.1 mg Prolonged-release tablet

100 EU/1/97/051/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 02/03/2011

Mirapexin Medartuum AB 01/04/2011 0.18 mg Tablet 100 EU/1/97/051/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 06/04/2011

Mirapexin Medcor Pharmaceuticals BV

22/04/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/05/2011

Mirapexin Medcor Pharmaceuticals BV

22/04/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/05/2011

Mirapexin Medcor Pharmaceuticals BV

22/04/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/05/2011

Mirapexin Medcor Pharmaceuticals BV

04/11/2011 0.26 mg Prolonged-release tablet

10 EU/1/97/051/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

10/11/2011

Mirapexin Mediwin Ltd 08/06/2011 0.52 mg Prolonged-release tablet

10 EU/1/97/051/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

20/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 135/255

Page 136: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin Mediwin Ltd 30/06/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/051/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

14/07/2011

Mirapexin Mediwin Ltd 05/07/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

14/07/2011

Mirapexin Mediwin Ltd 30/08/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/051/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

05/09/2011

Mirapexin MPT Pharma 24/01/2011 0.088 mg Tablet 30 EU/1/97/051/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

10/02/2011

Mirapexin Orifarm AB 14/10/2011 0.52 mg Prolonged-release tablet

100 EU/1/97/051/018 Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 28/10/2011

Mirapexin Orifarm AB 14/10/2011 1.05 mg Prolonged-release tablet

100 EU/1/97/051/021 Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 28/10/2011

Mirapexin Orifarm AB 14/10/2011 2.1 mg Prolonged-release tablet

100 EU/1/97/051/024 Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 28/10/2011

Mirapexin Swingward Ltd TA Medihealth

23/02/2011 0.52 mg Prolonged-release tablet

30 EU/1/97/051/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

02/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 136/255

Page 137: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mirapexin Swingward Ltd TA Medihealth

27/05/2011 0.26 mg Prolonged-release tablet

30 EU/1/97/051/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

30/05/2011

Mirapexin Swingward Ltd TA Medihealth

12/12/2011 0.088 mg Tablet 30 EU/1/97/051/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands

United Kingdom

21/12/2011

Mircera CC Pharma 17/01/2011 50 µg/0.3 ml Solution for injection

3 x 1 pre-filled syringe

EU/1/07/400/023 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Latvia, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/01/2011

Mircera CC Pharma 21/03/2011 75 µg/0.3 ml Solution for injection

3 x 1 pre-filled syringe

EU/1/07/400/024 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Latvia, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/04/2011

Mircera Dr Fisher Farma BV

28/10/2011 100 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, United Kingdom

The Netherlands

15/11/2011

Mircera Dr Fisher Farma BV

28/10/2011 50 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/11/2011

Mircera Dr Fisher Farma BV

28/10/2011 75 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/11/2011

Mircera Emra-Med 06/07/2011 100 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Mircera Emra-Med 06/07/2011 120 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 137/255

Page 138: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mircera Emra-Med 06/07/2011 150 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Mircera Emra-Med 06/07/2011 200 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Mircera Emra-Med 06/07/2011 250 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Mircera Emra-Med 06/07/2011 360 µg/0.6 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Mircera Emra-Med 06/07/2011 50 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Mircera Emra-Med 06/07/2011 75 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Mircera Kohlpharma GmbH

21/11/2011 50 µg/0.3 ml Solution for injection

3 x 1 pre-filled syringe

EU/1/07/400/023 Greece, Spain Germany 24/11/2011

Mircera Kohlpharma GmbH

21/11/2011 75 µg/0.3 ml Solution for injection

3 x 1 pre-filled syringe

EU/1/07/400/024 Greece, Spain Germany 23/11/2011

Mircera Medcor Pharmaceuticals BV

30/06/2011 100 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

04/08/2011

Mircera Medcor Pharmaceuticals BV

30/06/2011 200 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

04/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 138/255

Page 139: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mircera Medcor Pharmaceuticals BV

30/06/2011 50 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

04/08/2011

Mircera Orifarm AB 04/03/2011 100 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 21/03/2011

Mircera Orifarm AB 04/03/2011 50 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 21/03/2011

Mircera Orifarm AB 04/03/2011 75 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 21/03/2011

Mircera Orifarm AS 04/03/2011 100 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/010 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 23/03/2011

Mircera Orifarm AS 04/03/2011 75 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 31/03/2011

Mircera Orifarm AS 22/08/2011 200 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 23/08/2011

Mircera Pharma Westen GmbH

15/11/2011 100 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/010 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/11/2011

Mircera Pharma Westen GmbH

15/11/2011 120 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 139/255

Page 140: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Mircera Pharma Westen GmbH

15/11/2011 150 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/011 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/11/2011

Mircera Pharma Westen GmbH

15/11/2011 200 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/012 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 24/11/2011

Mircera Pharma Westen GmbH

15/11/2011 250 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/013 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/11/2011

Mircera Pharma Westen GmbH

15/11/2011 360 µg/0.6 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/021 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 24/11/2011

Mircera Pharma Westen GmbH

15/11/2011 50 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/11/2011

Mircera Pharma Westen GmbH

15/11/2011 75 µg/0.3 ml Solution for injection

1 pre-filled syringe

EU/1/07/400/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/11/2011

Mozobil Orifarm AB 10/05/2011 20 mg/ml Solution for injection

1 vial EU/1/09/537/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/05/2011

MULTAQ Doncaster Pharmaceuticals Group Ltd

09/02/2011 400 mg Film-coated tablet 60 EU/1/09/591/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

03/03/2011

MULTAQ G-Pharma Ltd 09/03/2011 400 mg Film-coated tablet 60 EU/1/09/591/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

29/03/2011

MULTAQ Orifarm AB 17/10/2011 400 mg Film-coated tablet 20 EU/1/09/591/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 08/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 140/255

Page 141: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

MULTAQ Swingward Ltd TA Medihealth

22/06/2011 400 mg Film-coated tablet 60 EU/1/09/591/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

08/07/2011

MULTAQ Waymade PLC 11/01/2011 400 mg Film-coated tablet 60 EU/1/09/591/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

17/01/2011

Neoclarityn Autumn Healthcare Ltd

23/05/2011 5 mg Film-coated tablet 30 EU/1/00/161/011 Ireland, United Kingdom Ireland, United Kingdom

14/06/2011

Neoclarityn Dr Fisher Farma BV

26/09/2011 5 mg Film-coated tablet 30 EU/1/00/161/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

14/11/2011

Neoclarityn Imed Healthcare Ltd

06/07/2011 5 mg Film-coated tablet 30 EU/1/00/161/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

28/07/2011

Neoclarityn PCO Manufacturing

16/06/2011 0.5 mg/ml Oral solution 1 bottle EU/1/00/161/062 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

14/07/2011

NeoRecormon Abacus Medicine A/S

21/06/2011 10000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/036 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 29/06/2011

NeoRecormon Abacus Medicine A/S

21/06/2011 10000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/036 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

Sweden 05/07/2011

NeoRecormon Abacus Medicine A/S

21/06/2011 4000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/042 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 29/06/2011

NeoRecormon Abacus Medicine A/S

21/06/2011 4000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/042 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 05/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 141/255

Page 142: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

NeoRecormon Abacus Medicine A/S

21/06/2011 6000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/044 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 29/06/2011

NeoRecormon Abacus Medicine A/S

21/09/2011 6000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/044 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 19/10/2011

NeoRecormon Haemato Pharm AG

05/05/2011 10000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/036 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

NeoRecormon Haemato Pharm AG

05/05/2011 2000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/030 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

NeoRecormon Haemato Pharm AG

05/05/2011 30000 IU Solution for injection

4 pre-filled syringes

EU/1/97/031/046 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

NeoRecormon Haemato Pharm AG

05/05/2011 5000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

NeoRecormon Haemato Pharm AG

05/05/2011 6000 IU Solution for injection

6 pre-filled syringes

EU/1/97/031/044 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 142/255

Page 143: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Neulasta ABACUS MEDICINE A/S

21/09/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/09/2011

Neulasta Beragena Arzneimittel GmbH

01/06/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 29/06/2011

Neulasta CC Pharma 07/06/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/06/2011

Neulasta Dr Fisher Farma BV

04/05/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, United Kingdom

The Netherlands

10/05/2011

Neulasta Emra-Med 22/03/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

18/04/2011

Neulasta Haemato Pharm AG

06/01/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

31/01/2011

Neulasta Haemato Pharm AG

11/03/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 143/255

Page 144: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Neulasta Haemato Pharm AG

17/05/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/05/2011

Neulasta Inopha GmbH 03/02/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

16/02/2011

Neulasta Inopha GmbH 26/09/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/10/2011

Neulasta MedicoPharm AG

11/04/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

20/04/2011

Neulasta mibe GmbH Arzneimittel

01/06/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Greece Germany 28/06/2011

Neulasta NewNeopharm BV

27/10/2010 6 mg Solution for injection

1 pre-filled syringe (non blister)

EU/1/02/227/002 Austria, Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/03/2011

Neulasta NewNeopharm BV

04/07/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 144/255

Page 145: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Neulasta Omnia Läkemedel AB

10/10/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Bulgaria, Estonia, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 20/12/2011

Neulasta Orifarm AB 04/10/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 04/11/2011

Neulasta Oy Cross Pharma AB

07/03/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Finland 15/03/2011

Neulasta Paranova Läkemedel AB

28/04/2005 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 20/06/2011

Neulasta Paranova OY 31/08/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 07/09/2011

Neulasta Paranova OY 26/10/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 14/11/2011

Neulasta Parx AB 11/07/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, United Kingdom

Sweden 04/11/2011

Neulasta Pharmachim AB

04/10/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 18/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 145/255

Page 146: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Neulasta Propharmed GmbH

24/03/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/04/2011

Neulasta Tabsn Caps Pack ApS

05/07/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 06/07/2011

Neulasta Veron Pharma Vertriebs GmbH

31/01/2011 6 mg Solution for injection

1 pre-filled syringe with needle guard

EU/1/02/227/004 Austria Germany 03/03/2011

Neulasta Veron Pharma Vertriebs GmbH

16/04/2011 6 mg Solution for injection

1 pre-filled syringe

EU/1/02/227/001 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 17/05/2011

Neupro Amimed Direct Ltd

13/07/2010 2 mg/24h Transdermal patch 7 patches EU/1/05/331/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/05/2011

Neupro Amimed Direct Ltd

13/07/2010 4 mg/24h Transdermal patch 7 patches EU/1/05/331/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/05/2011

Neupro Amimed Direct Ltd

13/07/2010 6 mg/24h Transdermal patch 7 patches EU/1/05/331/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/05/2011

Neupro Amimed Direct Ltd

13/07/2010 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/05/2011

Neupro Amimed Direct Ltd

13/07/2010 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/05/2011

Neupro Amimed Direct Ltd

16/07/2010 8 mg/24h Transdermal patch 7 patches EU/1/05/331/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/05/2011

Neupro Doncaster Pharmaceuticals Group Ltd

25/02/2011 2 mg/24h Transdermal patch 28 patches EU/1/05/331/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

04/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 146/255

Page 147: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Neupro Doncaster Pharmaceuticals Group Ltd

02/03/2011 4 mg/24h Transdermal patch 28 patches EU/1/05/331/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

04/04/2011

Neupro Doncaster Pharmaceuticals Group Ltd

02/03/2011 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

04/04/2011

Neupro Doncaster Pharmaceuticals Group Ltd

03/03/2011 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

04/04/2011

Neupro EuroPharma DK

02/02/2011 4 mg/24h Transdermal patch 7 patches EU/1/05/331/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/02/2011

Neupro EuroPharma DK

02/02/2011 4 mg/24h Transdermal patch 28 patches EU/1/05/331/005 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/02/2011

Neupro EuroPharma DK

15/02/2011 8 mg/24h Transdermal patch 7 patches EU/1/05/331/010 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 16/02/2011

Neupro EuroPharma DK

15/02/2011 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 16/02/2011

Neupro EuroPharma DK

12/10/2011 2 mg/24h Transdermal patch 7 patches EU/1/05/331/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/11/2011

Neupro EuroPharma DK

12/10/2011 2 mg/24h Transdermal patch 28 patches EU/1/05/331/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 147/255

Page 148: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Neupro EuroPharma DK

12/10/2011 6 mg/24h Transdermal patch 7 patches EU/1/05/331/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/11/2011

Neupro EuroPharma DK

12/10/2011 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/11/2011

Neupro Medcor Pharmaceuticals BV

20/06/2011 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/06/2011

Neupro Medcor Pharmaceuticals BV

20/06/2011 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/06/2011

Neupro MTK Pharma GmbH

10/03/2011 4 mg/24h Transdermal patch 84 patches EU/1/05/331/024 Austria, Czech Republic, Italy, Spain, The Netherlands, United Kingdom

Germany 12/04/2011

Neupro MTK Pharma GmbH

10/03/2011 6 mg/24h Transdermal patch 84 patches EU/1/05/331/030 Austria, Czech Republic, Italy, Spain, The Netherlands, United Kingdom

Germany 12/04/2011

Neupro MTK Pharma GmbH

10/03/2011 8 mg/24h Transdermal patch 84 patches EU/1/05/331/036 Austria, Czech Republic, Italy, Spain, The Netherlands, United Kingdom

Germany 12/04/2011

Neupro MTK Pharma GmbH

07/11/2011 2 mg/24h Transdermal patch 84 patches EU/1/05/331/018 Austria, Czech Republic, France, Italy, Spain, The Netherlands, United Kingdom

Germany 14/11/2011

Neupro PCO Manufacturing

20/06/2011 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

22/06/2011

Neupro Pharma Westen GmbH

04/10/2011 2 mg/24h Transdermal patch 56 patches EU/1/05/331/016 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/12/2011

Neupro Pharma Westen GmbH

04/10/2011 6 mg/24h Transdermal patch 56 patches EU/1/05/331/028 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 148/255

Page 149: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Neupro Pharma Westen GmbH

04/10/2011 8 mg/24h Transdermal patch 56 patches EU/1/05/331/034 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/12/2011

Neupro Waymade PLC 04/10/2011 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

11/10/2011

NeuroBloc CC Pharma 24/02/2011 5000 U/ml Solution for injection

1 vial EU/1/00/166/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/03/2011

NeuroBloc CC Pharma 06/07/2011 5000 U/ml Solution for injection

1 vial EU/1/00/166/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

NeuroBloc CC Pharma 29/08/2011 5000 U/ml Solution for injection

1 vial EU/1/00/166/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/09/2011

Nevanac Euro Registratie Collectief BV

30/05/2011 1 mg/ml Eye drops, suspension

1 bottle EU/1/07/433/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

28/06/2011

Nexavar Axicorp Pharma GmbH

20/06/2011 200 mg Film-coated tablet 112 EU/1/06/342/001 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/07/2011

Nexavar Haemato Pharm AG

11/03/2011 200 mg Film-coated tablet 112 EU/1/06/342/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

Denmark 29/03/2011

Nexavar Omnia Läkemedel AB

07/06/2011 200 mg Film-coated tablet 112 EU/1/06/342/001 Bulgaria, France, Greece, Italy, Lithuania, Poland, Romania, Spain, United Kingdom

Sweden 17/06/2011

Nexavar Orifarm AB 12/05/2011 200 mg Film-coated tablet 112 EU/1/06/342/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 25/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 149/255

Page 150: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Nexavar Pharma Westen GmbH

30/09/2010 200 mg Film-coated tablet 112 EU/1/06/342/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/06/2011

Norvir CC Pharma 03/01/2011 100 mg Film-coated tablet 30 EU/1/96/016/005 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/01/2011

Norvir CC Pharma 28/04/2011 100 mg Film-coated tablet 90 (3 x 30) EU/1/96/016/007 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/05/2011

Norvir Pharma Westen GmbH

27/04/2011 100 mg Film-coated tablet 90 (3 x 30) EU/1/96/016/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/05/2011

NovoMix 30 FlexPen

EU-Pharma BV 24/05/2011 100 U/ml Suspension for injection

5 pre-filled pens

EU/1/00/142/009 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

10/08/2011

NovoMix 50 FlexPen

Euro Registratie Collectief BV

15/12/2010 100 U/ml Suspension for injection

5 pre-filled pens

EU/1/00/142/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

11/02/2011

NovoNorm BB Farma s.r.l.

17/11/2011 0.5 mg Tablet 120 EU/1/98/076/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

NovoNorm CC Pharma 17/10/2011 0.5 mg Tablet 120 EU/1/98/076/006 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

NovoNorm CC Pharma 17/10/2011 1 mg Tablet 120 EU/1/98/076/013 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

NovoNorm CC Pharma 17/10/2011 2 mg Tablet 120 EU/1/98/076/020 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

NovoNorm Euro Registratie Collectief BV

12/07/2011 0.5 mg Tablet 90 EU/1/98/076/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

13/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 150/255

Page 151: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

NovoNorm Euro Registratie Collectief BV

12/07/2011 1 mg Tablet 90 EU/1/98/076/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

13/07/2011

NovoRapid Axicorp Pharma GmbH

07/09/2011 100 U/ml Solution for injection

5 x (1 x 10 ml) vials

EU/1/99/119/015 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/10/2011

NovoRapid CC Pharma 19/04/2011 100 U/ml Solution for injection

10 cartridges

EU/1/99/119/006 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

NovoRapid Emra-Med 25/01/2010 100 U/ml Solution for injection

5 x (1 x 10 ml) vials

EU/1/99/119/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/01/2011

NovoRapid EU-Pharma BV 30/05/2011 100 U/ml Solution for injection

5 pre-filled pens

EU/1/99/119/009 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

28/06/2011

NovoRapid PCO Manufacturing

15/11/2011 100 U/ml Solution for injection

1 vial EU/1/99/119/001 United Kingdom Ireland 08/12/2011

Noxafil Euro Registratie Collectief BV

13/12/2010 40 mg/ml Oral suspension 1 bottle EU/1/05/320/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

06/01/2011

Noxafil Orifarm AB 19/05/2011 40 mg/ml Oral suspension 1 bottle EU/1/05/320/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 23/05/2011

Noxafil Orifarm AS 11/05/2011 40 mg/ml Oral suspension 1 bottle EU/1/05/320/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 25/05/2011

Noxafil Propharmed GmbH

31/03/2011 40 mg/ml Oral suspension 1 bottle EU/1/05/320/001 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/04/2011

NutropinAq Dr Fisher Farma BV

15/12/2010 10 mg/2 ml Solution for injection

1 cartridge EU/1/00/164/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

27/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 151/255

Page 152: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Olanzapine Mylan Doncaster Pharmaceuticals Group Ltd

06/10/2011 2.5 mg Film-coated tablet 28 EU/1/08/475/001 Ireland, Malta, United Kingdom Ireland, Malta, United Kingdom

18/10/2011

Olanzapine Mylan Doncaster Pharmaceuticals Group Ltd

07/10/2011 10 mg Film-coated tablet 28 EU/1/08/475/019 Ireland, Malta, United Kingdom Ireland, Malta, United Kingdom

18/10/2011

Olanzapine Mylan Doncaster Pharmaceuticals Group Ltd

07/10/2011 5 mg Film-coated tablet 28 EU/1/08/475/007 Ireland, Malta, United Kingdom Ireland, Malta, United Kingdom

18/10/2011

Omnitrope Concept Pharma Vertriebs GmbH

07/06/2011 3.3 mg/ml Solution for injection in cartridge

1 cartridge EU/1/06/332/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/07/2011

Omnitrope Concept Pharma Vertriebs GmbH

07/06/2011 6.7 mg/ml Solution for injection in cartridge

1 cartridge EU/1/06/332/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/07/2011

Omnitrope Medartuum AB 13/01/2011 6.7 mg/ml Solution for injection in cartridge

1 cartridge EU/1/06/332/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 17/02/2011

Omnitrope MTK Pharma GmbH

17/02/2011 3.3 mg/ml Solution for injection in cartridge

10 cartridges

EU/1/06/332/006 France, Italy Germany 25/02/2011

Omnitrope MTK Pharma GmbH

17/02/2011 6.7 mg/ml Solution for injection in cartridge

10 cartridges

EU/1/06/332/009 Austria, France, Italy Germany 25/02/2011

Omnitrope Pharmachim AB

20/06/2011 3.3 mg/ml Solution for injection in cartridge

1 cartridge EU/1/06/332/004 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 12/07/2011

Omnitrope Pharmachim AB

20/06/2011 6.7 mg/ml Solution for injection in cartridge

1 cartridge EU/1/06/332/007 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 12/07/2011

Onbrez Breezhaler 2 Care 4 18/05/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 152/255

Page 153: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Onbrez Breezhaler 2 Care 4 18/05/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/05/2011

Onbrez Breezhaler 2 Care 4 18/05/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/05/2011

Onbrez Breezhaler Amimed Direct Ltd

14/06/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

29/06/2011

Onbrez Breezhaler Amimed Direct Ltd

14/06/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

29/06/2011

Onbrez Breezhaler Axicorp Pharma GmbH

21/02/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/03/2011

Onbrez Breezhaler Axicorp Pharma GmbH

15/03/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Onbrez Breezhaler B&S Healthcare Ltd

18/07/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/09/2011

Onbrez Breezhaler B&S Healthcare Ltd

18/07/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/09/2011

Onbrez Breezhaler B2B Medical GmbH

10/08/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 153/255

Page 154: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Onbrez Breezhaler B2B Medical GmbH

10/08/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/08/2011

Onbrez Breezhaler Beragena Arzneimittel GmbH

14/04/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 05/05/2011

Onbrez Breezhaler Beragena Arzneimittel GmbH

14/04/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 05/05/2011

Onbrez Breezhaler BR Pharma International Ltd

22/02/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/02/2011

Onbrez Breezhaler BR Pharma International Ltd

10/05/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/08/2011

Onbrez Breezhaler CC Pharma 14/12/2010 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/01/2011

Onbrez Breezhaler CC Pharma 14/12/2010 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/01/2011

Onbrez Breezhaler CC Pharma 28/02/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Onbrez Breezhaler CC Pharma 12/04/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/04/2011

Onbrez Breezhaler Dr Fisher Farma BV

28/03/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

30/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 154/255

Page 155: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Onbrez Breezhaler Dr Fisher Farma BV

18/07/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

20/07/2011

Onbrez Breezhaler Dr Fisher Farma BV

23/08/2011 150 µg Inhalation powder, hard capsule

10 + 1 inhaler

EU/1/09/593/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

24/08/2011

Onbrez Breezhaler Dr Fisher Farma BV

23/08/2011 300 µg Inhalation powder, hard capsule

10 + 1 inhaler

EU/1/09/593/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

24/08/2011

Onbrez Breezhaler Emra-Med 21/09/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, TheNetherlands, United Kingdom

Germany 20/10/2011

Onbrez Breezhaler Emra-Med 25/11/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/11/2011

Onbrez Breezhaler Euro Registratie Collectief BV

14/12/2010 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

04/01/2011

Onbrez Breezhaler EuroPharma DK

07/07/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/08/2011

Onbrez Breezhaler EuroPharma DK

07/07/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/08/2011

Onbrez Breezhaler EuroPharma DK

07/07/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 155/255

Page 156: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Onbrez Breezhaler EuroPharma DK

07/07/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/08/2011

Onbrez Breezhaler Interport Ltd 04/11/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

United Kingdom

14/11/2011

Onbrez Breezhaler Interport Ltd 04/11/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

United Kingdom

09/11/2011

Onbrez Breezhaler Kohlpharma GmbH

12/01/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Italy, Spain Germany 25/01/2011

Onbrez Breezhaler Kohlpharma GmbH

25/01/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, France, Ireland, Italy, Spain Germany 23/03/2011

Onbrez Breezhaler Kohlpharma GmbH

29/03/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Italy, Norway, United Kingdom Germany 04/05/2011

Onbrez Breezhaler Kohlpharma GmbH

20/04/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Italy Germany 04/05/2011

Onbrez Breezhaler Medcor Pharmaceuticals BV

28/02/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

18/03/2011

Onbrez Breezhaler Medcor Pharmaceuticals BV

28/02/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

18/03/2011

Onbrez Breezhaler MedicoPharm AG

24/02/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 156/255

Page 157: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Onbrez Breezhaler MedicoPharm AG

24/02/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/03/2011

Onbrez Breezhaler MedicoPharm AG

24/02/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/03/2011

Onbrez Breezhaler MedicoPharm AG

24/02/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/03/2011

Onbrez Breezhaler Mediwin Ltd 10/02/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands

United Kingdom

23/02/2011

Onbrez Breezhaler Mediwin Ltd 24/03/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands

United Kingdom

01/04/2011

Onbrez Breezhaler MPT Pharma 04/01/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

10/01/2011

Onbrez Breezhaler MPT Pharma 04/01/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

07/01/2011

Onbrez Breezhaler MPT Pharma 04/01/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

03/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 157/255

Page 158: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Onbrez Breezhaler MPT Pharma 04/01/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

03/02/2011

Onbrez Breezhaler Orifarm AS 28/01/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/03/2011

Onbrez Breezhaler Orifarm AS 28/01/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/03/2011

Onbrez Breezhaler Paranova Danmark AS

12/09/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Romania, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/10/2011

Onbrez Breezhaler Paranova Danmark AS

13/09/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/10/2011

Onbrez Breezhaler Paranova Danmark AS

13/09/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/593/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/10/2011

Onbrez Breezhaler Paranova Danmark AS

13/09/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/593/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Romania, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/10/2011

Onglyza Lexon (UK) Ltd

12/12/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

20/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 158/255

Page 159: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Onglyza Orifarm AS 27/10/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/11/2011

Onglyza Paranova Danmark AS

26/09/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/10/2011

Onglyza Paranova Danmark AS

26/09/2011 5 mg Film-coated tablet 98 EU/1/09/545/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/10/2011

Onglyza PCO Manufacturing

22/03/2011 5 mg Film-coated tablet 28 EU/1/09/545/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

06/06/2011

Onglyza PCO Manufacturing

24/03/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

22/07/2011

Onglyza Swingward Ltd TA Medihealth

15/03/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

28/04/2011

Onglyza Waymade PLC 14/07/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/08/2011

Opatanol B&S Healthcare Ltd

16/11/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

07/12/2011

Opatanol Clear Pharmacy

20/12/2010 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

11/01/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 159/255

Page 160: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Opatanol Dr Fisher Farma BV

13/07/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/08/2011

Opatanol Lexon (UK) Ltd

13/12/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

20/12/2011

Opatanol Paranova Läkemedel AB

02/08/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 23/08/2011

Opatanol Paranova Läkemedel AB

02/08/2011 1 mg/ml Eye drops, solution 3 bottles EU/1/02/217/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 23/08/2011

Opatanol Profind Wholesale Ltd.

12/10/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

13/12/2011

Optruma Mediwin Ltd 28/11/2011 60 mg Film-coated tablet 28 EU/1/98/074/002 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

France 07/12/2011

Optruma Mediwin Ltd 28/11/2011 60 mg Film-coated tablet 84 EU/1/98/074/003 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Spain, Sweden, The Netherlands, United Kingdom

France 07/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 160/255

Page 161: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Orencia Medartuum AB 24/05/2011 250 mg Powder for concentrate for solution for infusion

1 vial + 1 syringe

EU/1/07/389/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 31/05/2011

Orencia Orifarm AB 31/01/2011 250 mg Powder for concentrate for solution for infusion

1 vial + 1 syringe

EU/1/07/389/001 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 17/03/2011

Orencia Pharmachim AB

26/10/2011 250 mg Powder for concentrate for solution for infusion

1 vial + 1 syringe

EU/1/07/389/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 22/11/2011

Orencia Pharmachim AB

26/10/2011 250 mg Powder for concentrate for solution for infusion

3 vials + 3 syringes

EU/1/07/389/003 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 22/11/2011

Orfadin Abacus Medicine A/S

30/06/2011 10 mg Capsule, hard 60 EU/1/04/303/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/07/2011

Orfadin Abacus Medicine A/S

30/06/2011 5 mg Capsule, hard 60 EU/1/04/303/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/07/2011

Orfadin Abacus Medicine A/S

09/08/2011 2 mg Capsule, hard 60 EU/1/04/303/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/08/2011

Orgalutran Orifarm AB 30/06/2011 0.25 mg/ 0.5 ml

Solution for injection

5 pre-filled syringes

EU/1/00/130/002 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/07/2011

Orgalutran Orifarm AS 30/06/2011 0.25 mg/ 0.5 ml

Solution for injection

1 pre-filled syringe

EU/1/00/130/001 Austria, Belgium, Cyprus, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/07/2011

Orgalutran Orifarm AS 30/06/2011 0.25 mg/ 0.5 ml

Solution for injection

5 pre-filled syringes

EU/1/00/130/002 Austria, Belgium, Cyprus, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 161/255

Page 162: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Orgalutran Pharmachim AB

08/07/2011 0.25 mg/ 0.5 ml

Solution for injection

1 pre-filled syringe

EU/1/00/130/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 19/07/2011

Oslif Breezhaler BR Pharma International Ltd

14/03/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/586/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/04/2011

Oslif Breezhaler BR Pharma International Ltd

14/03/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/586/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/08/2011

Oslif Breezhaler Pharma Westen GmbH

16/02/2011 150 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/586/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/03/2011

Oslif Breezhaler Pharma Westen GmbH

16/02/2011 150 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/586/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/03/2011

Oslif Breezhaler Pharma Westen GmbH

16/02/2011 300 µg Inhalation powder, hard capsule

30 (3 x 10) + 1 inhaler

EU/1/09/586/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/03/2011

Oslif Breezhaler Pharma Westen GmbH

16/02/2011 300 µg Inhalation powder, hard capsule

3 x (30 + 1 inhaler)

EU/1/09/586/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/03/2011

Ovitrelle Orifarm AB 27/10/2011 250 micrograms/ 0.5 ml

Solution for injection

1 pre-filled syringe

EU/1/00/165/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 10/11/2011

Ovitrelle Orifarm AS 27/10/2011 250 micrograms/ 0.5 ml

Solution for injection

1 pre-filled syringe

EU/1/00/165/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/11/2011

Pegasys Axicorp Pharma GmbH

12/07/2011 135 µg Solution for injection

4 pre-filled syringes + 4 injection needles

EU/1/02/221/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 162/255

Page 163: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Pegasys Medartuum AB 07/04/2011 135 µg Solution for injection

4 pre-filled syringes + 4 injection needles

EU/1/02/221/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/04/2011

Pegasys Omnia Läkemedel AB

28/09/2011 135 µg Solution for injection

4 pre-filled syringes + 4 injection needles

EU/1/02/221/006 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Latvia, Lithuania, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 20/10/2011

Pegasys Omnia Läkemedel AB

28/09/2011 180 µg Solution for injection

4 pre-filled syringes + 4 injection needles

EU/1/02/221/008 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Latvia, Lithuania, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 20/10/2011

Pegasys Orifarm AB 20/10/2011 180 µg Solution for injection

4 pre-filled syringes + 4 injection needles

EU/1/02/221/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 07/12/2011

Pegasys Orifarm AS 04/01/2011 180 µg Solution for injection

4 pre-filled syringes + 4 injection needles

EU/1/02/221/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/01/2011

Pegasys Veron Pharma Vertriebs GmbH

16/11/2011 180 µg Solution for injection

1 pre-filled syringe + 1 injection needle

EU/1/02/221/007 Austria, Greece Germany 28/11/2011

Pegasys Veron Pharma Vertriebs GmbH

16/11/2011 180 µg Solution for injection

4 pre-filled syringes + 4 injection needles

EU/1/02/221/008 Austria, Greece Germany 28/11/2011

PegIntron Emra-Med 06/06/2007 100 micrograms

Powder and solvent for solution for injection in pre-filled pen

4 pens + 4 injection needles + 8 cleansing swabs

EU/1/00/131/040 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 163/255

Page 164: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

PegIntron Orifarm AS 07/01/2011 120 micrograms

Powder and solvent for solution for injection in pre-filled pen

4 pens + 4 injection needles + 8 cleansing swabs

EU/1/00/131/044 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/01/2011

PegIntron Propharmed GmbH

19/04/2011 100 micrograms

Powder and solvent for solution for injection in pre-filled pen

4 pens + 4 injection needles + 8 cleansing swabs

EU/1/00/131/040 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

PegIntron Propharmed GmbH

19/04/2011 120 micrograms

Powder and solvent for solution for injection in pre-filled pen

4 pens + 4 injection needles + 8 cleansing swabs

EU/1/00/131/044 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

PegIntron Propharmed GmbH

19/04/2011 120 micrograms

Powder and solvent for solution for injection in pre-filled pen

12 pens + 12 injection needles + 24 cleansing swabs

EU/1/00/131/046 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

PegIntron Propharmed GmbH

19/04/2011 150 micrograms

Powder and solvent for solution for injection in pre-filled pen

4 pens + 4 injection needles + 8 cleansing swabs

EU/1/00/131/048 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

PegIntron Propharmed GmbH

20/04/2011 100 micrograms

Powder and solvent for solution for injection in pre-filled pen

12 pens + 12 injection needles + 24 cleansing swabs

EU/1/00/131/042 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/04/2011

Plavix 2 Care 4 27/06/2011 300 mg Film-coated tablet 30 x 1 EU/1/98/069/009 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/08/2011

Plavix Acta Pharma 29/07/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Bulgaria 26/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 164/255

Page 165: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Plavix AN Pharmacy Sp. z o.o.

17/12/2010 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 17/03/2011

Plavix BB Farma s.r.l.

22/03/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

France 14/04/2011

Plavix Combiphar Europe BV

05/02/2009 75 mg Film-coated tablet 30 EU/1/98/069/005a Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

05/07/2011

Plavix Delfarma SpZoo

02/03/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 16/03/2011

Plavix Lexon (UK) Ltd

31/03/2011 75 mg Film-coated tablet 30 EU/1/98/069/005a Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/05/2011

Plavix Mediwin Ltd 07/01/2011 75 mg Film-coated tablet 30 EU/1/98/069/005a Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

France 15/02/2011

Plavix PHARMECO ApS

06/04/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Czech Republic, Italy, Lithuania, Romania, Spain

Denmark 18/04/2011

Plavix PI-Pharma N.V.

11/10/2010 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Belgium 13/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 165/255

Page 166: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Plavix PI-Pharma N.V.

11/08/2011 75 mg Film-coated tablet 84 EU/1/98/069/003a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Belgium 13/12/2011

Plavix SAIMA Productos Y Servicios S.L.U.

07/06/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Germany Spain 23/08/2011

Pradaxa Axicorp Pharma GmbH

06/05/2011 110 mg Capsule, hard 30 x 1 EU/1/08/442/006 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/06/2011

Pradaxa Axicorp Pharma GmbH

06/05/2011 75 mg Capsule, hard 30 x 1 EU/1/08/442/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/06/2011

Pradaxa Emra-Med 26/09/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/10/2011

Pradaxa Euro Registratie Collectief BV

30/05/2011 75 mg Capsule, hard 30 x 1 EU/1/08/442/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

27/06/2011

Pradaxa Euro Registratie Collectief BV

16/09/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

20/09/2011

Pradaxa Euro Registratie Collectief BV

19/09/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

20/09/2011

Pradaxa Euro Registratie Collectief BV

20/09/2011 110 mg Capsule, hard 30 x 1 EU/1/08/442/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/09/2011

Pradaxa Europharma Sverige AB

25/10/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 166/255

Page 167: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Pradaxa Europharma Sverige AB

25/10/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 12/12/2011

Pradaxa Medartuum AB 26/10/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 28/10/2011

Pradaxa Orifarm AB 20/10/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Spain, The Netherlands, United Kingdom

Sweden 25/11/2011

Pradaxa Orifarm AB 20/10/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 25/11/2011

Pradaxa Orifarm AS 07/10/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/11/2011

Pradaxa Orifarm AS 07/10/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/11/2011

Pradaxa PCO Manufacturing

15/06/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

09/08/2011

Pradaxa PCO Manufacturing

15/06/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

09/08/2011

Pradaxa Pharma Westen GmbH

11/03/2011 110 mg Capsule, hard 30 x 1 EU/1/08/442/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 167/255

Page 168: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Pradaxa Pharma Westen GmbH

25/08/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/09/2011

Pradaxa Veron Pharma Vertriebs GmbH

31/03/2011 110 mg Capsule, hard 10 x 1 EU/1/08/442/005 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 17/05/2011

Pradaxa Veron Pharma Vertriebs GmbH

31/03/2011 110 mg Capsule, hard 30 x 1 EU/1/08/442/006 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 17/05/2011

Pradaxa Veron Pharma Vertriebs GmbH

31/03/2011 75 mg Capsule, hard 10 x 1 EU/1/08/442/001 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 17/05/2011

Pradaxa Veron Pharma Vertriebs GmbH

31/03/2011 75 mg Capsule, hard 30 x 1 EU/1/08/442/002 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 17/05/2011

Pradaxa Veron Pharma Vertriebs GmbH

27/09/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 11/10/2011

Prandin Paranova Läkemedel AB

08/04/2011 1 mg Tablet 90 EU/1/00/162/010 Spain, United Kingdom Sweden 20/04/2011

Prandin Paranova Läkemedel AB

08/04/2011 1 mg Tablet 120 EU/1/00/162/011 Spain, United Kingdom Sweden 20/04/2011

Prandin Paranova Läkemedel AB

11/04/2011 2 mg Tablet 90 EU/1/00/162/016 Spain, United Kingdom Sweden 20/04/2011

Prandin Paranova Läkemedel AB

11/04/2011 2 mg Tablet 120 EU/1/00/162/017 Spain, United Kingdom Sweden 20/04/2011

Prevenar 13 Axicorp Pharma GmbH

07/12/2010 0.5ml Suspension for injection

1 pre-filled syringe with separate needle

EU/1/09/590/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/01/2011

Prevenar 13 CC Pharma 20/12/2010 - - Suspension for injection

1 pre-filled syringe

EU/1/09/590/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/01/2011

Prezista Medcor Pharmaceuticals BV

10/05/2011 600 mg Film-coated tablet 60 EU/1/06/380/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

16/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 168/255

Page 169: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Prezista Orifarm AS 16/12/2010 600 mg Film-coated tablet 60 EU/1/06/380/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/01/2011

Prezista Orifarm OY 07/03/2011 400 mg Film-coated tablet 60 EU/1/06/380/003 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Finland 28/03/2011

Pritor BCN Farma SL 01/02/2011 40 mg Tablet 28 EU/1/98/089/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 15/02/2011

Pritor BCN Farma SL 23/03/2011 80 mg Tablet 28 EU/1/98/089/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 01/04/2011

Pritor Emra-Med 28/07/2011 40 mg Tablet 98 EU/1/98/089/004 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Pritor Emra-Med 28/07/2011 80 mg Tablet 98 EU/1/98/089/009 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Pritor Euromedicines, S.L.

13/12/2010 80 mg Tablet 28 EU/1/98/089/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 28/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 169/255

Page 170: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

PritorPlus B&S Healthcare Ltd

12/05/2011 80 mg/ 12.5 mg

Tablet 28 EU/1/02/215/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

11/07/2011

PritorPlus B&S Healthcare Ltd

12/05/2011 80 mg/ 25mg

Tablet 28 EU/1/02/215/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

11/07/2011

PritorPlus Emra-Med 26/07/2011 80 mg/ 12.5 mg

Tablet 98 EU/1/02/215/010 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/09/2011

PritorPlus Emra-Med 28/07/2011 80 mg/ 25mg

Tablet 98 EU/1/02/215/021 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/09/2011

PritorPlus Emra-Med 30/09/2011 40 mg/ 12.5 mg

Tablet 98 EU/1/02/215/005 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/10/2011

PritorPlus Euromedicines, S.L.

13/12/2010 80 mg/ 12.5 mg

Tablet 28 EU/1/02/215/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 28/02/2011

PritorPlus G-Pharma Ltd 02/02/2011 80 mg/ 12.5 mg

Tablet 28 EU/1/02/215/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

17/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 170/255

Page 171: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

PritorPlus G-Pharma Ltd 02/02/2011 80 mg/ 25mg

Tablet 28 EU/1/02/215/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

17/02/2011

PritorPlus Orifarm AB 08/03/2011 80 mg/ 12.5 mg

Tablet 98 EU/1/02/215/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 17/03/2011

Privigen Axicorp Pharma B.V.

26/07/2011 100 mg/ml Solution for infusion

1 vial EU/1/08/446/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/08/2011

Privigen Emra-Med 27/10/2011 100 mg/ml Solution for infusion

1 vial EU/1/08/446/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/11/2011

Privigen Haemato Pharm AG

03/08/2011 100 mg/ml Solution for infusion

1 vial EU/1/08/446/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/08/2011

Privigen Haemato Pharm AG

03/08/2011 100 mg/ml Solution for infusion

1 vial EU/1/08/446/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/08/2011

Privigen Haemato Pharm AG

03/08/2011 100 mg/ml Solution for infusion

1 vial EU/1/08/446/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/08/2011

Procoralan Autumn Healthcare Ltd

05/07/2011 5 mg Film-coated tablet 56 EU/1/05/316/003 Ireland, United Kingdom Ireland, United Kingdom

11/07/2011

Procoralan Autumn Healthcare Ltd

05/07/2011 7.5 mg Film-coated tablet 56 EU/1/05/316/010 Ireland, United Kingdom Ireland, United Kingdom

11/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 171/255

Page 172: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Procoralan Lexon (UK) Ltd

12/12/2011 5 mg Film-coated tablet 56 EU/1/05/316/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

21/12/2011

Procoralan PCO Manufacturing

11/05/2010 5 mg Film-coated tablet 56 EU/1/05/316/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

10/02/2011

Procoralan Profind Wholesale Ltd.

17/08/2011 5 mg Film-coated tablet 56 EU/1/05/316/003 United Kingdom Ireland 25/08/2011

Procoralan Profind Wholesale Ltd.

17/08/2011 7.5 mg Film-coated tablet 56 EU/1/05/316/010 United Kingdom Ireland 25/08/2011

Prolia Axicorp Pharma GmbH

07/12/2010 60 mg/ml Solution for injection

1 pre-filled syringe with automatic needle guard (blistered)

EU/1/10/618/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/02/2011

Prolia CC Pharma 02/12/2010 60 mg/ml Solution for injection

1 pre-filled syringe with automatic needle guard (blistered)

EU/1/10/618/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/01/2011

Prolia Eureco-Pharma B.V.

05/08/2011 60 mg/ml Solution for injection

1 pre-filled syringe with automatic needle guard (blistered)

EU/1/10/618/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, United Kingdom

The Netherlands

30/08/2011

Prolia Euro Registratie Collectief BV

14/11/2011 60 mg/ml Solution for injection

1 pre-filled syringe with automatic needle guard (blistered)

EU/1/10/618/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

22/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 172/255

Page 173: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Prolia Medcor Pharmaceuticals BV 0

20/06/2011 60 mg/ml Solution for injection

1 pre-filled syringe with automatic needle guard (blistered)

EU/1/10/618/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/06/2011

Prolia Pharma Westen GmbH

04/11/2011 60 mg/ml Solution for injection

1 pre-filled syringe with automatic needle guard (blistered)

EU/1/10/618/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

Prometax B&S Healthcare Ltd

17/05/2011 1.5 mg Capsule, hard 28 EU/1/98/092/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/05/2011

Prometax B&S Healthcare Ltd

17/05/2011 3 mg Capsule, hard 56 EU/1/98/092/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/05/2011

Prometax B&S Healthcare Ltd

17/05/2011 4.5 mg Capsule, hard 56 EU/1/98/092/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/05/2011

Prometax B&S Healthcare Ltd

17/05/2011 4.6 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/092/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 173/255

Page 174: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Prometax B&S Healthcare Ltd

17/05/2011 6 mg Capsule, hard 56 EU/1/98/092/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/05/2011

Prometax B&S Healthcare Ltd

17/05/2011 9.5 mg / 24 hours

Transdermal patch 30 sachets EU/1/98/092/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/05/2011

Prometax Emra-Med 24/05/2011 3 mg Capsule, hard 56 EU/1/98/092/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/05/2011

Prometax Emra-Med 24/05/2011 4.5 mg Capsule, hard 56 EU/1/98/092/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/05/2011

Protelos 2 Care 4 17/05/2010 2 g Granules for oral suspension

28 sachets EU/1/04/288/003 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/01/2011

Protelos 2 Care 4 02/07/2010 2 g Granules for oral suspension

84 sachets EU/1/04/288/005 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/01/2011

Protelos Euro Registratie Collectief BV

23/06/2011 2 g Granules for oral suspension

28 sachets EU/1/04/288/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

04/07/2011

Protopic Abacus Medicine A/S

18/08/2011 0.03% Ointment 1 tube EU/1/02/201/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/09/2011

Protopic Abacus Medicine A/S

18/08/2011 0.03% Ointment 1 tube EU/1/02/201/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 174/255

Page 175: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Protopic Abacus Medicine A/S

18/08/2011 0.1% Ointment 1 tube EU/1/02/201/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/09/2011

Protopic Abacus Medicine A/S

19/08/2011 0.1% Ointment 1 tube EU/1/02/201/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/09/2011

Protopic Autumn Healthcare Ltd

23/05/2011 0.03% Ointment 1 tube EU/1/02/201/001 Ireland, United Kingdom Ireland, United Kingdom

27/06/2011

Protopic Autumn Healthcare Ltd

07/06/2011 0.1% Ointment 1 tube EU/1/02/201/003 Ireland, United Kingdom Ireland, United Kingdom

27/06/2011

Protopic Autumn Healthcare Ltd

07/06/2011 0.1% Ointment 1 tube EU/1/02/201/004 Ireland, United Kingdom Ireland, United Kingdom

27/06/2011

Protopic Doncaster Pharmaceuticals Group Ltd

16/09/2011 0.1% Ointment 1 tube EU/1/02/201/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

23/09/2011

Protopic Doncaster Pharmaceuticals Group Ltd

19/09/2011 0.03% Ointment 1 tube EU/1/02/201/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

23/09/2011

Protopic Medartuum AB 06/10/2010 0.1% Ointment 1 tube EU/1/02/201/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/02/2011

Protopic Medartuum AB 05/09/2011 0.1% Ointment 1 tube EU/1/02/201/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 04/10/2011

Protopic Paranova Läkemedel AB

12/10/2011 0.1% Ointment 1 tube EU/1/02/201/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 27/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 175/255

Page 176: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Protopic Paranova Läkemedel AB

12/10/2011 0.1% Ointment 1 tube EU/1/02/201/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 27/10/2011

Puregon 2 Care 4 27/06/2011 300 IU/ 0.36 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/038 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/07/2011

Puregon 2 Care 4 27/06/2011 600 IU/ 0.72 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/039 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 27/07/2011

Puregon Abacus Medicine A/S

30/09/2011 300 IU/ 0.36 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/038 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 18/10/2011

Puregon Axicorp Pharma GmbH

28/06/2011 900 IU/ 1.08 ml

Solution for injection

1 cartridge + 3 packs with 3 pen needles

EU/1/96/008/041 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/07/2011

Puregon Axicorp Pharma GmbH

12/07/2011 300 IU/ 0.36 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/038 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/07/2011

Puregon Axicorp Pharma GmbH

26/07/2011 600 IU/ 0.72 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/039 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/08/2011

Puregon EuroPharma DK

19/05/2011 300 IU/ 0.36 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/038 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 31/05/2011

Puregon EuroPharma DK

19/05/2011 600 IU/ 0.72 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/039 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 31/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 176/255

Page 177: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Puregon Haemato Pharm AG

08/12/2010 600 IU/ 0.72 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/039 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

19/01/2011

Puregon Haemato Pharm AG

09/12/2010 300 IU/ 0.36 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/038 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

19/01/2011

Puregon Haemato Pharm AG

10/12/2010 900 IU/ 1.08 ml

Solution for injection

1 cartridge + 3 packs with 3 pen needles

EU/1/96/008/041 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

19/01/2011

Puregon Haemato Pharm AG

08/03/2011 300 IU/ 0.36 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/038 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/03/2011

Puregon Haemato Pharm AG

08/03/2011 600 IU/ 0.72 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/039 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/03/2011

Puregon Haemato Pharm AG

08/03/2011 900 IU/ 1.08 ml

Solution for injection

1 cartridge + 3 packs with 3 pen needles

EU/1/96/008/041 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 177/255

Page 178: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Puregon Pharmachim AB

11/03/2011 300 IU/ 0.36 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/038 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/04/2011

Puregon Pharmachim AB

11/03/2011 600 IU/ 0.72 ml

Solution for injection

1 cartridge + 2 packs with 3 pen needles

EU/1/96/008/039 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/04/2011

Puregon Pharmachim AB

11/03/2011 900 IU/ 1.08 ml

Solution for injection

1 cartridge + 3 packs with 3 pen needles

EU/1/96/008/041 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/04/2011

Rapamune Kohlpharma GmbH

02/02/2011 0.5 mg Coated tablet 3 x 10 EU/1/01/171/013 Austria Germany 28/03/2011

Rapamune Kohlpharma GmbH

02/02/2011 0.5 mg Coated tablet 10 x 10 EU/1/01/171/014 Austria Germany 28/03/2011

Rapilysin Orifarm AS 28/07/2011 10 U Powder and solvent for solution for injection

2 vials + 2 pre-filled syringes + 2 reconstitution devices/needles

EU/1/96/018/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/08/2011

Rasilez Amimed Direct Ltd

10/06/2011 150 mg Film-coated tablet 30 EU/1/07/405/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/06/2011

Rasilez Amimed Direct Ltd

14/06/2011 300 mg Film-coated tablet 30 EU/1/07/405/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/06/2011

Rasilez Axicorp Pharma GmbH

22/02/2011 150 mg Film-coated tablet 98 EU/1/07/405/028 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 178/255

Page 179: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Rasilez B&S Healthcare Ltd

16/08/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

17/08/2011

Rasilez B&S Healthcare Ltd

07/10/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/10/2011

Rasilez Beragena Arzneimittel GmbH

18/10/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 03/11/2011

Rasilez Beragena Arzneimittel GmbH

18/10/2011 150 mg Film-coated tablet 98 EU/1/07/405/028 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 08/11/2011

Rasilez Beragena Arzneimittel GmbH

18/10/2011 300 mg Film-coated tablet 98 EU/1/07/405/038 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 08/11/2011

Rasilez Beragena Arzneimittel GmbH

18/10/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 08/11/2011

Rasilez CC Pharma 22/07/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/09/2011

Rasilez cc Pharma 22/07/2011 300 mg Film-coated tablet 56 EU/1/07/405/035 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/09/2011

Rasilez CC Pharma 22/07/2011 300 mg Film-coated tablet 98 EU/1/07/405/038 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/09/2011

Rasilez Chemilines Ltd 07/01/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

12/04/2011

Rasilez Chemilines Ltd 07/01/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

12/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 179/255

Page 180: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Rasilez Dr Fisher Farma BV

25/05/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

05/07/2011

Rasilez Dr Fisher Farma BV

27/07/2011 150 mg Film-coated tablet 14 EU/1/07/405/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

02/08/2011

Rasilez Dr Fisher Farma BV

27/07/2011 300 mg Film-coated tablet 14 EU/1/07/405/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

02/08/2011

Rasilez Dr Fisher Farma BV

25/08/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

31/08/2011

Rasilez Emra-Med 07/12/2010 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/01/2011

Rasilez Emra-Med 03/01/2011 150 mg Film-coated tablet 56 EU/1/07/405/025 Austria, Portugal Germany 24/01/2011

Rasilez Emra-Med 03/01/2011 150 mg Film-coated tablet 98 EU/1/07/405/028 Austria, Portugal Germany 24/01/2011

Rasilez Emra-Med 03/01/2011 300 mg Film-coated tablet 98 EU/1/07/405/038 Austria, Greece Germany 24/01/2011

Rasilez Eureco-Pharma B.V.

11/02/2011 300 mg Film-coated tablet 30 EU/1/07/405/033 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

25/02/2011

Rasilez Eureco-Pharma B.V.

05/08/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

09/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 180/255

Page 181: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Rasilez Euro Registratie Collectief BV

04/07/2011 150 mg Film-coated tablet 30 EU/1/07/405/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/08/2011

Rasilez EuroPharma DK

14/08/2009 150 mg Film-coated tablet 28 EU/1/07/405/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/01/2011

Rasilez EuroPharma DK

14/08/2009 150 mg Film-coated tablet 84 (3 x 28) EU/1/07/405/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/01/2011

Rasilez G-Pharma Ltd 11/01/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

14/01/2011

Rasilez G-Pharma Ltd 11/01/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

14/01/2011

Rasilez Kosei Pharma UK Limited

13/07/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

01/08/2011

Rasilez Kosei Pharma UK Limited

13/07/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

01/08/2011

Rasilez Lexon (UK) Ltd

16/02/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 181/255

Page 182: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Rasilez Lexon (UK) Ltd

16/02/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

15/03/2011

Rasilez Mediwin Ltd 04/02/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

United Kingdom

23/03/2011

Rasilez Mediwin Ltd 11/04/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

United Kingdom

02/05/2011

Rasilez MPT Pharma 12/01/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/01/2011

Rasilez MPT Pharma 12/01/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

18/01/2011

Rasilez MPT Pharma 03/05/2011 150 mg Film-coated tablet 30 EU/1/07/405/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

25/05/2011

Rasilez PCO Manufacturing

07/02/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

17/02/2011

Rasilez PCO Manufacturing

17/02/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

08/03/2011

Rasilez Swingward Ltd TA Medihealth

16/09/2010 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

26/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 182/255

Page 183: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Rasilez Swingward Ltd TA Medihealth

20/10/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

21/11/2011

Rasilez HCT Axicorp Pharma GmbH

07/04/2011 150 mg / 12.5 mg

Film-coated tablet 98 EU/1/08/491/018 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/05/2011

Rasilez HCT Axicorp Pharma GmbH

12/05/2011 300 mg / 12.5 mg

Film-coated tablet 98 EU/1/08/491/058 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/05/2011

Rasilez HCT Axicorp Pharma GmbH

28/07/2011 300 mg / 25 mg

Film-coated tablet 98 EU/1/08/491/078 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/08/2011

Rasilez HCT Beragena Arzneimittel GmbH

10/10/2011 300 mg / 25 mg

Film-coated tablet 98 EU/1/08/491/078 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 25/10/2011

Rasilez HCT Beragena Arzneimittel GmbH

18/10/2011 150 mg / 12.5 mg

Film-coated tablet 98 EU/1/08/491/018 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 03/11/2011

Rasilez HCT Beragena Arzneimittel GmbH

18/10/2011 300 mg / 12.5 mg

Film-coated tablet 98 EU/1/08/491/058 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 25/10/2011

Rasilez HCT Euro Registratie Collectief BV

07/07/2011 150 mg / 12.5 mg

Film-coated tablet 30 EU/1/08/491/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

05/09/2011

Rebetol Haemato Pharm AG

09/03/2011 200 mg Capsule, hard 168 EU/1/99/107/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/04/2011

Rebetol Haemato Pharm AG

09/03/2011 200 mg Capsule, hard 84 EU/1/99/107/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 183/255

Page 184: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Rebif CC Pharma 10/10/2011 22 µg Solution for injection

12 pre-filled pens

EU/1/98/063/013 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/10/2011

Rebif CC Pharma 10/10/2011 44 µg Solution for injection

12 pre-filled pens

EU/1/98/063/016 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/10/2011

Rebif CC Pharma 21/11/2011 22 µg/0.5 ml Solution for injection

12 cartridges

EU/1/98/063/018 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/12/2011

Rebif CC Pharma 21/11/2011 44 µg/0.5 ml Solution for injection

12 cartridges

EU/1/98/063/019 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/12/2011

Rebif Haemato Pharm AG

21/06/2011 22 µg Solution for injection

12 pre-filled pens

EU/1/98/063/013 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

20/07/2011

Rebif Haemato Pharm AG

21/06/2011 44 µg Solution for injection

12 pre-filled pens

EU/1/98/063/016 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

20/07/2011

Rebif Kohlpharma GmbH

20/12/2010 8.8 µg (2.4 m IU) + 22 µg (6 m IU)

Solution for injection

Initiation pack: 6 pre-filled syringes of 8.8 µg + 6 pre-filled syringes of 22 µg

EU/1/98/063/007 Austria Germany 26/01/2011

Rebif Orifarm OY 03/03/2011 22 µg Solution for injection

12 pre-filled syringes

EU/1/98/063/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 09/03/2011

Rebif Pharma Westen GmbH

26/09/2011 22 µg Solution for injection

12 pre-filled pens

EU/1/98/063/013 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 184/255

Page 185: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Rebif Pharma Westen GmbH

26/09/2011 44 µg Solution for injection

12 pre-filled pens

EU/1/98/063/016 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/11/2011

Relistor Emra-Med 26/08/2010 12 mg/0.6 ml Solution for injection

7 vials + 7 sterile syringes + 14 alcohol swabs

EU/1/08/463/003 Austria, Belgium, France, Luxembourg Germany 14/06/2011

Relistor Euro Registratie Collectief BV

23/12/2010 12 mg/0.6 ml Solution for injection

7 vials + 7 sterile syringes + 14 alcohol swabs

EU/1/08/463/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

25/01/2011

Remicade Axicorp Pharma GmbH

09/06/2011 100 mg Powder for concentrate for solution for infusion

5 vials EU/1/99/116/005 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/06/2011

Remicade Eureco-Pharma B.V.

24/09/2010 100 mg Powder for concentrate for solution for infusion

1 vial EU/1/99/116/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

08/02/2011

Remicade Haemato Pharm AG

28/06/2011 100 mg Powder for concentrate for solution for infusion

1 vial EU/1/99/116/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

08/07/2011

Remicade MedicoPharm AG

21/01/2011 100 mg Powder for concentrate for solution for infusion

5 vials EU/1/99/116/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 24/03/2011

Remicade Paranova Läkemedel AB

13/09/2011 100 mg Powder for concentrate for solution for infusion

1 vial EU/1/99/116/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 29/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 185/255

Page 186: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Remicade Paranova Läkemedel AB

13/09/2011 100 mg Powder for concentrate for solution for infusion

3 vials EU/1/99/116/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 30/09/2011

Remicade Veron Pharma Vertriebs GmbH

13/12/2010 100 mg Powder for concentrate for solution for infusion

2 vials EU/1/99/116/002 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 03/02/2011

Renagel Aaston Healthcare GmbH

01/03/2011 800 mg Film-coated tablet 1 bottle of 180 without outer carton

EU/1/99/123/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/03/2011

Renagel Propharmed GmbH

29/03/2011 800 mg Film-coated tablet 1 bottle of 180 without outer carton

EU/1/99/123/012 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/04/2011

Renvela Beragena Arzneimittel GmbH

05/05/2011 2.4 g Powder for oral suspension

60 sachets EU/1/09/521/006 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 25/05/2011

Renvela Beragena Arzneimittel GmbH

05/05/2011 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 19/05/2011

Renvela CC Pharma 14/12/2010 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/01/2011

Renvela CC Pharma 07/01/2011 2.4 g Powder for oral suspension

60 sachets EU/1/09/521/006 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/01/2011

Renvela Cross Pharma AB

22/02/2011 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 05/04/2011

Renvela Emra-Med 18/02/2011 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 186/255

Page 187: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Renvela Medcor Pharmaceuticals BV

14/11/2011 2.4 g Powder for oral suspension

60 sachets EU/1/09/521/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

30/11/2011

Renvela Medcor Pharmaceuticals BV

14/11/2011 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

30/11/2011

Renvela MedicoPharm AG

28/01/2011 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, Cyprus, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/02/2011

Renvela Oy Cross Pharma AB

14/04/2011 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Finland 20/04/2011

Renvela PCO Manufacturing

16/06/2011 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

14/07/2011

Renvela Pharmachim AB

09/09/2011 800 mg Film-coated tablet 180 (without outer carton)

EU/1/09/521/003 Austria, Belgium, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 26/10/2011

Replagal Abacus Medicine A/S

05/07/2011 1 mg/ml Concentrate for solution for infusion

1 vial EU/1/01/189/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/07/2011

Replagal NewNeopharm BV

15/09/2011 1 mg/ml Concentrate for solution for infusion

1 vial EU/1/01/189/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/09/2011

Revatio Abacus Medicine A/S

06/12/2011 20 mg Film-coated tablet 90 EU/1/05/318/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 187/255

Page 188: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Revatio Medartuum AB 25/08/2011 20 mg Film-coated tablet 90 EU/1/05/318/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 30/08/2011

Revatio Pharmachim AB

08/07/2011 20 mg Film-coated tablet 90 EU/1/05/318/001 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 19/07/2011

Revlimid CC Pharma 08/11/2011 10 mg Capsule, hard 21 EU/1/07/391/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

Revlimid CC Pharma 08/11/2011 15 mg Capsule, hard 21 EU/1/07/391/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/11/2011

revlimid CC Pharma 08/11/2011 25 mg Capsule, hard 21 EU/1/07/391/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/11/2011

Revlimid Dr Fisher Farma BV

07/06/2011 25 mg Capsule, hard 21 EU/1/07/391/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/06/2011

Revlimid Dr Fisher Farma BV

04/11/2011 10 mg Capsule, hard 21 EU/1/07/391/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

16/11/2011

Revlimid Dr Fisher Farma BV

16/11/2011 15 mg Capsule, hard 21 EU/1/07/391/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

07/12/2011

Revlimid Medartuum AB 07/11/2011 25 mg Capsule, hard 21 EU/1/07/391/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 28/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 188/255

Page 189: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Revlimid Pharma Westen GmbH

11/01/2011 25 mg Capsule, hard 21 EU/1/07/391/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/02/2011

Revlimid Pharma Westen GmbH

15/11/2011 10 mg Capsule, hard 21 EU/1/07/391/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

Revlimid Pharma Westen GmbH

15/11/2011 15 mg Capsule, hard 21 EU/1/07/391/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

REVOLADE CC Pharma 17/01/2011 25 mg Film-coated tablet 14 EU/1/10/612/001 Austria, Norway Germany 11/03/2011

REVOLADE CC Pharma 17/01/2011 50 mg Film-coated tablet 14 EU/1/10/612/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/01/2011

REVOLADE CC Pharma 27/01/2011 25 mg Film-coated tablet 28 EU/1/10/612/002 Austria Germany 03/03/2011

REVOLADE CC Pharma 27/01/2011 50 mg Film-coated tablet 28 EU/1/10/612/005 Austria Germany 03/03/2011

REVOLADE Haemato Pharm AG

16/02/2011 25 mg Film-coated tablet 28 EU/1/10/612/002 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

24/03/2011

REVOLADE Haemato Pharm AG

16/02/2011 50 mg Film-coated tablet 28 EU/1/10/612/005 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

24/03/2011

Reyataz Aaston Healthcare GmbH

21/03/2011 300 mg Capsule, hard 3 x 30 EU/1/03/267/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 189/255

Page 190: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Reyataz Axicorp Pharma B.V.

09/02/2011 300 mg Capsule, hard 3 x 30 EU/1/03/267/010 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/02/2011

Reyataz BB Farma s.r.l.

17/11/2011 150 mg Capsule, hard 60 EU/1/03/267/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/12/2011

Reyataz BB Farma s.r.l.

17/11/2011 200 mg Capsule, hard 60 EU/1/03/267/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/12/2011

Reyataz Dr Fisher Farma BV

20/04/2011 150 mg Capsule, hard 60 EU/1/03/267/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

26/04/2011

Reyataz EU-Pharma BV 29/11/2011 300 mg Capsule, hard 30 EU/1/03/267/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

06/12/2011

Reyataz Medartuum AB 08/08/2011 300 mg Capsule, hard 30 EU/1/03/267/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/08/2011

Reyataz MedicoPharm AG

25/02/2009 300 mg Capsule, hard 30 EU/1/03/267/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/07/2011

Reyataz Pharmachim AB

04/08/2011 300 mg Capsule, hard 30 EU/1/03/267/008 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 190/255

Page 191: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Rilutek MedicoPharm AG

03/02/2011 50 mg Film-coated tablet 56 EU/1/96/010/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/02/2011

Rilutek Paranova Läkemedel AB

22/02/2011 50 mg Film-coated tablet 56 EU/1/96/010/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 29/03/2011

RoActemra CC Pharma 20/01/2011 20 mg/ml Concentrate for solution for infusion

4 vials EU/1/08/492/006 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/01/2011

RoActemra CC Pharma 20/01/2011 20 mg/ml Concentrate for solution for infusion

4 vials EU/1/08/492/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Latvia, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/01/2011

RoActemra Emra-Med 27/10/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/08/492/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/11/2011

RoActemra Emra-Med 27/10/2011 20 mg/ml Concentrate for solution for infusion

4 vials EU/1/08/492/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/11/2011

RoActemra Emra-Med 27/10/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/08/492/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/11/2011

RoActemra Emra-Med 27/10/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/08/492/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/11/2011

RoActemra Pharma Westen GmbH

11/10/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/08/492/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/10/2011

RoActemra Pharma Westen GmbH

24/10/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/08/492/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 191/255

Page 192: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Sifrol Axicorp Pharma GmbH

12/10/2011 1.05 mg Prolonged-release tablet

30 EU/1/97/050/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/10/2011

Sifrol Axicorp Pharma GmbH

12/10/2011 2.1 mg Prolonged-release tablet

30 EU/1/97/050/023 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/10/2011

Sifrol Axicorp Pharma GmbH

12/10/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/050/026 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/10/2011

Sifrol BR Pharma International Ltd

03/01/2011 1.57 mg Prolonged-release tablet

30 EU/1/97/050/029 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/01/2011

Sifrol BR Pharma International Ltd

14/02/2011 2.62 mg Prolonged-release tablet

30 EU/1/97/050/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/03/2011

Sifrol BR Pharma International Ltd

07/06/2011 3.15 mg Prolonged-release tablet

30 EU/1/97/050/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/06/2011

Sifrol MTK Pharma GmbH

11/01/2011 1.57 mg Prolonged-release tablet

30 EU/1/97/050/029 Norway, The Netherlands Germany 25/01/2011

Sifrol MTK Pharma GmbH

07/02/2011 1.57 mg Prolonged-release tablet

100 EU/1/97/050/030 Norway, The Netherlands Germany 18/02/2011

Sifrol Pharma Westen GmbH

28/02/2011 1.57 mg Prolonged-release tablet

100 EU/1/97/050/030 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/03/2011

Sifrol Pharma Westen GmbH

28/02/2011 2.62 mg Prolonged-release tablet

100 EU/1/97/050/033 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/03/2011

Sifrol Pharma Westen GmbH

08/03/2011 2.62 mg Prolonged-release tablet

30 EU/1/97/050/032 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 192/255

Page 193: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Sifrol Pharma Westen GmbH

17/03/2011 1.57 mg Prolonged-release tablet

30 EU/1/97/050/029 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/04/2011

Simponi Haemato Pharm AG

27/07/2011 50 mg Solution for injection in pre-filled pen

3 (3 x 1) pre-filled pens

EU/1/09/546/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/09/2011

Simponi Orifarm AB 05/10/2011 50 mg Solution for injection in pre-filled pen

1 pre-filled pen

EU/1/09/546/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 04/11/2011

Simponi Orifarm AS 05/05/2011 50 mg Solution for injection in pre-filled pen

1 pre-filled pen

EU/1/09/546/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/05/2011

Somavert CC Pharma 16/12/2010 15 mg Powder and solvent for solution for injection

30 vials + 30 vials

EU/1/02/240/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/02/2011

Somavert Orifarm AS 22/07/2011 10 mg Powder and solvent for solution for injection

30 vials + 30 vials

EU/1/02/240/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/08/2011

Somavert Orifarm AS 22/07/2011 15 mg Powder and solvent for solution for injection

30 vials + 30 vials

EU/1/02/240/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/08/2011

Somavert Orifarm AS 22/07/2011 20 mg Powder and solvent for solution for injection

30 vials + 30 vials

EU/1/02/240/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 193/255

Page 194: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

SonoVue Orifarm AB 27/07/2011 8 µl/ml Powder and solvent for dispersion for injection

1 vial + 1 pre-filled syringe + 1 'MiniSpike' rec. device

EU/1/01/177/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 17/08/2011

Sprycel CC Pharma 24/05/2011 50 mg Film-coated tablet 60 x 1 (unit dose)

EU/1/06/363/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/06/2011

Sprycel CC Pharma 24/05/2011 70 mg Film-coated tablet 60 x 1 (unit dose)

EU/1/06/363/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/05/2011

Sprycel CC Pharma 19/07/2011 20 mg Film-coated tablet 60 x 1 (unit dose)

EU/1/06/363/007 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/08/2011

Sprycel Haemato Pharm AG

01/06/2011 50 mg Film-coated tablet 60 EU/1/06/363/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/06/2011

Sprycel Omnia Läkemedel AB

09/06/2011 50 mg Film-coated tablet 60 EU/1/06/363/002 Bulgaria, Germany, Greece, The Netherlands, United Kingdom

Sweden 14/06/2011

Sprycel Omnia Läkemedel AB

11/11/2011 100 mg Film-coated tablet 30 EU/1/06/363/010 Portugal, Spain, The Netherlands, United Kingdom

Sweden 16/11/2011

Stalevo BR Pharma International Ltd

10/11/2011 150 mg / 37.5 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/12/2011

Stalevo Euro Registratie Collectief BV

19/07/2011 50 mg / 12.5 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

26/07/2011

Stalevo Euro Registratie Collectief BV

25/07/2011 100 mg / 25 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

26/07/2011

Stalevo Euro Registratie Collectief BV

13/09/2011 125 mg / 31.25 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 194/255

Page 195: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Stalevo Euro Registratie Collectief BV

13/09/2011 150 mg / 37.5 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/09/2011

Stalevo Euro Registratie Collectief BV

20/09/2011 200 mg / 50 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

22/09/2011

Stalevo EuroPharma DK

14/02/2011 125 mg / 31.25 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/031 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 01/03/2011

Stalevo EuroPharma DK

14/02/2011 75 mg / 18.75 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/026 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 01/03/2011

Stalevo Haemato Pharm AG

26/04/2011 100 mg / 25 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

Stalevo Haemato Pharm AG

26/04/2011 150 mg / 37.5 mg / 200 mg

Film-coated tablet 30 EU/1/03/260/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

Stalevo Haemato Pharm AG

26/04/2011 50 mg / 12.5 mg / 200 mg

Film-coated tablet 30 EU/1/03/260/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

Stalevo Haemato Pharm AG

26/04/2011 50 mg / 12.5 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

Stalevo Haemato Pharm AG

27/04/2011 100 mg / 25 mg / 200 mg

Film-coated tablet 30 EU/1/03/260/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 195/255

Page 196: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Stalevo Haemato Pharm AG

27/04/2011 150 mg / 37.5 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/05/2011

Stalevo Imed Healthcare Ltd

14/07/2011 100 mg / 25 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

20/07/2011

Stalevo Kohlpharma GmbH

22/09/2011 125 mg / 31.25 mg / 200 mg

Film-coated tablet 30 EU/1/03/260/030 France, Italy, The Netherlands, United Kingdom

Germany 27/10/2011

Stalevo Lexon (UK) Ltd

12/12/2011 100 mg / 25 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

20/12/2011

Stalevo Lexon (UK) Ltd

12/12/2011 150 mg / 37.5 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

20/12/2011

Stalevo Lexon (UK) Ltd

12/12/2011 50 mg / 12.5 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

20/12/2011

Stalevo Orifarm AS 23/09/2011 125 mg / 31.25 mg / 200 mg

Film-coated tablet 100 EU/1/03/260/031 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/10/2011

Stelara Orifarm AB 21/07/2011 45 mg Solution for injection in pre-filled syringe

1 pre-filled syringe

EU/1/08/494/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 09/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 196/255

Page 197: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Stocrin 2 Care 4 11/01/2011 600 mg Film-coated tablet 30 EU/1/99/111/008 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/01/2011

Stocrin Medcor Pharmaceuticals BV

04/03/2011 200 mg Film-coated tablet 90 EU/1/99/111/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

23/03/2011

Stocrin Medcor Pharmaceuticals BV

26/04/2011 600 mg Film-coated tablet 30 EU/1/99/111/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/05/2011

Stocrin Propharmed GmbH

07/04/2011 600 mg Film-coated tablet 30 EU/1/99/111/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/04/2011

Suboxone EuroPharma DK

08/07/2011 2 mg/0.5 mg Sublingual tablet 7 EU/1/06/359/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/07/2011

Suboxone EuroPharma DK

08/07/2011 2 mg/0.5 mg Sublingual tablet 28 EU/1/06/359/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/07/2011

Suboxone Omnia Läkemedel AB

18/10/2011 8 mg/2 mg Sublingual tablet 7 EU/1/06/359/003 The Netherlands, United Kingdom Sweden 14/11/2011

Suboxone Omnia Läkemedel AB

18/10/2011 8 mg/2 mg Sublingual tablet 28 EU/1/06/359/004 The Netherlands, United Kingdom Sweden 14/11/2011

Sustiva Orifarm AS 23/03/2011 600 mg Film-coated tablet 30 EU/1/99/110/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/04/2011

Sustiva Propharmed GmbH

09/08/2011 600 mg Film-coated tablet 30 EU/1/99/110/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/08/2011

Sutent Omnia Läkemedel AB

23/08/2011 50 mg Capsule, hard 30 EU/1/06/347/003 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 197/255

Page 198: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Sutent Omnia Läkemedel AB

14/11/2011 25 mg Capsule, hard 28 EU/1/06/347/005 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 08/12/2011

Sutent Omnia Läkemedel AB

14/11/2011 50 mg Capsule, hard 28 EU/1/06/347/006 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 08/12/2011

Sutent Orifarm AB 21/03/2011 25 mg Capsule, hard 28 EU/1/06/347/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/05/2011

Sutent Orifarm AB 21/03/2011 50 mg Capsule, hard 28 EU/1/06/347/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/05/2011

Sutent Orifarm AB 04/11/2011 12.5 mg Capsule, hard 28 EU/1/06/347/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 15/11/2011

Sutent UAB East Europe Pharmacy Group

12/04/2011 50 mg Capsule, hard 30 EU/1/06/347/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Lithuania 23/05/2011

Sutent UAB East Europe Pharmacy Group

05/07/2011 50 mg Capsule, hard 28 EU/1/06/347/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Lithuania 12/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 198/255

Page 199: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Synagis Lex ano UAB 08/03/2011 100 mg Powder and solvent for solution for injection

1 vial + 1 ampoule

EU/1/99/117/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Lithuania 18/03/2011

Synagis Orifarm OY 14/03/2011 100 mg Powder and solvent for solution for injection

1 vial + 1 ampoule

EU/1/99/117/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 14/04/2011

TachoSil Orifarm AB 14/02/2011 - - Medicated sponge 1 sponge of 9.5 x 4.8 cm

EU/1/04/277/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/03/2011

TachoSil Orifarm AB 14/02/2011 - - Medicated sponge 2 sponges of 4.8 x 4.8 cm

EU/1/04/277/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 24/03/2011

TachoSil Orifarm AB 14/02/2011 - - Medicated sponge 1 sponge of 3.0 x 2.5 cm

EU/1/04/277/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/03/2011

TachoSil Orifarm AB 14/02/2011 - - Medicated sponge 5 sponges of 3.0 x 2.5 cm

EU/1/04/277/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/03/2011

Tarceva CC Pharma 24/05/2011 25 mg Film-coated tablet 30 EU/1/05/311/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 199/255

Page 200: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Tarceva Medcor Pharmaceuticals BV

03/11/2011 150 mg Film-coated tablet 30 EU/1/05/311/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany,Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

The Netherlands

10/11/2011

Tarceva Orifarm AB 09/03/2011 100 mg Film-coated tablet 30 EU/1/05/311/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 18/03/2011

Tarceva Paranova Läkemedel AB

15/09/2011 100 mg Film-coated tablet 30 EU/1/05/311/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 05/10/2011

Tarceva Paranova Läkemedel AB

15/09/2011 150 mg Film-coated tablet 30 EU/1/05/311/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 05/10/2011

Targretin Axicorp Pharma GmbH

15/11/2011 75 mg Capsule, soft 100 EU/1/01/178/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/11/2011

Targretin MedicoPharm AG

10/02/2011 75 mg Capsule, soft 100 EU/1/01/178/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/03/2011

Targretin Propharmed GmbH

21/02/2011 75 mg Capsule, soft 100 EU/1/01/178/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/04/2011

Tasigna CC Pharma 24/05/2011 150 mg Capsule, hard 112 EU/1/07/422/006 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 200/255

Page 201: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Tasigna Emra-Med 07/09/2011 150 mg Capsule, hard 112 (4x28); (multipack)

EU/1/07/422/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/10/2011

Tasigna Haemato Pharm AG

03/08/2011 200 mg Capsule, hard 28 EU/1/07/422/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 31/08/2011

Tasigna Omnia Läkemedel AB

21/11/2011 200 mg Capsule, hard 112 (4x28); (multipack)

EU/1/07/422/003 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 08/12/2011

Tasigna Orifarm AS 18/11/2011 200 mg Capsule, hard 112 (4x28); (multipack)

EU/1/07/422/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 29/11/2011

Tasmar Emra-Med 09/09/2011 100 mg Film-coated tablet 30 EU/1/97/044/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/09/2011

Taxotere Axicorp Pharma GmbH

09/06/2011 80 mg/4 ml Concentrate for solution for infusion

1 vial EU/1/95/002/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/07/2011

Taxotere Pharma Westen GmbH

20/07/2011 160 mg/8 ml Concentrate for solution for infusion

1 vial EU/1/95/002/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/07/2011

Telzir Paranova OY 09/03/2011 700 mg Film-coated tablet 60 EU/1/04/282/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 04/04/2011

Telzir Propharmed GmbH

21/02/2011 700 mg Film-coated tablet 60 EU/1/04/282/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 201/255

Page 202: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Temodal BB Farma s.r.l.

12/07/2011 20 mg Capsule, hard 20 EU/1/98/096/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/07/2011

Temodal BB Farma s.r.l.

12/07/2011 5 mg Capsule, hard 20 EU/1/98/096/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/07/2011

Temodal BR Pharma International Ltd

26/03/2009 100 mg Capsule, hard 5 EU/1/98/096/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/02/2011

Temodal Medartuum AB 17/05/2011 100 mg Capsule, hard 20 EU/1/98/096/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 30/05/2011

Temodal Orifarm AB 21/06/2011 140 mg Capsule, hard 5 EU/1/98/096/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/08/2011

Temodal Orifarm AB 21/06/2011 180 mg Capsule, hard 5 EU/1/98/096/019 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/08/2011

Thyrogen Orifarm OY 11/03/2011 0.9 mg Powder for solution for injection

2 vials EU/1/99/122/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 11/05/2011

Toviaz 2 Care 4 10/12/2010 4 mg Prolonged-release tablet

84 EU/1/07/386/011 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 07/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 202/255

Page 203: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Toviaz 2 Care 4 10/12/2010 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 04/03/2011

Toviaz 2 Care 4 10/12/2010 8 mg Prolonged-release tablet

28 EU/1/07/386/008 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 04/03/2011

Toviaz 2 Care 4 10/12/2010 8 mg Prolonged-release tablet

84 EU/1/07/386/012 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 07/03/2011

Toviaz 2 Care 4 24/11/2011 4 mg Prolonged-release tablet

98 EU/1/07/386/005 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 01/12/2011

Toviaz 2 Care 4 24/11/2011 8 mg Prolonged-release tablet

98 EU/1/07/386/010 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 01/12/2011

Toviaz Amimed Direct Ltd

20/06/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

01/07/2011

Toviaz Cross Pharma AB

19/01/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 02/02/2011

Toviaz Cross Pharma AB

19/01/2011 4 mg Prolonged-release tablet

84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 02/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 203/255

Page 204: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Toviaz Cross Pharma AB

19/01/2011 8 mg Prolonged-release tablet

84 EU/1/07/386/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 02/02/2011

Toviaz Doncaster Pharmaceuticals Group Ltd

11/03/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

11/04/2011

Toviaz Doncaster Pharmaceuticals Group Ltd

11/03/2011 8 mg Prolonged-release tablet

28 EU/1/07/386/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

11/04/2011

Toviaz Emra-Med 09/09/2011 4 mg Prolonged-release tablet

100 (10 x 10)

EU/1/07/386/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 24/10/2011

Toviaz Medartuum AB 21/02/2011 8 mg Prolonged-release tablet

84 EU/1/07/386/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 02/03/2011

Toviaz Medartuum AB 08/11/2011 4 mg Prolonged-release tablet

84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 16/11/2011

Toviaz Omnia Läkemedel AB

07/06/2011 4 mg Prolonged-release tablet

84 EU/1/07/386/011 Czech Republic, France, Greece, Italy, Spain, United Kingdom

Sweden 17/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 204/255

Page 205: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Toviaz Omnia Läkemedel AB

07/06/2011 8 mg Prolonged-release tablet

84 EU/1/07/386/012 Czech Republic, France, Greece, Italy, Poland, Spain, United Kingdom

Sweden 14/06/2011

Toviaz Paranova Danmark AS

26/05/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/06/2011

Toviaz Paranova Danmark AS

26/05/2011 4 mg Prolonged-release tablet

84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 08/06/2011

Toviaz Paranova Danmark AS

26/05/2011 8 mg Prolonged-release tablet

28 EU/1/07/386/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/06/2011

Toviaz Paranova Danmark AS

26/05/2011 8 mg Prolonged-release tablet

84 EU/1/07/386/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 08/06/2011

Toviaz Paranova Läkemedel AB

12/10/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 27/10/2011

Toviaz Paranova Läkemedel AB

12/10/2011 4 mg Prolonged-release tablet

84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 27/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 205/255

Page 206: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Toviaz Paranova Läkemedel AB

12/10/2011 8 mg Prolonged-release tablet

84 EU/1/07/386/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 27/10/2011

Toviaz Paranova Läkemedel AB

12/10/2011 8 mg Prolonged-release tablet

28 EU/1/07/386/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 27/10/2011

Toviaz PCO Manufacturing

15/06/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

02/08/2011

Toviaz PCO Manufacturing

15/06/2011 8 mg Prolonged-release tablet

28 EU/1/07/386/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

02/08/2011

Toviaz Pharma Westen GmbH

06/12/2010 4 mg Prolonged-release tablet

100 (10 x 10)

EU/1/07/386/017 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/03/2011

Toviaz Pharmachim AB

15/09/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 13/10/2011

Toviaz Pharmachim AB

15/09/2011 4 mg Prolonged-release tablet

84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 12/10/2011

Toviaz Profind Wholesale Ltd.

17/08/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 United Kingdom Ireland 05/09/2011

Toviaz Profind Wholesale Ltd.

17/08/2011 8 mg Prolonged-release tablet

28 EU/1/07/386/008 United Kingdom Ireland 05/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 206/255

Page 207: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Toviaz Waymade PLC 07/04/2011 4 mg Prolonged-release tablet

28 EU/1/07/386/003 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

17/05/2011

Tracleer Haemato Pharm AG

09/03/2011 125 mg Film-coated tablet 56 EU/1/02/220/004 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/04/2011

Tracleer Haemato Pharm AG

09/03/2011 125 mg Film-coated tablet 56 EU/1/02/220/004 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

30/03/2011

Tracleer Haemato Pharm AG

09/03/2011 62.5 mg Film-coated tablet 56 EU/1/02/220/002 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/04/2011

Tracleer Haemato Pharm AG

09/03/2011 62.5 mg Film-coated tablet 56 EU/1/02/220/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

30/03/2011

Tracleer NewNeopharm BV

06/09/2011 125 mg Film-coated tablet 56 EU/1/02/220/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/09/2011

Tracleer NewNeopharm BV

06/09/2011 62.5 mg Film-coated tablet 56 EU/1/02/220/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/09/2011

Tracleer Orifarm AB 12/10/2011 125 mg Film-coated tablet 56 EU/1/02/220/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 17/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 207/255

Page 208: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Tracleer Orifarm AB 12/10/2011 62.5 mg Film-coated tablet 56 EU/1/02/220/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 20/10/2011

Tractocile NewNeopharm BV

07/09/2011 7.5 mg/ml Concentrate for solution for infusion

1 vial EU/1/99/124/002 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/09/2011

Tredaptive Emra-Med 07/01/2011 1000 mg / 20 mg

Modified-release tablet

28 EU/1/08/459/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/01/2011

Trizivir Aaston Healthcare GmbH

29/04/2011 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Trizivir Docpharm GmbH&CoKGaA

26/01/2011 - - Film-coated tablet 60 EU/1/00/156/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/02/2011

Trizivir Docpharm GmbH&CoKGaA

05/09/2011 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/09/2011

Trizivir Emra-Med 07/12/2010 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/03/2011

Trizivir Haemato Pharm AG

27/10/2011 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/11/2011

Trizivir Kohlpharma GmbH

20/12/2010 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, France, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/02/2011

Trizivir Medcor Pharmaceuticals BV

30/05/2011 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, United Kingdom

The Netherlands

27/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 208/255

Page 209: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Trizivir Mevita HandelsGmbH

10/12/2010 - - Film-coated tablet 60 EU/1/00/156/004 Austria, France, Italy, The Netherlands, United Kingdom

Germany 28/10/2011

Trizivir Propharmed GmbH

07/04/2011 - - Film-coated tablet 60 EU/1/00/156/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/04/2011

Trobalt BR Pharma International Ltd

16/08/2011 100 mg Film-coated tablet 84 EU/1/11/681/005 Ireland, United Kingdom Germany 22/08/2011

Trobalt BR Pharma International Ltd

17/08/2011 200 mg Film-coated tablet 84 EU/1/11/681/007 Ireland, United Kingdom Germany 22/08/2011

Trobalt BR Pharma International Ltd

17/08/2011 300 mg Film-coated tablet 84 EU/1/11/681/009 Ireland, United Kingdom Germany 22/08/2011

Trobalt BR Pharma International Ltd

18/08/2011 200 mg Film-coated tablet 168 (2 x 84) (multipack)

EU/1/11/681/008 Ireland, United Kingdom Germany 22/08/2011

Trobalt BR Pharma International Ltd

18/08/2011 300 mg Film-coated tablet 168 (2 x 84) (multipack)

EU/1/11/681/010 Ireland, United Kingdom Germany 22/08/2011

Trobalt Orifarm AS 04/10/2011 100 mg Film-coated tablet 84 EU/1/11/681/005 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/11/2011

Trobalt Orifarm AS 04/10/2011 300 mg Film-coated tablet 84 EU/1/11/681/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 06/12/2011

Trobalt Orifarm AS 04/10/2011 50 mg Film-coated tablet 84 EU/1/11/681/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/11/2011

Truvada eurorx Arzneimittel GmbH

17/11/2010 200 mg/ 245 mg

Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 05/01/2011

Truvada Haemato Pharm AG

01/06/2011 200 mg/ 245 mg

Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 209/255

Page 210: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Truvada Lex ano UAB 09/03/2011 200 mg/ 245 mg

Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Lithuania 16/03/2011

Truvada MedicoPharm AG

28/01/2011 200 mg/ 245 mg

Film-coated tablet 3 x 30 EU/1/04/305/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/02/2011

Truvada Orifarm OY 16/02/2011 200 mg/ 245 mg

Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 23/03/2011

Truvada Paranova OY 09/03/2011 200 mg/ 245 mg

Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 04/04/2011

Truvada Pharmachim AB

18/11/2011 200 mg/ 245 mg

Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Spain, The Netherlands, United Kingdom

Sweden 07/12/2011

Twinrix Adult BB Farma s.r.l.

16/11/2011 - - Suspension for injection

1 syringe with separate needle

EU/1/96/020/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/11/2011

Twinrix Adult BB Farma s.r.l.

16/11/2011 - - Suspension for injection

10 syringes with separate needle

EU/1/96/020/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 210/255

Page 211: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

TWYNSTA Emra-Med 20/06/2011 40 mg/5 mg Tablet 28 EU/1/10/648/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/06/2011

TWYNSTA Emra-Med 29/06/2011 40 mg/10 mg Tablet 28 EU/1/10/648/009 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/06/2011

TWYNSTA Emra-Med 29/06/2011 80 mg/10 mg Tablet 28 EU/1/10/648/023 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/06/2011

TWYNSTA Emra-Med 29/06/2011 80 mg/5 mg Tablet 28 EU/1/10/648/016 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/06/2011

TWYNSTA Emra-Med 15/09/2011 80 mg/5 mg Tablet 56 EU/1/10/648/018 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/10/2011

Twynsta Kohlpharma GmbH

23/11/2011 80 mg/10 mg Tablet 98 EU/1/10/648/027 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/12/2011

Twynsta Kohlpharma GmbH

23/11/2011 80 mg/5 mg Tablet 98 EU/1/10/648/020 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 01/12/2011

Tygacil Abacus Medicine A/S

15/07/2011 50 mg Powder for solution for infusion

10 vials EU/1/06/336/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 01/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 211/255

Page 212: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Tygacil Orifarm AB 10/05/2011 50 mg Powder for solution for infusion

10 vials EU/1/06/336/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 13/05/2011

Tysabri Axicorp Pharma B.V.

09/06/2011 300 mg Concentrate for solution for infusion

1 vial EU/1/06/346/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/06/2011

Tysabri Haemato Pharm AG

08/12/2011 300 mg Concentrate for solution for infusion

1 vial EU/1/06/346/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 22/12/2011

Tysabri Orifarm AB 18/03/2011 300 mg Concentrate for solution for infusion

1 vial EU/1/06/346/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 31/03/2011

Tysabri Orifarm OY 11/03/2011 300 mg Concentrate for solution for infusion

1 vial EU/1/06/346/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 24/03/2011

Tyverb Abacus Medicine A/S

05/07/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 11/07/2011

Tyverb Abacus Medicine A/S

07/07/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 10/08/2011

Tyverb CC Pharma 30/08/2011 250 mg Film-coated tablet 70 EU/1/07/440/004 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 212/255

Page 213: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Tyverb Emra-Med 07/10/2011 250 mg Film-coated tablet 70 EU/1/07/440/004 Ireland, The Netherlands, United Kingdom Germany 20/10/2011

Tyverb Haemato Pharm AG

11/04/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/05/2011

Tyverb Orifarm AB 13/05/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 23/05/2011

Tyverb Orifarm AB 21/09/2011 250 mg Film-coated tablet 70 (Bottle) EU/1/07/440/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/09/2011

Tyverb Orifarm AS 27/07/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/08/2011

Tyverb Pharma Westen GmbH

19/10/2011 250 mg Film-coated tablet 70 EU/1/07/440/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/11/2011

Urorec Beragena Arzneimittel GmbH

01/09/2011 4 mg Capsule, hard 100 EU/1/09/608/007 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 16/09/2011

Urorec Beragena Arzneimittel GmbH

01/09/2011 4 mg Capsule, hard 50 EU/1/09/608/005 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 16/09/2011

Urorec Beragena Arzneimittel GmbH

14/09/2011 8 mg Capsule, hard 50 EU/1/09/608/012 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 16/09/2011

Urorec Beragena Arzneimittel GmbH

14/09/2011 8 mg Capsule, hard 100 EU/1/09/608/014 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 16/09/2011

Urorec BERAGENA Arzneimittel GmbH

07/12/2011 4 mg Capsule, hard 30 EU/1/09/608/004 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 13/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 213/255

Page 214: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Urorec BERAGENA Arzneimittel GmbH

07/12/2011 8 mg Capsule, hard 30 EU/1/09/608/011 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 13/12/2011

Urorec CC Pharma 12/09/2011 8 mg Capsule, hard 50 EU/1/09/608/012 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/09/2011

Urorec CC Pharma 12/09/2011 8 mg Capsule, hard 100 EU/1/09/608/014 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/09/2011

Urorec Emra-Med 11/07/2011 8 mg Capsule, hard 100 EU/1/09/608/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/07/2011

Urorec Emra-Med 11/07/2011 8 mg Capsule, hard 50 EU/1/09/608/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/07/2011

Urorec Emra-Med 15/09/2011 4 mg Capsule, hard 100 EU/1/09/608/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/09/2011

Urorec Kohlpharma GmbH

12/09/2011 8 mg Capsule, hard 20 EU/1/09/608/010 France, Italy Germany 19/09/2011

Urorec Kohlpharma GmbH

12/09/2011 8 mg Capsule, hard 50 EU/1/09/608/012 France, Italy Germany 19/09/2011

Urorec Kohlpharma GmbH

12/09/2011 8 mg Capsule, hard 100 EU/1/09/608/014 France, Italy Germany 19/09/2011

Urorec Kohlpharma GmbH

06/10/2011 4 mg Capsule, hard 100 EU/1/09/608/007 Italy Germany 13/10/2011

Urorec Kohlpharma GmbH

10/11/2011 4 mg Capsule, hard 30 EU/1/09/608/004 Italy, Portugal Germany 15/11/2011

Urorec Pharma Westen Ges.m.b.H.

07/12/2011 8 mg Capsule, hard 100 EU/1/09/608/014 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 214/255

Page 215: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Valdoxan Amimed Direct Ltd

05/07/2011 25 mg Film-coated tablet 28 EU/1/08/499/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

12/07/2011

Valdoxan axicorp Pharma GmbH

06/12/2011 25 mg Film-coated tablet 98 EU/1/08/499/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/12/2011

Valdoxan Emra-Med 05/05/2011 25 mg Film-coated tablet 28 EU/1/08/499/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Valdoxan Emra-Med 05/05/2011 25 mg Film-coated tablet 98 EU/1/08/499/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Valdoxan Medcor Pharmaceuticals BV

24/02/2011 25 mg Film-coated tablet 28 EU/1/08/499/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

02/05/2011

Valdoxan STRATHCLYDE PHARMACEUTICALS LTD

06/12/2011 25 mg Film-coated tablet 28 EU/1/08/499/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

08/12/2011

Vectibix Orifarm AB 19/05/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/07/423/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 25/05/2011

Vectibix Orifarm AB 19/05/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/07/423/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 25/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 215/255

Page 216: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Vectibix Orifarm AS 11/05/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/07/423/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/06/2011

Vectibix Orifarm AS 11/05/2011 20 mg/ml Concentrate for solution for infusion

1 vial EU/1/07/423/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 24/06/2011

VELCADE Abacus Medicine A/S

07/07/2011 3.5 mg Powder for solution for injection

1 vial EU/1/04/274/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/07/2011

VELCADE Inopha GmbH 26/05/2011 3.5 mg Powder for solution for injection

1 vial EU/1/04/274/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 16/06/2011

VELCADE Orifarm OY 24/02/2011 3.5 mg Powder for solution for injection

1 vial EU/1/04/274/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 25/05/2011

VELCADE Propharmed GmbH

24/03/2011 3.5 mg Powder for solution for injection

1 vial EU/1/04/274/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/04/2011

Ventavis CC Pharma 26/04/2011 10 µg/ml Nebuliser solution 30 ampoules

EU/1/03/255/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/05/2011

Ventavis CC Pharma 26/04/2011 10 µg/ml Nebuliser solution 168 ampoules

EU/1/03/255/005 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 216/255

Page 217: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Vfend 2 Care 4 06/12/2010 200 mg Tablet 56 EU/1/02/212/020 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 08/03/2011

Vfend 2 Care 4 06/12/2010 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 08/03/2011

Vfend 2 Care 4 06/12/2010 50 mg Tablet 28 EU/1/02/212/005 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Sweden 08/03/2011

Vfend 2 Care 4 17/12/2010 50 mg Tablet 28 EU/1/02/212/005 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom

Denmark 03/03/2011

Vfend Abacus Medicine A/S

07/07/2011 200 mg Powder for solution for infusion

1 vial EU/1/02/212/025 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 13/07/2011

Vfend Beragena Arzneimittel GmbH

23/11/2011 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 22/12/2011

Vfend BR Pharma International Ltd

18/01/2011 200 mg Tablet 14 EU/1/02/212/015 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands

Ireland, Malta, United Kingdom

16/02/2011

Vfend EuroPharma DK

11/02/2011 40 mg/ml Powder for oral suspension

1 bottle EU/1/02/212/026 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 02/03/2011

Vfend Haemato Pharm AG

23/06/2011 200 mg Powder for solution for infusion

1 vial EU/1/02/212/025 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 13/07/2011

Vfend Medartuum AB 05/07/2011 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 12/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 217/255

Page 218: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Vfend Medartuum AB 05/07/2011 200 mg Tablet 56 EU/1/02/212/020 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom

Sweden 22/07/2011

Vfend MedicoPharm AG

24/11/2009 200 mg Tablet 30 EU/1/02/212/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/02/2011

Vfend Orifarm AS 30/09/2010 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/01/2011

Vfend Orifarm AS 06/12/2011 200 mg Tablet 56 EU/1/02/212/020 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/12/2011

Vfend Paranova Läkemedel AB

27/09/2011 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 04/10/2011

Vfend PCO Manufacturing

11/07/2011 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

08/08/2011

Vfend Pharma Westen GmbH

14/03/2011 200 mg Tablet 100 EU/1/02/212/021 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/03/2011

Viagra BCN Farma SL 24/01/2011 100 mg Film-coated tablet 4 EU/1/98/077/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 01/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 218/255

Page 219: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Viagra BCN Farma SL 24/01/2011 100 mg Film-coated tablet 8 EU/1/98/077/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 01/02/2011

Viagra BCN Farma SL 24/01/2011 50 mg Film-coated tablet 4 EU/1/98/077/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 01/02/2011

Viagra BCN Farma SL 24/01/2011 50 mg Film-coated tablet 8 EU/1/98/077/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom

Spain 01/02/2011

Viagra CC Pharma 16/11/2011 25 mg Film-coated tablet 4 EU/1/98/077/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/12/2011

Viagra Emra-Med 11/03/2011 50 mg Film-coated tablet 4 EU/1/98/077/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Viagra Medartuum AB 31/03/2010 50 mg Film-coated tablet 12 EU/1/98/077/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 30/05/2011

Viagra Omnia Läkemedel AB

13/05/2011 50 mg Film-coated tablet 12 EU/1/98/077/008 France, Germany, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Sweden 02/08/2011

Viagra Orifarm AS 29/11/2011 100 mg Film-coated tablet 8 EU/1/98/077/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 219/255

Page 220: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Viagra PCO Manufacturing

19/01/2009 100 mg Film-coated tablet 4 EU/1/98/077/010 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Iceland, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

07/02/2011

Victoza Abacus Medicine A/S

08/04/2011 6 mg/ml Solution for injection in pre-filled pen

3 pre-filled pens

EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/04/2011

Victoza Abacus Medicine A/S

11/05/2011 6 mg/ml Solution for injection in pre-filled pen

1 pre-filled pen

EU/1/09/529/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/06/2011

Victoza Abacus Medicine A/S

19/05/2011 6 mg/ml Solution for injection in pre-filled pen

2 pre-filled pens

EU/1/09/529/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 07/06/2011

Victoza CC Pharma 31/01/2011 6 mg/ml Solution for injection in pre-filled pen

5 pre-filled pens

EU/1/09/529/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/02/2011

Victoza Cross Pharma AB

05/04/2011 6 mg/ml Solution for injection in pre-filled pen

3 pre-filled pens

EU/1/09/529/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 30/05/2011

Victoza Dr Fisher Farma BV

04/05/2011 6 mg/ml Solution for injection in pre-filled pen

2 pre-filled pens

EU/1/09/529/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

10/05/2011

Victoza Medartuum AB 05/12/2011 6 mg/ml Solution for injection in pre-filled pen

3 pre-filled pens

EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 08/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 220/255

Page 221: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Victoza Medcor Pharmaceuticals BV

09/06/2011 6 mg/ml Solution for injection in pre-filled pen

2 pre-filled pens

EU/1/09/529/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/06/2011

Victoza Orifarm AS 07/09/2011 6 mg/ml Solution for injection in pre-filled pen

3 pre-filled pens

EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/09/2011

Victoza Paranova Danmark AS

01/06/2011 6 mg/ml Solution for injection in pre-filled pen

2 pre-filled pens

EU/1/09/529/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/06/2011

Victoza Paranova Danmark AS

01/06/2011 6 mg/ml Solution for injection in pre-filled pen

3 pre-filled pens

EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 30/06/2011

Victoza Paranova Läkemedel AB

03/01/2011 6 mg/ml Solution for injection in pre-filled pen

3 pre-filled pens

EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 07/02/2011

Victoza Paranova OY 25/05/2011 6 mg/ml Solution for injection in pre-filled pen

3 pre-filled pens

EU/1/09/529/003 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Finland 04/07/2011

Victoza PCO Manufacturing

21/03/2011 6 mg/ml Solution for injection in pre-filled pen

2 pre-filled pens

EU/1/09/529/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

07/06/2011

Victoza Pharmachim AB

01/11/2011 6 mg/ml Solution for injection in pre-filled pen

3 pre-filled pens

EU/1/09/529/003 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 11/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 221/255

Page 222: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Victoza Pharmachim AB

01/11/2011 6 mg/ml Solution for injection in pre-filled pen

2 pre-filled pens

EU/1/09/529/002 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands

Sweden 14/11/2011

Victrelis HAEMATO PHARM AG

15/12/2011 200 mg Capsule, hard 336 (4 packs of 84) hard

EU/1/11/704/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/12/2011

Vidaza Abacus Medicine A/S

07/07/2011 25 mg/ml Powder for suspension for injection

1 vial EU/1/08/488/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 22/07/2011

Vidaza Orifarm AB 10/12/2010 25 mg/ml Powder for suspension for injection

1 vial EU/1/08/488/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 03/01/2011

Vimpat Axicorp Pharma GmbH

03/02/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/02/2011

Vimpat Axicorp Pharma GmbH

24/02/2011 100 mg Film-coated tablet 168 EU/1/08/470/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Vimpat Axicorp Pharma GmbH

06/09/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/09/2011

Vimpat B2B Medical GmbH

10/06/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/07/2011

Vimpat B2B Medical GmbH

10/06/2011 100 mg Film-coated tablet 168 EU/1/08/470/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 222/255

Page 223: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Vimpat B2B Medical GmbH

10/06/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/07/2011

Vimpat B2B Medical GmbH

26/09/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/10/2011

Vimpat Beragena Arzneimittel GmbH

02/12/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 19/12/2011

Vimpat BR Pharma International Ltd

06/06/2011 150 mg Film-coated tablet 168 EU/1/08/470/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/06/2011

Vimpat BR Pharma International Ltd

07/06/2011 150 mg Film-coated tablet 56 EU/1/08/470/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/06/2011

Vimpat Doncaster Pharmaceuticals Group Ltd

24/01/2011 150 mg Film-coated tablet 14 EU/1/08/470/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

02/02/2011

Vimpat Doncaster Pharmaceuticals Group Ltd

17/02/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

21/02/2011

Vimpat Doncaster Pharmaceuticals Group Ltd

17/02/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

21/02/2011

Vimpat Dr Fisher Farma BV

03/02/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

19/04/2011

Vimpat Dr Fisher Farma BV

26/10/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

28/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 223/255

Page 224: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Vimpat Emra-Med 14/10/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/12/2011

Vimpat Emra-Med 14/11/2011 150 mg Film-coated tablet 168 EU/1/08/470/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/12/2011

Vimpat Emra-Med 14/11/2011 150 mg Film-coated tablet 56 EU/1/08/470/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/12/2011

Vimpat Emra-Med 14/11/2011 200 mg Film-coated tablet 56 EU/1/08/470/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/12/2011

Vimpat Emra-Med 14/11/2011 200 mg Film-coated tablet 168 EU/1/08/470/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 21/12/2011

Vimpat G-Pharma Ltd 14/02/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

02/03/2011

Vimpat G-Pharma Ltd 14/02/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

02/03/2011

Vimpat G-Pharma Ltd 14/02/2011 150 mg Film-coated tablet 14 EU/1/08/470/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

02/03/2011

Vimpat G-Pharma Ltd 14/02/2011 150 mg Film-coated tablet 56 EU/1/08/470/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

02/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 224/255

Page 225: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Vimpat G-Pharma Ltd 14/02/2011 200 mg Film-coated tablet 56 EU/1/08/470/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

02/03/2011

Vimpat G-Pharma Ltd 14/02/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

02/03/2011

Vimpat Kohlpharma GmbH

10/11/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Belgium, France, Greece, Italy, The Netherlands

Germany 15/11/2011

Vimpat Mevita HandelsGmbH

17/02/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 15/08/2011

Vimpat Mevita HandelsGmbH

17/02/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 15/08/2011

Vimpat Mevita HandelsGmbH

17/02/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 15/08/2011

Vimpat O.P.D. Laboratories Ltd

24/06/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

18/08/2011

Vimpat O.P.D. Laboratories Ltd

24/06/2011 200 mg Film-coated tablet 56 EU/1/08/470/011 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

18/08/2011

Vimpat O.P.D. Laboratories Ltd

24/06/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden

United Kingdom

18/08/2011

Vimpat Swingward Ltd TA Medihealth

27/04/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands

United Kingdom

03/05/2011

Vimpat Veron Pharma Vertriebs GmbH

23/11/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Greece Germany 22/12/2011

Vimpat Veron Pharma Vertriebs GmbH

23/11/2011 100 mg Film-coated tablet 168 EU/1/08/470/006 Austria Germany 22/12/2011

Vimpat Veron Pharma Vertriebs GmbH

23/11/2011 200 mg Film-coated tablet 168 EU/1/08/470/012 Austria Germany 22/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 225/255

Page 226: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Vimpat Veron Pharma Vertriebs GmbH

23/11/2011 200 mg Film-coated tablet 56 EU/1/08/470/011 Austria, Greece Germany 22/12/2011

Vimpat Veron Pharma Vertriebs GmbH

23/11/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 22/12/2011

Vimpat Veron Pharma Vertriebs GmbH

23/11/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Austria Germany 22/12/2011

Vimpat Vital Supplies UK Limited

24/06/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

22/08/2011

Vimpat Vital Supplies UK Limited

24/06/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

22/08/2011

Vimpat Vital Supplies UK Limited

06/10/2011 150 mg Film-coated tablet 56 EU/1/08/470/008 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands

United Kingdom

28/11/2011

Vimpat Waymade PLC 13/07/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

15/07/2011

Vimpat Waymade PLC 13/07/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

15/07/2011

Vimpat Waymade PLC 22/07/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

16/09/2011

Viramune Axicorp Pharma GmbH

17/02/2011 200 mg Tablet 120 EU/1/97/055/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/03/2011

Viramune EU-Pharma BV 10/11/2011 200 mg Tablet 60 EU/1/97/055/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

29/11/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 226/255

Page 227: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Viramune Orifarm OY 24/02/2011 200 mg Tablet 60 EU/1/97/055/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 16/03/2011

Viramune Paranova OY 16/03/2011 200 mg Tablet 60 EU/1/97/055/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 01/04/2011

Viread EuroPharma DK

08/07/2011 245 mg Film-coated tablet 30 EU/1/01/200/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 14/07/2011

Visudyne Orifarm AB 21/07/2011 15 mg Powder for solution for infusion

1 vial EU/1/00/140/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/07/2011

Volibris Haemato Pharm AG

16/02/2011 5 mg Film-coated tablet 30 EU/1/08/451/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

16/03/2011

Volibris Haemato Pharm AG

21/02/2011 10 mg Film-coated tablet 30 EU/1/08/451/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Austria, Germany

16/03/2011

Votrient Emra-Med 30/08/2011 200 mg Film-coated tablet 30 EU/1/10/628/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 227/255

Page 228: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Votrient Emra-Med 30/08/2011 400 mg Film-coated tablet 30 EU/1/10/628/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 14/09/2011

Votrient Orifarm AB 18/11/2011 400 mg Film-coated tablet 60 EU/1/10/628/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 29/11/2011

Votrient Pharma Westen GmbH

29/08/2011 200 mg Film-coated tablet 90 EU/1/10/628/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/09/2011

Votrient Pharma Westen GmbH

07/09/2011 400 mg Film-coated tablet 60 EU/1/10/628/004 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/10/2011

VPRIV CC Pharma GmbH

06/12/2011 400 U Powder for solution for infusion

1 vial EU/1/10/646/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/12/2011

Xagrid 2 Care 4 08/02/2011 0.5 mg Capsule, hard 100 EU/1/04/295/001 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 23/03/2011

Xarelto Abacus Medicine A/S

29/06/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 25/07/2011

Xarelto Abacus Medicine A/S

08/07/2011 10 mg Film-coated tablet 100 x 1 EU/1/08/472/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 25/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 228/255

Page 229: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Xarelto Clear Pharmacy

16/11/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

21/11/2011

Xarelto Clear Pharmacy

16/11/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

22/11/2011

Xarelto Doncaster Pharmaceuticals Group Ltd

05/10/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

12/10/2011

Xarelto Doncaster Pharmaceuticals Group Ltd

05/10/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

12/10/2011

Xarelto Dr Fisher Farma BV

26/08/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

30/08/2011

Xarelto Emra-Med 01/02/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 02/02/2011

Xarelto Emra-Med 01/02/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 03/02/2011

Xarelto EU-Pharma BV 12/07/2011 10 mg Film-coated tablet 30 EU/1/08/472/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

12/07/2011

Xarelto EU-Pharma BV 27/09/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

05/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 229/255

Page 230: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Xarelto Eureco-Pharma B.V.

03/01/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

21/02/2011

Xarelto Eureco-Pharma B.V.

11/10/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/11/2011

Xarelto EuroPharma DK

14/04/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/04/2011

Xarelto EuroPharma DK

14/04/2011 10 mg Film-coated tablet 100 x 1 EU/1/08/472/008 Austria, Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/04/2011

Xarelto EuroPharma DK

14/04/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/04/2011

Xarelto Medcor Pharmaceuticals BV

24/02/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

15/03/2011

Xarelto Medcor Pharmaceuticals BV

26/04/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

03/05/2011

Xeloda Axicorp Pharma GmbH

09/06/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 230/255

Page 231: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Xeloda Dr Fisher Farma BV

09/12/2010 150 mg Film-coated tablet 60 EU/1/00/163/001 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

04/01/2011

Xeloda Inopha GmbH 22/03/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom

The Netherlands

23/03/2011

Xeloda Orifarm AB 01/02/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 03/03/2011

Xeloda Orifarm AS 27/07/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/08/2011

Xeloda Orifarm AS 01/09/2011 150 mg Film-coated tablet 60 EU/1/00/163/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 12/09/2011

Xeloda Pharmachim AB

26/09/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Bulgaria, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 24/10/2011

Xenical 2 Care 4 05/01/2011 120 mg Capsule, hard 42 EU/1/98/071/002 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 13/01/2011

Xenical 2 Care 4 05/01/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Denmark 09/02/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 231/255

Page 232: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Xenical Axicorp Pharma GmbH

23/09/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Luxembourg, Norway, Portugal, Sweden, The Netherlands, United Kingdom

Germany 28/09/2011

Xenical Elpis Ltd. 03/02/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Latvia 08/09/2011

Xenical Mediwin Ltd 12/07/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Italy 01/08/2011

Xenical Parallell Pharma AB

07/02/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom

Sweden 31/03/2011

Xenical Pretium Farm Sp. z o.o.

07/10/2011 120 mg Capsule, hard 42 EU/1/98/071/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 23/11/2011

Xenical Pretium Farm Sp. z o.o.

07/10/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 23/11/2011

Xenical SAIMA Productos Y Servicios S.L.U.

24/04/2011 120 mg Capsule, hard 84 EU/1/98/071/003 United Kingdom Spain 17/05/2011

Xenical STRATHCLYDE PHARMACEUTICALS LTD

21/11/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

01/12/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 232/255

Page 233: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Xeplion CC Pharma 09/11/2011 100 mg Suspension for injection in pre-filled syringe

1 pre-filled syringe + 2 needles

EU/1/11/672/004 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/12/2011

Xeplion CC Pharma 09/11/2011 150 mg Suspension for injection in pre-filled syringe

1 pre-filled syringe + 2 needles

EU/1/11/672/005 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 16/12/2011

Xeristar BR Pharma International Ltd

10/05/2011 60 mg Gastro-resistant capsule, hard

98 EU/1/04/297/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Xeristar CC Pharma 12/04/2011 30 mg Gastro-resistant capsule, hard

28 EU/1/04/297/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/04/2011

Xeristar CC Pharma 12/04/2011 60 mg Gastro-resistant capsule, hard

28 EU/1/04/297/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/04/2011

Xeristar Euro Registratie Collectief BV

12/04/2010 30 mg Gastro-resistant capsule, hard

7 EU/1/04/297/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

01/06/2011

Xeristar Euro Registratie Collectief BV

12/04/2010 60 mg Gastro-resistant capsule, hard

28 EU/1/04/297/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

01/06/2011

Xeristar EuroPharma DK

14/04/2011 30 mg Gastro-resistant capsule, hard

28 EU/1/04/297/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/04/2011

Xeristar EuroPharma DK

14/04/2011 30 mg Gastro-resistant capsule, hard

7 EU/1/04/297/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 26/04/2011

Xeristar MedicoPharm AG

22/10/2010 60 mg Gastro-resistant capsule, hard

98 EU/1/04/297/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 28/03/2011

Xeristar MedicoPharm AG

20/01/2011 30 mg Gastro-resistant capsule, hard

28 EU/1/04/297/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Spain, Sweden, The Netherlands, United Kingdom

Germany 24/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 233/255

Page 234: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Xeristar NewNeopharm BV

18/05/2011 30 mg Gastro-resistant capsule, hard

28 EU/1/04/297/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 15/06/2011

XGEVA Haemato Pharm AG

20/09/2011 120 mg Solution for injection

1 vial EU/1/11/703/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/09/2011

Xolair Abacus Medicine A/S

11/05/2011 150 mg Solution for injection

1 pre-filled syringe

EU/1/05/319/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 27/05/2011

Xolair CC Pharma 23/05/2011 150 mg Solution for injection

1 pre-filled syringe

EU/1/05/319/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

Xolair CC Pharma 23/05/2011 75 mg Solution for injection

1 pre-filled syringe

EU/1/05/319/005 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 27/05/2011

Xolair Dr Fisher Farma BV

09/03/2011 150 mg Powder and solvent for solution for injection

1 vial + 1 ampoule

EU/1/05/319/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

14/03/2011

Xolair Medartuum AB 18/02/2011 150 mg Powder and solvent for solution for injection

1 vial + 1 ampoule

EU/1/05/319/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 14/03/2011

Xolair Orifarm AB 03/01/2011 150 mg Powder and solvent for solution for injection

1 vial + 1 ampoule

EU/1/05/319/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 03/03/2011

Xolair Pharma Westen GmbH

02/03/2011 150 mg Powder and solvent for solution for injection

10 intermediate packs (1 vial + 1 ampoule)

EU/1/05/319/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Sweden, The Netherlands, United Kingdom

Germany 17/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 234/255

Page 235: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Yentreve ADL Pharma GmbH

10/06/2011 40 mg Gastro-resistant capsule, hard

98 EU/1/04/280/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/06/2011

Yentreve ADL Pharma GmbH

10/06/2011 40 mg Gastro-resistant capsule, hard

28 EU/1/04/280/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 28/06/2011

Yentreve ADL Pharma GmbH

24/06/2011 20 mg Gastro-resistant capsule, hard

28 EU/1/04/280/007 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 07/07/2011

Yentreve ADL Pharma GmbH

24/06/2011 20 mg Gastro-resistant capsule, hard

98 EU/1/04/280/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Germany 07/07/2011

Yentreve Axicorp Pharma GmbH

29/08/2011 20 mg Gastro-resistant capsule, hard

98 EU/1/04/280/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/09/2011

Yentreve Axicorp Pharma GmbH

27/09/2011 40 mg Gastro-resistant capsule, hard

98 EU/1/04/280/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/10/2011

Yentreve Veron Pharma Vertriebs GmbH

31/03/2011 20 mg Gastro-resistant capsule, hard

98 EU/1/04/280/008 Austria, Belgium Germany 21/06/2011

Yentreve Veron Pharma Vertriebs GmbH

31/03/2011 20 mg Gastro-resistant capsule, hard

28 EU/1/04/280/007 Austria, Belgium Germany 21/06/2011

Yentreve Veron Pharma Vertriebs GmbH

31/03/2011 40 mg Gastro-resistant capsule, hard

98 EU/1/04/280/004 Austria, Belgium Germany 21/06/2011

Yentreve Veron Pharma Vertriebs GmbH

31/03/2011 40 mg Gastro-resistant capsule, hard

28 EU/1/04/280/002 Austria, Belgium Germany 21/06/2011

Zarzio Medartuum AB 01/07/2011 30 MU (60 MU/ml)

Solution for injection or infusion

5 pre-filled syringes with needle guard

EU/1/08/495/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 06/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 235/255

Page 236: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zarzio Medartuum AB 01/07/2011 48 MU (96 MU/ml)

Solution for injection or infusion

5 pre-filled syringes with needle guard

EU/1/08/495/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom

Sweden 06/07/2011

Zebinix Emra-Med 14/09/2011 800 mg Tablet 30 EU/1/09/514/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/10/2011

Zeffix Delfarma SpZoo

12/08/2011 100 mg Film-coated tablet 28 EU/1/99/114/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Poland 24/08/2011

Zeffix Euro Registratie Collectief BV

14/11/2011 100 mg Film-coated tablet 28 EU/1/99/114/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

17/11/2011

Zeffix MPT Pharma 16/12/2010 100 mg Film-coated tablet 28 EU/1/99/114/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/01/2011

Zeffix MPT Pharma 16/12/2010 100 mg Film-coated tablet 84 EU/1/99/114/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

31/01/2011

Ziagen Orifarm OY 15/03/2011 300 mg Film-coated tablet 60 EU/1/99/112/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Finland 10/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 236/255

Page 237: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zometa Inopha GmbH 08/03/2011 4 mg Concentrate for solution for infusion

1 vial EU/1/01/176/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom

The Netherlands

28/03/2011

Zometa Paranova Danmark AS

13/07/2011 4 mg Powder and solvent for solution for infusion

1 vial + 1 ampoule

EU/1/01/176/001 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/08/2011

Zometa Paranova Läkemedel AB

05/07/2011 4 mg Powder and solvent for solution for infusion

1 vial + 1 ampoule

EU/1/01/176/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom

Sweden 02/08/2011

Zonegran Abacus Medicine A/S

12/04/2011 100 mg Capsule, hard 56 EU/1/04/307/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/04/2011

Zonegran Abacus Medicine A/S

12/04/2011 50 mg Capsule, hard 56 EU/1/04/307/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/04/2011

Zonegran Abacus Medicine A/S

15/06/2011 100 mg Capsule, hard 98 EU/1/04/307/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 22/06/2011

Zonegran B&S Healthcare Ltd

10/05/2011 100 mg Capsule, hard 56 EU/1/04/307/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

30/05/2011

Zonegran Chemilines Ltd 27/04/2010 50 mg Capsule, hard 14 EU/1/04/307/010 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands

Ireland, United Kingdom

04/10/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 237/255

Page 238: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zonegran Mediwin Ltd 04/04/2011 50 mg Capsule, hard 14 EU/1/04/307/010 Austria, Belgium, France, Germany, Greece, Italy, Malta, Portugal, Spain, The Netherlands

United Kingdom

11/05/2011

Zonegran Paranova Danmark AS

20/05/2009 100 mg Capsule, hard 98 EU/1/04/307/007 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 20/07/2011

Zonegran STRATHCLYDE PHARMACEUTICALS LTD

27/09/2011 25 mg Capsule, hard 28 EU/1/04/307/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

24/10/2011

Zonegran STRATHCLYDE PHARMACEUTICALS LTD

27/09/2011 50 mg Capsule, hard 28 EU/1/04/307/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

24/10/2011

Zonegran STRATHCLYDE PHARMACEUTICALS LTD

24/10/2011 25 mg Capsule, hard 14 EU/1/04/307/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

16/11/2011

Zutectra CC Pharma 22/08/2011 500 IU Solution for injection

5 pre-filled syringes

EU/1/09/600/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 23/08/2011

Zypadhera 2 Care 4 30/09/2010 210 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/001 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 238/255

Page 239: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zypadhera 2 Care 4 30/09/2010 300 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/002 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/03/2011

Zypadhera 2 Care 4 30/09/2010 405 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/003 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 10/03/2011

Zypadhera CC Pharma 15/12/2011 300 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 19/12/2011

Zypadhera CC Pharma 15/12/2011 405 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/12/2011

Zypadhera Haemato Pharm AG

26/08/2011 210 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 239/255

Page 240: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zypadhera Haemato Pharm AG

26/08/2011 300 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/09/2011

Zypadhera Haemato Pharm AG

26/08/2011 405 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/09/2011

Zypadhera Kohlpharma GmbH

13/09/2011 300 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/002 Lithuania Germany 05/10/2011

Zypadhera Kohlpharma GmbH

13/09/2011 405 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/003 Lithuania Germany 05/10/2011

Zypadhera Medcor Pharmaceuticals BV

01/06/2011 300 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, United Kingdom

The Netherlands

07/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 240/255

Page 241: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zypadhera Orifarm AS 19/09/2011 300 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/10/2011

Zypadhera Orifarm AS 23/09/2011 405 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/10/2011

Zypadhera Orifarm AS 20/10/2011 210 mg Powder and solvent for prolonged release suspension for injection

1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles

EU/1/08/479/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/11/2011

Zyprexa Abacus Medicine A/S

14/01/2011 7.5 mg Coated tablet 28 EU/1/96/022/011 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Denmark 19/01/2011

Zyprexa ADL Pharma GmbH

30/05/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/07/2011

Zyprexa ADL Pharma GmbH

30/05/2011 5 mg Coated tablet 70 EU/1/96/022/030 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/07/2011

Zyprexa ADL Pharma GmbH

30/05/2011 5 mg Coated tablet 56 EU/1/96/022/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 241/255

Page 242: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa ADL Pharma GmbH

30/05/2011 5 mg Coated tablet 35 EU/1/96/022/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 18/07/2011

Zyprexa BB Farma s.r.l.

14/02/2011 10 mg Coated tablet 28 EU/1/96/022/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/03/2011

Zyprexa BB Farma s.r.l.

14/02/2011 10 mg Coated tablet 56 EU/1/96/022/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/03/2011

Zyprexa BB Farma s.r.l.

14/02/2011 10 mg Coated tablet 35 EU/1/96/022/026 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/03/2011

Zyprexa BB Farma s.r.l.

14/02/2011 10 mg Coated tablet 70 EU/1/96/022/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 09/03/2011

Zyprexa BB Farma s.r.l.

14/02/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/03/2011

Zyprexa BB Farma s.r.l.

14/02/2011 5 mg Coated tablet 56 EU/1/96/022/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 242/255

Page 243: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa BB Farma s.r.l.

14/02/2011 5 mg Coated tablet 35 EU/1/96/022/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/03/2011

Zyprexa BB Farma s.r.l.

14/02/2011 5 mg Coated tablet 70 EU/1/96/022/030 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 10/03/2011

Zyprexa BB Farma s.r.l.

21/02/2011 2.5 mg Coated tablet 28 EU/1/96/022/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/03/2011

Zyprexa BB Farma s.r.l.

21/02/2011 2.5 mg Coated tablet 35 EU/1/96/022/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/03/2011

Zyprexa BB Farma s.r.l.

21/02/2011 2.5 mg Coated tablet 70 EU/1/96/022/029 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/03/2011

Zyprexa BB Farma s.r.l.

21/02/2011 2.5 mg Coated tablet 56 EU/1/96/022/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 11/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 243/255

Page 244: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa BB Farma s.r.l.

10/03/2011 7.5 mg Coated tablet 70 EU/1/96/022/031 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway,Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/03/2011

Zyprexa BB Farma s.r.l.

10/03/2011 7.5 mg Coated tablet 35 EU/1/96/022/025 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/03/2011

Zyprexa BB Farma s.r.l.

10/03/2011 7.5 mg Coated tablet 28 EU/1/96/022/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/03/2011

Zyprexa BB Farma s.r.l.

10/03/2011 7.5 mg Coated tablet 56 EU/1/96/022/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/03/2011

Zyprexa BB Farma s.r.l.

15/03/2011 20 mg Coated tablet 35 EU/1/96/022/028 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Zyprexa BB Farma s.r.l.

15/03/2011 20 mg Coated tablet 70 EU/1/96/022/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 244/255

Page 245: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa BB Farma s.r.l.

15/03/2011 20 mg Coated tablet 28 EU/1/96/022/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Zyprexa BB Farma s.r.l.

15/03/2011 20 mg Coated tablet 56 EU/1/96/022/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/03/2011

Zyprexa CC Pharma 15/08/2011 2.5 mg Coated tablet 98 EU/1/96/022/035 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/08/2011

Zyprexa CC Pharma 16/08/2011 10 mg Coated tablet 98 EU/1/96/022/038 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/08/2011

Zyprexa CC Pharma 16/08/2011 15 mg Coated tablet 98 EU/1/96/022/039 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/08/2011

Zyprexa CC Pharma 16/08/2011 5 mg Coated tablet 98 EU/1/96/022/036 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/08/2011

Zyprexa CC Pharma 16/08/2011 7.5 mg Coated tablet 98 EU/1/96/022/037 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/08/2011

Zyprexa ChemVet Pharma ApS

08/04/2011 7.5 mg Coated tablet 56 EU/1/96/022/006 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/06/2011

Zyprexa ChemVet Pharma ApS

27/07/2011 20 mg Coated tablet 28 EU/1/96/022/014 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 04/08/2011

Zyprexa ChemVet Pharma ApS

28/07/2011 10 mg Coated tablet 28 EU/1/96/022/009 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/08/2011

Zyprexa ChemVet Pharma ApS

28/07/2011 15 mg Coated tablet 28 EU/1/96/022/012 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 05/08/2011

Zyprexa ChemVet Pharma ApS

28/07/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 245/255

Page 246: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa Clear Pharmacy

20/12/2010 2.5 mg Coated tablet 28 EU/1/96/022/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom

Ireland, Malta, United Kingdom

11/01/2011

Zyprexa Docpharm GmbH&CoKGaA

03/05/2011 10 mg Coated tablet 98 EU/1/96/022/038 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Zyprexa Docpharm GmbH&CoKGaA

03/05/2011 15 mg Coated tablet 98 EU/1/96/022/039 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/07/2011

Zyprexa Docpharm GmbH&CoKGaA

03/05/2011 2.5 mg Coated tablet 98 EU/1/96/022/035 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Zyprexa Docpharm GmbH&CoKGaA

03/05/2011 5 mg Coated tablet 98 EU/1/96/022/036 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Zyprexa Docpharm GmbH&CoKGaA

03/05/2011 7.5 mg Coated tablet 98 EU/1/96/022/037 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 06/07/2011

Zyprexa Kohlpharma GmbH

19/05/2011 10 mg Coated tablet 98 EU/1/96/022/038 Finland, France, Greece, Italy, Norway, Spain, The Netherlands, United Kingdom

Germany 22/06/2011

Zyprexa Kohlpharma GmbH

19/05/2011 5 mg Coated tablet 98 EU/1/96/022/036 Finland, France, Greece, Italy, Norway, Spain, The Netherlands, United Kingdom

Germany 22/06/2011

Zyprexa Kohlpharma GmbH

01/09/2011 2.5 mg Coated tablet 56 EU/1/96/022/019 Austria, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 29/09/2011

Zyprexa Kohlpharma GmbH

01/09/2011 2.5 mg Coated tablet 98 EU/1/96/022/035 Austria, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 29/09/2011

Zyprexa Kohlpharma GmbH

01/09/2011 7.5 mg Coated tablet 98 EU/1/96/022/037 Finland, France, Greece, Spain, United Kingdom

Germany 29/09/2011

Zyprexa Kohlpharma GmbH

22/09/2011 15 mg Coated tablet 98 EU/1/96/022/039 Austria, Greece, The Netherlands, United Kingdom

Germany 29/09/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 246/255

Page 247: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa MPT Pharma 09/06/2011 10 mg Coated tablet 28 EU/1/96/022/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

29/06/2011

Zyprexa MPT Pharma 09/06/2011 10 mg Coated tablet 56 EU/1/96/022/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

29/06/2011

Zyprexa MPT Pharma 09/06/2011 15 mg Coated tablet 28 EU/1/96/022/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

27/06/2011

Zyprexa MPT Pharma 09/06/2011 2.5 mg Coated tablet 28 EU/1/96/022/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

27/06/2011

Zyprexa MPT Pharma 09/06/2011 20 mg Coated tablet 28 EU/1/96/022/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

27/06/2011

Zyprexa MPT Pharma 09/06/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

27/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 247/255

Page 248: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa MPT Pharma 09/06/2011 7.5 mg Coated tablet 56 EU/1/96/022/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

29/06/2011

Zyprexa MPT Pharma 09/06/2011 7.5 mg Coated tablet 28 EU/1/96/022/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

29/06/2011

Zyprexa Omnia Läkemedel AB

14/06/2011 5 mg Coated tablet 28 EU/1/96/022/004 Belgium, France, Greece, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 26/08/2011

Zyprexa Omnia Läkemedel AB

15/06/2011 10 mg Coated tablet 56 EU/1/96/022/010 Belgium, France, Greece, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom

Sweden 17/08/2011

Zyprexa Pharma Westen GmbH

14/03/2011 15 mg Coated tablet 98 EU/1/96/022/039 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/04/2011

Zyprexa Pharma Westen GmbH

14/03/2011 2.5 mg Coated tablet 98 EU/1/96/022/035 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/04/2011

Zyprexa Pharma Westen GmbH

14/03/2011 5 mg Coated tablet 98 EU/1/96/022/036 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 07/04/2011

Zyprexa PI-Pharma N.V.

06/01/2011 10 mg Coated tablet 28 EU/1/96/022/009 Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Belgium 08/03/2011

Zyprexa PI-Pharma N.V.

06/01/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Belgium 08/03/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 248/255

Page 249: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa Propharmed GmbH

27/04/2011 15 mg Coated tablet 35 EU/1/96/022/027 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Zyprexa Propharmed GmbH

27/04/2011 15 mg Coated tablet 70 EU/1/96/022/033 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Zyprexa Propharmed GmbH

27/04/2011 2.5 mg Coated tablet 35 EU/1/96/022/023 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Zyprexa Propharmed GmbH

27/04/2011 2.5 mg Coated tablet 70 EU/1/96/022/029 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Zyprexa Propharmed GmbH

27/04/2011 20 mg Coated tablet 35 EU/1/96/022/028 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Zyprexa Propharmed GmbH

27/04/2011 5 mg Coated tablet 35 EU/1/96/022/024 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Zyprexa Propharmed GmbH

27/04/2011 7.5 mg Coated tablet 70 EU/1/96/022/031 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Zyprexa Propharmed GmbH

28/04/2011 5 mg Coated tablet 70 EU/1/96/022/030 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/05/2011

Zyprexa Propharmed GmbH

28/06/2011 10 mg Coated tablet 35 EU/1/96/022/026 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/08/2011

Zyprexa Propharmed GmbH

28/06/2011 10 mg Coated tablet 70 EU/1/96/022/032 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/08/2011

Zyprexa Velotab ADL Pharma GmbH

18/05/2011 10 mg Orodispersible tablet

28 EU/1/99/125/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/07/2011

Zyprexa Velotab ADL Pharma GmbH

18/05/2011 10 mg Orodispersible tablet

35 EU/1/99/125/010 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/07/2011

Zyprexa Velotab ADL Pharma GmbH

18/05/2011 10 mg Orodispersible tablet

56 EU/1/99/125/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/07/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 249/255

Page 250: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa Velotab ADL Pharma GmbH

18/05/2011 10 mg Orodispersible tablet

70 EU/1/99/125/014 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 04/07/2011

Zyprexa Velotab ADL Pharma GmbH

18/05/2011 20 mg Orodispersible tablet

28 EU/1/99/125/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/07/2011

Zyprexa Velotab ADL Pharma GmbH

18/05/2011 20 mg Orodispersible tablet

35 EU/1/99/125/012 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/07/2011

Zyprexa Velotab ADL Pharma GmbH

18/05/2011 20 mg Orodispersible tablet

56 EU/1/99/125/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/07/2011

Zyprexa Velotab ADL Pharma GmbH

18/05/2011 20 mg Orodispersible tablet

70 EU/1/99/125/016 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 12/07/2011

Zyprexa Velotab BB Farma s.r.l.

06/04/2011 5 mg Orodispersible tablet

28 EU/1/99/125/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

Zyprexa Velotab BB Farma s.r.l.

06/04/2011 5 mg Orodispersible tablet

35 EU/1/99/125/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

Zyprexa Velotab BB Farma s.r.l.

06/04/2011 5 mg Orodispersible tablet

56 EU/1/99/125/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 250/255

Page 251: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa Velotab BB Farma s.r.l.

06/04/2011 5 mg Orodispersible tablet

70 EU/1/99/125/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 15/04/2011

Zyprexa Velotab BB Farma s.r.l.

26/04/2011 10 mg Orodispersible tablet

28 EU/1/99/125/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/05/2011

Zyprexa Velotab BB Farma s.r.l.

26/04/2011 10 mg Orodispersible tablet

35 EU/1/99/125/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/05/2011

Zyprexa Velotab BB Farma s.r.l.

26/04/2011 10 mg Orodispersible tablet

56 EU/1/99/125/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/05/2011

Zyprexa Velotab BB Farma s.r.l.

26/04/2011 10 mg Orodispersible tablet

70 EU/1/99/125/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/05/2011

Zyprexa Velotab BB Farma s.r.l.

28/04/2011 15 mg Orodispersible tablet

28 EU/1/99/125/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/05/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 251/255

Page 252: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa Velotab BB Farma s.r.l.

28/04/2011 15 mg Orodispersible tablet

35 EU/1/99/125/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/05/2011

Zyprexa Velotab BB Farma s.r.l.

28/04/2011 15 mg Orodispersible tablet

56 EU/1/99/125/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/05/2011

Zyprexa Velotab BB Farma s.r.l.

28/04/2011 15 mg Orodispersible tablet

70 EU/1/99/125/015 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 13/05/2011

Zyprexa Velotab CC Pharma 16/08/2011 10 mg Orodispersible tablet

98 EU/1/99/125/018 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/08/2011

Zyprexa Velotab CC Pharma 16/08/2011 15 mg Orodispersible tablet

98 EU/1/99/125/019 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/08/2011

Zyprexa Velotab CC Pharma 16/08/2011 20 mg Orodispersible tablet

98 EU/1/99/125/020 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/08/2011

Zyprexa Velotab CC Pharma 16/08/2011 5 mg Orodispersible tablet

98 EU/1/99/125/017 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/08/2011

Zyprexa Velotab ChemVet Pharma ApS

29/07/2011 10 mg Orodispersible tablet

28 EU/1/99/125/002 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/08/2011

Zyprexa Velotab ChemVet Pharma ApS

29/07/2011 15 mg Orodispersible tablet

28 EU/1/99/125/003 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 17/08/2011

Zyprexa Velotab ChemVet Pharma ApS

29/07/2011 20 mg Orodispersible tablet

28 EU/1/99/125/004 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 18/08/2011

Zyprexa Velotab ChemVet Pharma ApS

29/07/2011 5 mg Orodispersible tablet

28 EU/1/99/125/001 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Denmark 16/08/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 252/255

Page 253: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa Velotab Docpharm GmbH&CoKGaA

03/05/2011 10 mg Orodispersible tablet

98 EU/1/99/125/018 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/05/2011

Zyprexa Velotab Docpharm GmbH&CoKGaA

03/05/2011 15 mg Orodispersible tablet

98 EU/1/99/125/019 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Zyprexa Velotab Docpharm GmbH&CoKGaA

03/05/2011 20 mg Orodispersible tablet

98 EU/1/99/125/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 17/05/2011

Zyprexa Velotab Docpharm GmbH&CoKGaA

03/05/2011 5 mg Orodispersible tablet

98 EU/1/99/125/017 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 25/05/2011

Zyprexa Velotab Emra-Med 07/06/2011 10 mg Orodispersible tablet

98 EU/1/99/125/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 20/06/2011

Zyprexa Velotab Emra-Med 25/11/2011 5 mg Orodispersible tablet

98 EU/1/99/125/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 30/11/2011

Zyprexa Velotab Interport Ltd 07/03/2011 20 mg Orodispersible tablet

28 EU/1/99/125/004 Austria, Belgium, France, Germany, Greece, Italy, Portugal, Spain, The Netherlands

United Kingdom

10/03/2011

Zyprexa Velotab Kohlpharma GmbH

29/03/2011 10 mg Orodispersible tablet

98 EU/1/99/125/018 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 27/04/2011

Zyprexa Velotab Kohlpharma GmbH

19/05/2011 15 mg Orodispersible tablet

98 EU/1/99/125/019 Greece, Spain, The Netherlands, United Kingdom

Germany 22/06/2011

Zyprexa Velotab Kohlpharma GmbH

19/05/2011 20 mg Orodispersible tablet

98 EU/1/99/125/020 Greece, The Netherlands, United Kingdom Germany 22/06/2011

Zyprexa Velotab Kohlpharma GmbH

19/05/2011 5 mg Orodispersible tablet

98 EU/1/99/125/017 France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom

Germany 22/06/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 253/255

Page 254: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Zyprexa Velotab MPT Pharma 20/06/2011 10 mg Orodispersible tablet

28 EU/1/99/125/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

30/06/2011

Zyprexa Velotab MPT Pharma 20/06/2011 10 mg Orodispersible tablet

56 EU/1/99/125/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

30/06/2011

Zyprexa Velotab MPT Pharma 20/06/2011 15 mg Orodispersible tablet

28 EU/1/99/125/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

30/06/2011

Zyprexa Velotab MPT Pharma 20/06/2011 20 mg Orodispersible tablet

28 EU/1/99/125/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

30/06/2011

Zyprexa Velotab MPT Pharma 20/06/2011 5 mg Orodispersible tablet

28 EU/1/99/125/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Ireland, United Kingdom

30/06/2011

Zyprexa Velotab Pharma Westen GmbH

14/03/2011 10 mg Orodispersible tablet

98 EU/1/99/125/018 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/04/2011

Zyprexa Velotab Pharma Westen GmbH

14/03/2011 15 mg Orodispersible tablet

98 EU/1/99/125/019 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/04/2011

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 254/255

Page 255: 04 October 2012 EMA/643088/2012 Initial Notices for ... · 04 October 2012 . EMA/643088/2012 ... Pharma ADL GmbH . 18/05/2011 ; 5 mg . Tablet ; 28 x 1 . EU/1/04/276/002 ; ... Oral

Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 255/255

zyprexa velotab Pharma Westen GmbH

18/04/2011 5 mg Orodispersible tablet

98 EU/1/99/125/017 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom

Germany 24/05/2011

Zyprexa Velotab Propharmed GmbH

29/06/2011 10 mg Orodispersible tablet

70 EU/1/99/125/014 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 08/07/2011

Zyprexa Velotab Propharmed GmbH

01/07/2011 10 mg Orodispersible tablet

35 EU/1/99/125/010 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 22/07/2011

Zyprexa Velotab Propharmed GmbH

08/07/2011 15 mg Orodispersible tablet

35 EU/1/99/125/011 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/07/2011

Zyprexa Velotab Propharmed GmbH

08/07/2011 15 mg Orodispersible tablet

70 EU/1/99/125/015 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/07/2011

Zyprexa Velotab Propharmed GmbH

11/07/2011 5 mg Orodispersible tablet

35 EU/1/99/125/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom

Germany 26/07/2011

Zytiga Haemato Pharm AG

25/11/2011 250 mg Tablet 120 EU/1/11/714/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom

Germany 29/11/2011